<?xml version="1.0" encoding="UTF-8" ?>
<!-- This is a WordPress eXtended RSS file generated by WordPress as an export of your site. -->
<!-- It contains information about your site's posts, pages, comments, categories, and other content. -->
<!-- You may use this file to transfer that content from one site to another. -->
<!-- This file is not intended to serve as a complete backup of your site. -->

<!-- To import this information into a WordPress site follow these steps: -->
<!-- 1. Log in to that site as an administrator. -->
<!-- 2. Go to Tools: Import in the WordPress admin panel. -->
<!-- 3. Install the "WordPress" importer from the list. -->
<!-- 4. Activate & Run Importer. -->
<!-- 5. Upload this file using the form provided on that page. -->
<!-- 6. You will first be asked to map the authors in this export file to users -->
<!--    on the site. For each author, you may choose to map to an -->
<!--    existing user on the site or to create a new user. -->
<!-- 7. WordPress will then import each of the posts, pages, comments, categories, etc. -->
<!--    contained in this file into your site. -->

<!-- generator="WordPress/3.8.5" created="2015-03-10 17:14" -->
<rss version="2.0"
	xmlns:excerpt="http://wordpress.org/export/1.2/excerpt/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:wp="http://wordpress.org/export/1.2/"
>

<channel>
	<title>Prion Alliance</title>
	<link>http://www.prionalliance.org</link>
	<description>Not if, when.</description>
	<pubDate>Tue, 10 Mar 2015 17:14:11 +0000</pubDate>
	<language>en-US</language>
	<wp:wxr_version>1.2</wp:wxr_version>
	<wp:base_site_url>http://www.prionalliance.org</wp:base_site_url>
	<wp:base_blog_url>http://www.prionalliance.org</wp:base_blog_url>

	<wp:author><wp:author_id>1</wp:author_id><wp:author_login>admin</wp:author_login><wp:author_email>prionalliance@gmail.com</wp:author_email><wp:author_display_name><![CDATA[admin]]></wp:author_display_name><wp:author_first_name><![CDATA[]]></wp:author_first_name><wp:author_last_name><![CDATA[]]></wp:author_last_name></wp:author>
	<wp:author><wp:author_id>2</wp:author_id><wp:author_login>sonia</wp:author_login><wp:author_email>sonia.vallabh@gmail.com</wp:author_email><wp:author_display_name><![CDATA[sonia]]></wp:author_display_name><wp:author_first_name><![CDATA[Sonia]]></wp:author_first_name><wp:author_last_name><![CDATA[Vallabh]]></wp:author_last_name></wp:author>
	<wp:author><wp:author_id>3</wp:author_id><wp:author_login>eric</wp:author_login><wp:author_email>ericminikel@gmail.com</wp:author_email><wp:author_display_name><![CDATA[Eric Minikel]]></wp:author_display_name><wp:author_first_name><![CDATA[Eric]]></wp:author_first_name><wp:author_last_name><![CDATA[Minikel]]></wp:author_last_name></wp:author>

	<wp:category><wp:term_id>4</wp:term_id><wp:category_nicename>faq</wp:category_nicename><wp:category_parent></wp:category_parent><wp:cat_name><![CDATA[FAQ]]></wp:cat_name></wp:category>
	<wp:category><wp:term_id>1</wp:term_id><wp:category_nicename>uncategorized</wp:category_nicename><wp:category_parent></wp:category_parent><wp:cat_name><![CDATA[Uncategorized]]></wp:cat_name></wp:category>
	<wp:term><wp:term_id>3</wp:term_id><wp:term_taxonomy>nav_menu</wp:term_taxonomy><wp:term_slug>the-menu</wp:term_slug><wp:term_name><![CDATA[The Menu]]></wp:term_name></wp:term>

	<generator>http://wordpress.org/?v=3.8.5</generator>

	<item>
				<title>prnp-correlates.png</title>
		<link>http://www.prionalliance.org/?attachment_id=11</link>
		<pubDate>Sun, 07 Oct 2012 16:25:56 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/wp-content/uploads/2012/10/prnp-correlates.png</guid>
		<description></description>
		<contentencoded><![CDATA[http://69.195.124.66/~prionall/wp-content/uploads/2012/10/prnp-correlates.png]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>11</wp:post_id>
		<wppost_date>2012-10-07 16:25:56</wppost_date>
		<wppost_date_gmt>2012-10-07 16:25:56</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>open</wp:ping_status>
		<wp:post_name>prnp-correlates-png</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/10/prnp-correlates.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/10/prnp-correlates.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"965";s:6:"height";s:3:"147";s:14:"hwstring_small";s:23:"height='19' width='128'";s:4:"file";s:27:"2012/10/prnp-correlates.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:27:"prnp-correlates-150x147.png";s:5:"width";s:3:"150";s:6:"height";s:3:"147";}s:6:"medium";a:3:{s:4:"file";s:26:"prnp-correlates-300x45.png";s:5:"width";s:3:"300";s:6:"height";s:2:"45";}s:13:"small-feature";a:3:{s:4:"file";s:26:"prnp-correlates-500x76.png";s:5:"width";s:3:"500";s:6:"height";s:2:"76";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_context</wp:meta_key>
			<wp:meta_value><![CDATA[custom-header]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_is_custom_header</wp:meta_key>
			<wp:meta_value><![CDATA[twentyeleven]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>paypal</title>
		<link>http://www.prionalliance.org/donate/paypal/</link>
		<pubDate>Tue, 06 Nov 2012 20:47:54 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/wp-content/uploads/2012/11/paypal.gif</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>96</wp:post_id>
		<wppost_date>2012-11-06 20:47:54</wppost_date>
		<wppost_date_gmt>2012-11-06 20:47:54</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>paypal</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>74</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/paypal.gif</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/paypal.gif]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"200";s:6:"height";s:2:"50";s:14:"hwstring_small";s:23:"height='32' width='128'";s:4:"file";s:18:"2012/11/paypal.gif";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:17:"paypal-150x50.gif";s:5:"width";s:3:"150";s:6:"height";s:2:"50";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>sonia</title>
		<link>http://www.prionalliance.org/people/sonia/</link>
		<pubDate>Sat, 10 Nov 2012 22:58:26 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/wp-content/uploads/2012/11/sonia.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>108</wp:post_id>
		<wppost_date>2012-11-10 22:58:26</wppost_date>
		<wppost_date_gmt>2012-11-10 22:58:26</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>sonia</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/sonia.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/sonia.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"134";s:6:"height";s:3:"136";s:14:"hwstring_small";s:22:"height='96' width='94'";s:4:"file";s:17:"2012/11/sonia.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>eric</title>
		<link>http://www.prionalliance.org/people/eric/</link>
		<pubDate>Sat, 10 Nov 2012 22:58:41 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/wp-content/uploads/2012/11/eric.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>109</wp:post_id>
		<wppost_date>2012-11-10 22:58:41</wppost_date>
		<wppost_date_gmt>2012-11-10 22:58:41</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>eric</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/eric.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/eric.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"134";s:6:"height";s:3:"137";s:14:"hwstring_small";s:22:"height='96' width='93'";s:4:"file";s:16:"2012/11/eric.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>greta</title>
		<link>http://www.prionalliance.org/people/greta/</link>
		<pubDate>Sat, 10 Nov 2012 22:58:54 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/wp-content/uploads/2012/11/greta.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>110</wp:post_id>
		<wppost_date>2012-11-10 22:58:54</wppost_date>
		<wppost_date_gmt>2012-11-10 22:58:54</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>greta</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/greta.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/greta.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"135";s:6:"height";s:3:"133";s:14:"hwstring_small";s:22:"height='96' width='97'";s:4:"file";s:17:"2012/11/greta.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>eric-minikel</title>
		<link>http://www.prionalliance.org/people/eric-minikel/</link>
		<pubDate>Mon, 12 Nov 2012 03:15:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/wp-content/uploads/2012/11/eric-minikel.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>140</wp:post_id>
		<wppost_date>2012-11-12 03:15:00</wppost_date>
		<wppost_date_gmt>2012-11-12 03:15:00</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>eric-minikel</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/eric-minikel.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/eric-minikel.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"294";s:6:"height";s:3:"361";s:14:"hwstring_small";s:22:"height='96' width='78'";s:4:"file";s:24:"2012/11/eric-minikel.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:24:"eric-minikel-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:24:"eric-minikel-244x300.jpg";s:5:"width";s:3:"244";s:6:"height";s:3:"300";}s:14:"post-thumbnail";a:3:{s:4:"file";s:24:"eric-minikel-294x288.jpg";s:5:"width";s:3:"294";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:24:"eric-minikel-294x288.jpg";s:5:"width";s:3:"294";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:24:"eric-minikel-244x300.jpg";s:5:"width";s:3:"244";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:4:"Eric";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1352672070";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>sonia-vallabh</title>
		<link>http://www.prionalliance.org/people/sonia-vallabh/</link>
		<pubDate>Mon, 12 Nov 2012 03:15:16 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/wp-content/uploads/2012/11/sonia-vallabh.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>141</wp:post_id>
		<wppost_date>2012-11-12 03:15:16</wppost_date>
		<wppost_date_gmt>2012-11-12 03:15:16</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>sonia-vallabh</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/sonia-vallabh.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/sonia-vallabh.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"328";s:6:"height";s:3:"423";s:14:"hwstring_small";s:22:"height='96' width='74'";s:4:"file";s:25:"2012/11/sonia-vallabh.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:25:"sonia-vallabh-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:25:"sonia-vallabh-232x300.jpg";s:5:"width";s:3:"232";s:6:"height";s:3:"300";}s:14:"post-thumbnail";a:3:{s:4:"file";s:25:"sonia-vallabh-328x288.jpg";s:5:"width";s:3:"328";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:25:"sonia-vallabh-328x288.jpg";s:5:"width";s:3:"328";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:25:"sonia-vallabh-232x300.jpg";s:5:"width";s:3:"232";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:4:"Eric";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>shawn grover</title>
		<link>http://www.prionalliance.org/people/shawn/</link>
		<pubDate>Mon, 12 Nov 2012 18:29:23 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2012/11/shawn.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>153</wp:post_id>
		<wppost_date>2012-11-12 18:29:23</wppost_date>
		<wppost_date_gmt>2012-11-12 18:29:23</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>open</wp:ping_status>
		<wp:post_name>shawn</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/shawn.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/shawn.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"148";s:6:"height";s:3:"178";s:14:"hwstring_small";s:22:"height='96' width='79'";s:4:"file";s:17:"2012/11/shawn.jpg";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:17:"shawn-148x150.jpg";s:5:"width";s:3:"148";s:6:"height";s:3:"150";}}s:10:"image_meta";a:10:{s:8:"aperture";s:2:"13";s:6:"credit";s:0:"";s:6:"camera";s:9:"NIKON D90";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1323170772";s:9:"copyright";s:0:"";s:12:"focal_length";s:2:"60";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:5:"0.008";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>in</title>
		<link>http://www.prionalliance.org/people/in/</link>
		<pubDate>Mon, 12 Nov 2012 18:56:35 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2012/11/in.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>163</wp:post_id>
		<wppost_date>2012-11-12 18:56:35</wppost_date>
		<wppost_date_gmt>2012-11-12 18:56:35</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>open</wp:ping_status>
		<wp:post_name>in</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/in.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/in.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"16";s:6:"height";s:2:"16";s:14:"hwstring_small";s:22:"height='16' width='16'";s:4:"file";s:14:"2012/11/in.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>progress-favicon</title>
		<link>http://www.prionalliance.org/?attachment_id=172</link>
		<pubDate>Mon, 19 Nov 2012 18:53:59 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2012/11/progress-favicon.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>172</wp:post_id>
		<wppost_date>2012-11-19 18:53:59</wppost_date>
		<wppost_date_gmt>2012-11-19 18:53:59</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>open</wp:ping_status>
		<wp:post_name>progress-favicon</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/progress-favicon.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/progress-favicon.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"16";s:6:"height";s:2:"16";s:14:"hwstring_small";s:22:"height='16' width='16'";s:4:"file";s:28:"2012/11/progress-favicon.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>stephen-steiner</title>
		<link>http://www.prionalliance.org/people/stephen-steiner/</link>
		<pubDate>Fri, 30 Nov 2012 22:34:06 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2012/11/stephen-steiner.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>188</wp:post_id>
		<wppost_date>2012-11-30 22:34:06</wppost_date>
		<wppost_date_gmt>2012-11-30 22:34:06</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>open</wp:ping_status>
		<wp:post_name>stephen-steiner</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>104</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/11/stephen-steiner.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/11/stephen-steiner.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"139";s:6:"height";s:3:"174";s:14:"hwstring_small";s:22:"height='96' width='76'";s:4:"file";s:27:"2012/11/stephen-steiner.jpg";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:27:"stephen-steiner-139x150.jpg";s:5:"width";s:3:"139";s:6:"height";s:3:"150";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:4:"Eric";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1354296789";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>our view of human history</title>
		<link>http://www.prionalliance.org/?attachment_id=228</link>
		<pubDate>Fri, 21 Dec 2012 20:20:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>228</wp:post_id>
		<wppost_date>2012-12-21 20:20:00</wppost_date>
		<wppost_date_gmt>2012-12-21 20:20:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-the-future</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>227</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/12/prion-alliance-the-future.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"212";s:6:"height";s:3:"204";s:14:"hwstring_small";s:22:"height='96' width='99'";s:4:"file";s:37:"2012/12/prion-alliance-the-future.png";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:37:"prion-alliance-the-future-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>prion-alliance-the-future</title>
		<link>http://www.prionalliance.org/2012/12/22/20-of-the-way-there/prion-alliance-the-future-2/</link>
		<pubDate>Sat, 22 Dec 2012 04:48:53 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future1.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>234</wp:post_id>
		<wppost_date>2012-12-22 04:48:53</wppost_date>
		<wppost_date_gmt>2012-12-22 04:48:53</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-the-future-2</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>233</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future1.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/12/prion-alliance-the-future1.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"227";s:6:"height";s:3:"227";s:14:"hwstring_small";s:22:"height='96' width='96'";s:4:"file";s:38:"2012/12/prion-alliance-the-future1.png";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:38:"prion-alliance-the-future1-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>IMG_20130122_151554</title>
		<link>http://www.prionalliance.org/?attachment_id=263</link>
		<pubDate>Tue, 22 Jan 2013 21:33:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2012/10/IMG_20130122_151554.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>263</wp:post_id>
		<wppost_date>2013-01-22 21:33:52</wppost_date>
		<wppost_date_gmt>2013-01-22 21:33:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>img_20130122_151554</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2012/10/IMG_20130122_151554.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2012/10/IMG_20130122_151554.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"1280";s:6:"height";s:3:"960";s:14:"hwstring_small";s:23:"height='96' width='128'";s:4:"file";s:31:"2012/10/IMG_20130122_151554.jpg";s:5:"sizes";a:6:{s:9:"thumbnail";a:3:{s:4:"file";s:31:"IMG_20130122_151554-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:31:"IMG_20130122_151554-300x225.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"225";}s:5:"large";a:3:{s:4:"file";s:32:"IMG_20130122_151554-1024x768.jpg";s:5:"width";s:4:"1024";s:6:"height";s:3:"768";}s:14:"post-thumbnail";a:3:{s:4:"file";s:32:"IMG_20130122_151554-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:32:"IMG_20130122_151554-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:31:"IMG_20130122_151554-400x300.jpg";s:5:"width";s:3:"400";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"3";s:6:"credit";s:0:"";s:6:"camera";s:12:"Galaxy Nexus";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1358867754";s:9:"copyright";s:0:"";s:12:"focal_length";s:4:"1.95";s:3:"iso";s:3:"100";s:13:"shutter_speed";s:8:"0.009982";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Vote for us to win the Rare Disease Challenge</title>
		<link>http://www.prionalliance.org/2013/02/28/vote-for-us-to-win-the-rare-disease-challenge/prion-alliance-1/</link>
		<pubDate>Thu, 28 Feb 2013 17:42:05 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/02/prion-alliance-1.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>293</wp:post_id>
		<wppost_date>2013-02-28 17:42:05</wppost_date>
		<wppost_date_gmt>2013-02-28 17:42:05</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-1</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>287</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/02/prion-alliance-1.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/02/prion-alliance-1.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"885";s:6:"height";s:3:"767";s:14:"hwstring_small";s:23:"height='96' width='110'";s:4:"file";s:28:"2013/02/prion-alliance-1.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:28:"prion-alliance-1-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:28:"prion-alliance-1-300x260.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"260";}s:14:"post-thumbnail";a:3:{s:4:"file";s:28:"prion-alliance-1-885x288.jpg";s:5:"width";s:3:"885";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:28:"prion-alliance-1-885x288.jpg";s:5:"width";s:3:"885";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:28:"prion-alliance-1-346x300.jpg";s:5:"width";s:3:"346";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"3";s:6:"credit";s:0:"";s:6:"camera";s:12:"Galaxy Nexus";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1361531503";s:9:"copyright";s:0:"";s:12:"focal_length";s:4:"1.95";s:3:"iso";s:2:"64";s:13:"shutter_speed";s:8:"0.007564";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>rare-disease-challenge-final-counts</title>
		<link>http://www.prionalliance.org/2013/03/15/rare-disease-challenge-recap-no-10k-but-plenty-of-other-good-things/rare-disease-challenge-final-counts/</link>
		<pubDate>Fri, 15 Mar 2013 17:22:44 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/03/rare-disease-challenge-final-counts.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>300</wp:post_id>
		<wppost_date>2013-03-15 17:22:44</wppost_date>
		<wppost_date_gmt>2013-03-15 17:22:44</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>rare-disease-challenge-final-counts</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>299</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/03/rare-disease-challenge-final-counts.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/03/rare-disease-challenge-final-counts.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"688";s:6:"height";s:3:"490";s:14:"hwstring_small";s:23:"height='91' width='128'";s:4:"file";s:47:"2013/03/rare-disease-challenge-final-counts.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:47:"rare-disease-challenge-final-counts-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:47:"rare-disease-challenge-final-counts-300x213.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"213";}s:14:"post-thumbnail";a:3:{s:4:"file";s:47:"rare-disease-challenge-final-counts-688x288.jpg";s:5:"width";s:3:"688";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:47:"rare-disease-challenge-final-counts-688x288.jpg";s:5:"width";s:3:"688";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:47:"rare-disease-challenge-final-counts-421x300.jpg";s:5:"width";s:3:"421";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:4:"Eric";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1363353723";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>get2013</title>
		<link>http://www.prionalliance.org/2013/04/26/reflections-on-the-get2013-conference/get2013/</link>
		<pubDate>Fri, 26 Apr 2013 15:01:05 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/04/get2013.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>309</wp:post_id>
		<wppost_date>2013-04-26 15:01:05</wppost_date>
		<wppost_date_gmt>2013-04-26 15:01:05</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>get2013</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>307</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/04/get2013.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/04/get2013.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"288";s:6:"height";s:3:"249";s:14:"hwstring_small";s:23:"height='96' width='111'";s:4:"file";s:19:"2013/04/get2013.png";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:19:"get2013-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>get2013conf</title>
		<link>http://www.prionalliance.org/2013/04/26/reflections-on-the-get2013-conference/get2013conf/</link>
		<pubDate>Fri, 26 Apr 2013 15:03:37 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/04/get2013conf.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>310</wp:post_id>
		<wppost_date>2013-04-26 15:03:37</wppost_date>
		<wppost_date_gmt>2013-04-26 15:03:37</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>get2013conf</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>307</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/04/get2013conf.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/04/get2013conf.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"294";s:6:"height";s:3:"170";s:14:"hwstring_small";s:23:"height='74' width='128'";s:4:"file";s:23:"2013/04/get2013conf.png";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:23:"get2013conf-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>pinker</title>
		<link>http://www.prionalliance.org/2013/04/26/reflections-on-the-get2013-conference/pinker/</link>
		<pubDate>Sun, 05 May 2013 14:00:50 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/04/pinker.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>319</wp:post_id>
		<wppost_date>2013-05-05 14:00:50</wppost_date>
		<wppost_date_gmt>2013-05-05 14:00:50</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>pinker</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>307</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/04/pinker.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/04/pinker.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"401";s:6:"height";s:3:"261";s:14:"hwstring_small";s:23:"height='83' width='128'";s:4:"file";s:18:"2013/04/pinker.png";s:5:"sizes";a:2:{s:9:"thumbnail";a:3:{s:4:"file";s:18:"pinker-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:18:"pinker-300x195.png";s:5:"width";s:3:"300";s:6:"height";s:3:"195";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>hdbuzz</title>
		<link>http://www.prionalliance.org/2013/04/26/reflections-on-the-get2013-conference/hdbuzz/</link>
		<pubDate>Sun, 05 May 2013 14:01:38 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/04/hdbuzz.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>320</wp:post_id>
		<wppost_date>2013-05-05 14:01:38</wppost_date>
		<wppost_date_gmt>2013-05-05 14:01:38</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>hdbuzz</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>307</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/04/hdbuzz.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/04/hdbuzz.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"400";s:6:"height";s:3:"260";s:14:"hwstring_small";s:23:"height='83' width='128'";s:4:"file";s:18:"2013/04/hdbuzz.png";s:5:"sizes";a:2:{s:9:"thumbnail";a:3:{s:4:"file";s:18:"hdbuzz-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:18:"hdbuzz-300x195.png";s:5:"width";s:3:"300";s:6:"height";s:3:"195";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>96-well-plate-600px</title>
		<link>http://www.prionalliance.org/2013/05/07/no-effective-therapy-yet-but-lots-to-be-optimistic-about/96-well-plate-600px/</link>
		<pubDate>Tue, 07 May 2013 18:19:16 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/05/96-well-plate-600px.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[A 96-well plate. In high-throughput screening, robotics are used to test hundreds of plates like these full of different chemical compounds.]]></excerpt:encoded>
		<wp:post_id>324</wp:post_id>
		<wppost_date>2013-05-07 18:19:16</wppost_date>
		<wppost_date_gmt>2013-05-07 18:19:16</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>96-well-plate-600px</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>322</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/05/96-well-plate-600px.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/05/96-well-plate-600px.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"410";s:14:"hwstring_small";s:23:"height='87' width='128'";s:4:"file";s:31:"2013/05/96-well-plate-600px.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:31:"96-well-plate-600px-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:31:"96-well-plate-600px-300x205.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"205";}s:14:"post-thumbnail";a:3:{s:4:"file";s:31:"96-well-plate-600px-600x288.jpg";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:31:"96-well-plate-600px-600x288.jpg";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:31:"96-well-plate-600px-439x300.jpg";s:5:"width";s:3:"439";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:4:"2.75";s:6:"credit";s:0:"";s:6:"camera";s:12:"Galaxy Nexus";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1367936012";s:9:"copyright";s:0:"";s:12:"focal_length";s:4:"3.43";s:3:"iso";s:3:"125";s:13:"shutter_speed";s:8:"0.029997";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>The conference was at this big expensive castle in the mountains.</title>
		<link>http://www.prionalliance.org/2013/06/02/highlights-of-prion2013/banff-fairmont-prion2013/</link>
		<pubDate>Sun, 02 Jun 2013 00:16:14 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/06/banff-fairmont-prion2013.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>331</wp:post_id>
		<wppost_date>2013-06-02 00:16:14</wppost_date>
		<wppost_date_gmt>2013-06-02 00:16:14</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>banff-fairmont-prion2013</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>330</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/06/banff-fairmont-prion2013.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/06/banff-fairmont-prion2013.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"1000";s:6:"height";s:3:"593";s:14:"hwstring_small";s:23:"height='75' width='128'";s:4:"file";s:36:"2013/06/banff-fairmont-prion2013.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:36:"banff-fairmont-prion2013-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:36:"banff-fairmont-prion2013-300x177.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"177";}s:14:"post-thumbnail";a:3:{s:4:"file";s:37:"banff-fairmont-prion2013-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:37:"banff-fairmont-prion2013-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:36:"banff-fairmont-prion2013-500x296.jpg";s:5:"width";s:3:"500";s:6:"height";s:3:"296";}}s:10:"image_meta";a:10:{s:8:"aperture";s:4:"2.75";s:6:"credit";s:0:"";s:6:"camera";s:12:"Galaxy Nexus";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1369609192";s:9:"copyright";s:0:"";s:12:"focal_length";s:4:"3.43";s:3:"iso";s:2:"80";s:13:"shutter_speed";s:8:"0.009999";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>cannabis-520px</title>
		<link>http://www.prionalliance.org/2013/06/09/cannabidiol-for-prion-disease-not-so-fast/cannabis-520px/</link>
		<pubDate>Thu, 06 Jun 2013 14:37:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/06/cannabis-520px.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>335</wp:post_id>
		<wppost_date>2013-06-06 14:37:52</wppost_date>
		<wppost_date_gmt>2013-06-06 14:37:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>cannabis-520px</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>334</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/06/cannabis-520px.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/06/cannabis-520px.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"520";s:6:"height";s:3:"480";s:14:"hwstring_small";s:23:"height='96' width='104'";s:4:"file";s:26:"2013/06/cannabis-520px.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:26:"cannabis-520px-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:26:"cannabis-520px-300x276.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"276";}s:14:"post-thumbnail";a:3:{s:4:"file";s:26:"cannabis-520px-520x288.jpg";s:5:"width";s:3:"520";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:26:"cannabis-520px-520x288.jpg";s:5:"width";s:3:"520";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:26:"cannabis-520px-325x300.jpg";s:5:"width";s:3:"325";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>microryza-1</title>
		<link>http://www.prionalliance.org/2013/08/15/support-our-project-to-test-anle138b-against-genetic-prion-disease/microryza-1/</link>
		<pubDate>Thu, 15 Aug 2013 18:31:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/08/microryza-1.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>355</wp:post_id>
		<wppost_date>2013-08-15 18:31:00</wppost_date>
		<wppost_date_gmt>2013-08-15 18:31:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>microryza-1</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>352</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/08/microryza-1.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/08/microryza-1.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"581";s:6:"height";s:3:"226";s:14:"hwstring_small";s:23:"height='49' width='128'";s:4:"file";s:23:"2013/08/microryza-1.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:23:"microryza-1-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:23:"microryza-1-300x116.png";s:5:"width";s:3:"300";s:6:"height";s:3:"116";}s:13:"small-feature";a:3:{s:4:"file";s:23:"microryza-1-500x194.png";s:5:"width";s:3:"500";s:6:"height";s:3:"194";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>cropped-prnp-correlates.png</title>
		<link>http://www.prionalliance.org/?attachment_id=375</link>
		<pubDate>Fri, 06 Sep 2013 17:39:21 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/cropped-prnp-correlates.png</guid>
		<description></description>
		<contentencoded><![CDATA[http://www.prionalliance.org/wp-content/uploads/2013/09/cropped-prnp-correlates.png]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>375</wp:post_id>
		<wppost_date>2013-09-06 17:39:21</wppost_date>
		<wppost_date_gmt>2013-09-06 17:39:21</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>cropped-prnp-correlates-png</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/cropped-prnp-correlates.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_context</wp:meta_key>
			<wp:meta_value><![CDATA[custom-header]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/cropped-prnp-correlates.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"1000";s:6:"height";s:3:"288";s:14:"hwstring_small";s:23:"height='36' width='128'";s:4:"file";s:35:"2013/09/cropped-prnp-correlates.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:35:"cropped-prnp-correlates-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:34:"cropped-prnp-correlates-300x86.png";s:5:"width";s:3:"300";s:6:"height";s:2:"86";}s:13:"small-feature";a:3:{s:4:"file";s:35:"cropped-prnp-correlates-500x144.png";s:5:"width";s:3:"500";s:6:"height";s:3:"144";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_is_custom_header</wp:meta_key>
			<wp:meta_value><![CDATA[twentyelevenwithsidebar]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>prnp-correlates.png</title>
		<link>http://www.prionalliance.org/?attachment_id=376</link>
		<pubDate>Fri, 06 Sep 2013 17:40:04 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/prnp-correlates.png</guid>
		<description></description>
		<contentencoded><![CDATA[http://www.prionalliance.org/wp-content/uploads/2013/09/prnp-correlates.png]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>376</wp:post_id>
		<wppost_date>2013-09-06 17:40:04</wppost_date>
		<wppost_date_gmt>2013-09-06 17:40:04</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prnp-correlates-png-2</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/prnp-correlates.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/prnp-correlates.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_context</wp:meta_key>
			<wp:meta_value><![CDATA[custom-header]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"965";s:6:"height";s:3:"147";s:14:"hwstring_small";s:23:"height='19' width='128'";s:4:"file";s:27:"2013/09/prnp-correlates.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:27:"prnp-correlates-150x147.png";s:5:"width";s:3:"150";s:6:"height";s:3:"147";}s:6:"medium";a:3:{s:4:"file";s:26:"prnp-correlates-300x45.png";s:5:"width";s:3:"300";s:6:"height";s:2:"45";}s:13:"small-feature";a:3:{s:4:"file";s:26:"prnp-correlates-500x76.png";s:5:"width";s:3:"500";s:6:"height";s:2:"76";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_is_custom_header</wp:meta_key>
			<wp:meta_value><![CDATA[twentyelevenwithsidebar]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>microryza-project-funded</title>
		<link>http://www.prionalliance.org/2013/09/17/gss-study-funded-now-fundraising-for-ffi-and-e200k/microryza-project-funded/</link>
		<pubDate>Tue, 17 Sep 2013 11:08:19 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-project-funded.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>383</wp:post_id>
		<wppost_date>2013-09-17 11:08:19</wppost_date>
		<wppost_date_gmt>2013-09-17 11:08:19</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>microryza-project-funded</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>380</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-project-funded.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/microryza-project-funded.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"322";s:14:"hwstring_small";s:23:"height='68' width='128'";s:4:"file";s:36:"2013/09/microryza-project-funded.png";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:36:"microryza-project-funded-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:36:"microryza-project-funded-300x161.png";s:5:"width";s:3:"300";s:6:"height";s:3:"161";}s:14:"post-thumbnail";a:3:{s:4:"file";s:36:"microryza-project-funded-600x288.png";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:36:"microryza-project-funded-600x288.png";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:36:"microryza-project-funded-500x268.png";s:5:"width";s:3:"500";s:6:"height";s:3:"268";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>43crop</title>
		<link>http://www.prionalliance.org/our-story/43crop/</link>
		<pubDate>Sun, 22 Sep 2013 20:52:37 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/01/43crop.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>387</wp:post_id>
		<wppost_date>2013-09-22 20:52:37</wppost_date>
		<wppost_date_gmt>2013-09-22 20:52:37</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>43crop</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>265</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/01/43crop.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/01/43crop.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"431";s:14:"hwstring_small";s:23:"height='91' width='128'";s:4:"file";s:18:"2013/01/43crop.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:18:"43crop-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:18:"43crop-300x215.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"215";}s:14:"post-thumbnail";a:3:{s:4:"file";s:18:"43crop-600x288.jpg";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:18:"43crop-600x288.jpg";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:18:"43crop-417x300.jpg";s:5:"width";s:3:"417";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:3:"2.8";s:6:"credit";s:0:"";s:6:"camera";s:9:"NIKON D60";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1379666168";s:9:"copyright";s:0:"";s:12:"focal_length";s:2:"17";s:3:"iso";s:3:"800";s:13:"shutter_speed";s:6:"0.0004";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>microryza-goal3-now-reached</title>
		<link>http://www.prionalliance.org/?attachment_id=417</link>
		<pubDate>Fri, 27 Sep 2013 11:41:04 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-goal3-now-reached.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>417</wp:post_id>
		<wppost_date>2013-09-27 11:41:04</wppost_date>
		<wppost_date_gmt>2013-09-27 11:41:04</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>microryza-goal3-now-reached</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>415</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-goal3-now-reached.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/microryza-goal3-now-reached.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"276";s:14:"hwstring_small";s:23:"height='58' width='128'";s:4:"file";s:39:"2013/09/microryza-goal3-now-reached.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:39:"microryza-goal3-now-reached-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:39:"microryza-goal3-now-reached-300x138.png";s:5:"width";s:3:"300";s:6:"height";s:3:"138";}s:13:"small-feature";a:3:{s:4:"file";s:39:"microryza-goal3-now-reached-500x230.png";s:5:"width";s:3:"500";s:6:"height";s:3:"230";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>dna</title>
		<link>http://www.prionalliance.org/2013/09/27/heres-whats-next/dna/</link>
		<pubDate>Fri, 27 Sep 2013 17:03:24 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/dna.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>435</wp:post_id>
		<wppost_date>2013-09-27 17:03:24</wppost_date>
		<wppost_date_gmt>2013-09-27 17:03:24</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>dna</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>426</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/dna.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/dna.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"100";s:6:"height";s:2:"80";s:14:"hwstring_small";s:23:"height='80' width='100'";s:4:"file";s:15:"2013/09/dna.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>molecule999</title>
		<link>http://www.prionalliance.org/2013/09/27/heres-whats-next/molecule999/</link>
		<pubDate>Fri, 27 Sep 2013 17:04:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/molecule999.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>436</wp:post_id>
		<wppost_date>2013-09-27 17:04:52</wppost_date>
		<wppost_date_gmt>2013-09-27 17:04:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>molecule999</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>426</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/molecule999.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/molecule999.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"100";s:6:"height";s:2:"91";s:14:"hwstring_small";s:23:"height='91' width='100'";s:4:"file";s:23:"2013/09/molecule999.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>silence</title>
		<link>http://www.prionalliance.org/2013/09/27/heres-whats-next/silence/</link>
		<pubDate>Fri, 27 Sep 2013 17:06:04 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/silence.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>437</wp:post_id>
		<wppost_date>2013-09-27 17:06:04</wppost_date>
		<wppost_date_gmt>2013-09-27 17:06:04</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>silence</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>426</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/silence.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/silence.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"100";s:6:"height";s:3:"121";s:14:"hwstring_small";s:22:"height='96' width='79'";s:4:"file";s:19:"2013/09/silence.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>cosmos</title>
		<link>http://www.prionalliance.org/2013/09/27/heres-whats-next/cosmos/</link>
		<pubDate>Fri, 27 Sep 2013 17:06:51 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/cosmos.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>438</wp:post_id>
		<wppost_date>2013-09-27 17:06:51</wppost_date>
		<wppost_date_gmt>2013-09-27 17:06:51</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>cosmos</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>426</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/cosmos.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/cosmos.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"100";s:6:"height";s:2:"83";s:14:"hwstring_small";s:23:"height='83' width='100'";s:4:"file";s:18:"2013/09/cosmos.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>dnahelix</title>
		<link>http://www.prionalliance.org/2013/09/27/heres-whats-next/dnahelix/</link>
		<pubDate>Fri, 27 Sep 2013 17:11:50 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/dnahelix.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>439</wp:post_id>
		<wppost_date>2013-09-27 17:11:50</wppost_date>
		<wppost_date_gmt>2013-09-27 17:11:50</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>dnahelix</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>426</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/dnahelix.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/dnahelix.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"100";s:6:"height";s:2:"76";s:14:"hwstring_small";s:23:"height='76' width='100'";s:4:"file";s:20:"2013/09/dnahelix.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>microryza-project-complete</title>
		<link>http://www.prionalliance.org/2013/09/28/microryza-project-closes-at-17217/microryza-project-complete/</link>
		<pubDate>Sat, 28 Sep 2013 07:07:27 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-project-complete.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>450</wp:post_id>
		<wppost_date>2013-09-28 07:07:27</wppost_date>
		<wppost_date_gmt>2013-09-28 07:07:27</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>microryza-project-complete</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>449</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-project-complete.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/09/microryza-project-complete.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"272";s:14:"hwstring_small";s:23:"height='58' width='128'";s:4:"file";s:38:"2013/09/microryza-project-complete.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:38:"microryza-project-complete-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:38:"microryza-project-complete-300x136.png";s:5:"width";s:3:"300";s:6:"height";s:3:"136";}s:13:"small-feature";a:3:{s:4:"file";s:38:"microryza-project-complete-500x226.png";s:5:"width";s:3:"500";s:6:"height";s:3:"226";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>kvcatscradle</title>
		<link>http://www.prionalliance.org/2013/11/26/what-are-prions/kvcatscradle/</link>
		<pubDate>Thu, 21 Nov 2013 14:17:29 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/11/kvcatscradle.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>460</wp:post_id>
		<wppost_date>2013-11-21 14:17:29</wppost_date>
		<wppost_date_gmt>2013-11-21 14:17:29</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>kvcatscradle</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>459</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/11/kvcatscradle.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/11/kvcatscradle.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"555";s:6:"height";s:3:"403";s:14:"hwstring_small";s:23:"height='92' width='128'";s:4:"file";s:24:"2013/11/kvcatscradle.jpg";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:24:"kvcatscradle-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:24:"kvcatscradle-300x217.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"217";}s:14:"post-thumbnail";a:3:{s:4:"file";s:24:"kvcatscradle-555x288.jpg";s:5:"width";s:3:"555";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:24:"kvcatscradle-555x288.jpg";s:5:"width";s:3:"555";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:24:"kvcatscradle-413x300.jpg";s:5:"width";s:3:"413";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>prnp-prp-prion</title>
		<link>http://www.prionalliance.org/2013/11/26/what-are-prions/prnp-prp-prion/</link>
		<pubDate>Thu, 21 Nov 2013 14:36:23 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/11/prnp-prp-prion.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>461</wp:post_id>
		<wppost_date>2013-11-21 14:36:23</wppost_date>
		<wppost_date_gmt>2013-11-21 14:36:23</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prnp-prp-prion</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>459</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/11/prnp-prp-prion.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/11/prnp-prp-prion.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"657";s:6:"height";s:3:"321";s:14:"hwstring_small";s:23:"height='62' width='128'";s:4:"file";s:26:"2013/11/prnp-prp-prion.png";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:26:"prnp-prp-prion-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:26:"prnp-prp-prion-300x146.png";s:5:"width";s:3:"300";s:6:"height";s:3:"146";}s:14:"post-thumbnail";a:3:{s:4:"file";s:26:"prnp-prp-prion-657x288.png";s:5:"width";s:3:"657";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:26:"prnp-prp-prion-657x288.png";s:5:"width";s:3:"657";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:26:"prnp-prp-prion-500x244.png";s:5:"width";s:3:"500";s:6:"height";s:3:"244";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>genetic-sporadic-acquired</title>
		<link>http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/genetic-sporadic-acquired/</link>
		<pubDate>Thu, 21 Nov 2013 15:55:41 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/11/genetic-sporadic-acquired.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>466</wp:post_id>
		<wppost_date>2013-11-21 15:55:41</wppost_date>
		<wppost_date_gmt>2013-11-21 15:55:41</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>genetic-sporadic-acquired</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>465</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/11/genetic-sporadic-acquired.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/11/genetic-sporadic-acquired.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"416";s:14:"hwstring_small";s:23:"height='88' width='128'";s:4:"file";s:37:"2013/11/genetic-sporadic-acquired.png";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:37:"genetic-sporadic-acquired-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:37:"genetic-sporadic-acquired-300x208.png";s:5:"width";s:3:"300";s:6:"height";s:3:"208";}s:14:"post-thumbnail";a:3:{s:4:"file";s:37:"genetic-sporadic-acquired-600x288.png";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:37:"genetic-sporadic-acquired-600x288.png";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:37:"genetic-sporadic-acquired-432x300.png";s:5:"width";s:3:"432";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>genetic-sporadic-acquired-400px</title>
		<link>http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/genetic-sporadic-acquired-400px/</link>
		<pubDate>Thu, 21 Nov 2013 15:56:27 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/11/genetic-sporadic-acquired-400px.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>467</wp:post_id>
		<wppost_date>2013-11-21 15:56:27</wppost_date>
		<wppost_date_gmt>2013-11-21 15:56:27</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>genetic-sporadic-acquired-400px</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>465</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/11/genetic-sporadic-acquired-400px.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/11/genetic-sporadic-acquired-400px.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"400";s:6:"height";s:3:"277";s:14:"hwstring_small";s:23:"height='88' width='128'";s:4:"file";s:43:"2013/11/genetic-sporadic-acquired-400px.png";s:5:"sizes";a:2:{s:9:"thumbnail";a:3:{s:4:"file";s:43:"genetic-sporadic-acquired-400px-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:43:"genetic-sporadic-acquired-400px-300x207.png";s:5:"width";s:3:"300";s:6:"height";s:3:"207";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Prion protein (green) can fold up into many different prion strains (red)</title>
		<link>http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/one-prp-many-prion-strains/</link>
		<pubDate>Mon, 02 Dec 2013 15:46:22 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/12/one-prp-many-prion-strains.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>492</wp:post_id>
		<wppost_date>2013-12-02 15:46:22</wppost_date>
		<wppost_date_gmt>2013-12-02 15:46:22</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>one-prp-many-prion-strains</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>465</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/12/one-prp-many-prion-strains.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/12/one-prp-many-prion-strains.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"212";s:14:"hwstring_small";s:23:"height='45' width='128'";s:4:"file";s:38:"2013/12/one-prp-many-prion-strains.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:38:"one-prp-many-prion-strains-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:38:"one-prp-many-prion-strains-300x106.png";s:5:"width";s:3:"300";s:6:"height";s:3:"106";}s:13:"small-feature";a:3:{s:4:"file";s:38:"one-prp-many-prion-strains-500x176.png";s:5:"width";s:3:"500";s:6:"height";s:3:"176";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>prnp-on-chr20p</title>
		<link>http://www.prionalliance.org/2013/12/09/what-does-it-mean-to-have-a-genetic-prion-disease/prnp-on-chr20p/</link>
		<pubDate>Tue, 03 Dec 2013 23:57:05 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/12/prnp-on-chr20p.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>496</wp:post_id>
		<wppost_date>2013-12-03 23:57:05</wppost_date>
		<wppost_date_gmt>2013-12-03 23:57:05</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prnp-on-chr20p</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>474</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/12/prnp-on-chr20p.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/12/prnp-on-chr20p.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"600";s:6:"height";s:3:"449";s:14:"hwstring_small";s:23:"height='96' width='128'";s:4:"file";s:26:"2013/12/prnp-on-chr20p.png";s:5:"sizes";a:5:{s:9:"thumbnail";a:3:{s:4:"file";s:26:"prnp-on-chr20p-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:26:"prnp-on-chr20p-300x224.png";s:5:"width";s:3:"300";s:6:"height";s:3:"224";}s:14:"post-thumbnail";a:3:{s:4:"file";s:26:"prnp-on-chr20p-600x288.png";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:26:"prnp-on-chr20p-600x288.png";s:5:"width";s:3:"600";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:26:"prnp-on-chr20p-400x300.png";s:5:"width";s:3:"400";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>ibuprofen-3d-skeleton</title>
		<link>http://www.prionalliance.org/2014/02/04/what-are-the-potential-treatments-for-prion-disease/ibuprofen-3d-skeleton/</link>
		<pubDate>Sat, 14 Dec 2013 21:33:39 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/12/ibuprofen-3d-skeleton.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>512</wp:post_id>
		<wppost_date>2013-12-14 21:33:39</wppost_date>
		<wppost_date_gmt>2013-12-14 21:33:39</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>ibuprofen-3d-skeleton</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>511</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/12/ibuprofen-3d-skeleton.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/12/ibuprofen-3d-skeleton.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"300";s:6:"height";s:3:"204";s:14:"hwstring_small";s:23:"height='87' width='128'";s:4:"file";s:33:"2013/12/ibuprofen-3d-skeleton.png";s:5:"sizes";a:1:{s:9:"thumbnail";a:3:{s:4:"file";s:33:"ibuprofen-3d-skeleton-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>the-times-fatal-insomnia-the-couple-searching-for-a-cure</title>
		<link>http://www.prionalliance.org/?attachment_id=526</link>
		<pubDate>Mon, 23 Dec 2013 22:22:08 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2013/12/the-times-fatal-insomnia-the-couple-searching-for-a-cure.pdf</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>526</wp:post_id>
		<wppost_date>2013-12-23 22:22:08</wppost_date>
		<wppost_date_gmt>2013-12-23 22:22:08</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>the-times-fatal-insomnia-the-couple-searching-for-a-cure</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2013/12/the-times-fatal-insomnia-the-couple-searching-for-a-cure.pdf</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:0:{}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2013/12/the-times-fatal-insomnia-the-couple-searching-for-a-cure.pdf]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>19765</title>
		<link>http://www.prionalliance.org/2014/01/01/happy-2014/attachment/19765/</link>
		<pubDate>Wed, 01 Jan 2014 22:46:33 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/19765.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>529</wp:post_id>
		<wppost_date>2014-01-01 22:46:33</wppost_date>
		<wppost_date_gmt>2014-01-01 22:46:33</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>19765</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>528</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/19765.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/19765.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"321";s:6:"height";s:2:"56";s:14:"hwstring_small";s:23:"height='22' width='128'";s:4:"file";s:17:"2014/01/19765.png";s:5:"sizes";a:2:{s:9:"thumbnail";a:3:{s:4:"file";s:16:"19765-150x56.png";s:5:"width";s:3:"150";s:6:"height";s:2:"56";}s:6:"medium";a:3:{s:4:"file";s:16:"19765-300x52.png";s:5:"width";s:3:"300";s:6:"height";s:2:"52";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>the-times-2013-12-23-unless-we-find-a-cure-insomnia-will-kill-me</title>
		<link>http://www.prionalliance.org/?attachment_id=534</link>
		<pubDate>Thu, 09 Jan 2014 21:54:24 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/the-times-2013-12-23-unless-we-find-a-cure-insomnia-will-kill-me.pdf</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>534</wp:post_id>
		<wppost_date>2014-01-09 21:54:24</wppost_date>
		<wppost_date_gmt>2014-01-09 21:54:24</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>the-times-2013-12-23-unless-we-find-a-cure-insomnia-will-kill-me</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/the-times-2013-12-23-unless-we-find-a-cure-insomnia-will-kill-me.pdf</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/the-times-2013-12-23-unless-we-find-a-cure-insomnia-will-kill-me.pdf]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:0:{}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>human NPCs</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/attachment/08155142/</link>
		<pubDate>Fri, 17 Jan 2014 22:34:01 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/08155142.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[Above, human induced pluripotent stem cells have been differentiated into NPCs, or neural progenitor cells.  From here, they can be further differentiated into different kinds of neurons.]]></excerpt:encoded>
		<wp:post_id>539</wp:post_id>
		<wppost_date>2014-01-17 22:34:01</wppost_date>
		<wppost_date_gmt>2014-01-17 22:34:01</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>08155142</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/08155142.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/08155142.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"1280";s:6:"height";s:3:"960";s:14:"hwstring_small";s:23:"height='96' width='128'";s:4:"file";s:20:"2014/01/08155142.jpg";s:5:"sizes";a:6:{s:9:"thumbnail";a:3:{s:4:"file";s:20:"08155142-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:20:"08155142-300x225.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"225";}s:5:"large";a:3:{s:4:"file";s:21:"08155142-1024x768.jpg";s:5:"width";s:4:"1024";s:6:"height";s:3:"768";}s:14:"post-thumbnail";a:3:{s:4:"file";s:21:"08155142-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:21:"08155142-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:20:"08155142-400x300.jpg";s:5:"width";s:3:"400";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:9:"DS-Fi1-L2";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1386517902";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:16:"0.00142857142857";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>iPSC neurons</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/attachment/03150509/</link>
		<pubDate>Fri, 17 Jan 2014 22:47:50 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/03150509.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[From NPCs, these cells have been differentiated into neurons.]]></excerpt:encoded>
		<wp:post_id>541</wp:post_id>
		<wppost_date>2014-01-17 22:47:50</wppost_date>
		<wppost_date_gmt>2014-01-17 22:47:50</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>03150509</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/03150509.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/03150509.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"1280";s:6:"height";s:3:"960";s:14:"hwstring_small";s:23:"height='96' width='128'";s:4:"file";s:20:"2014/01/03150509.jpg";s:5:"sizes";a:6:{s:9:"thumbnail";a:3:{s:4:"file";s:20:"03150509-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:20:"03150509-300x225.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"225";}s:5:"large";a:3:{s:4:"file";s:21:"03150509-1024x768.jpg";s:5:"width";s:4:"1024";s:6:"height";s:3:"768";}s:14:"post-thumbnail";a:3:{s:4:"file";s:21:"03150509-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:21:"03150509-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:20:"03150509-400x300.jpg";s:5:"width";s:3:"400";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:9:"DS-Fi1-L2";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1372863909";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:15:"0.0166666666667";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>iPSC neurons 2</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/aggft-28n6-p45-2/</link>
		<pubDate>Sat, 18 Jan 2014 18:14:00 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/AggFT-28n6-p45-2.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[Sometimes, neurons-in-a-dish look like this!  Crazy.]]></excerpt:encoded>
		<wp:post_id>544</wp:post_id>
		<wppost_date>2014-01-18 18:14:00</wppost_date>
		<wppost_date_gmt>2014-01-18 18:14:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>aggft-28n6-p45-2</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/AggFT-28n6-p45-2.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/AggFT-28n6-p45-2.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"1280";s:6:"height";s:3:"960";s:14:"hwstring_small";s:23:"height='96' width='128'";s:4:"file";s:28:"2014/01/AggFT-28n6-p45-2.jpg";s:5:"sizes";a:6:{s:9:"thumbnail";a:3:{s:4:"file";s:28:"AggFT-28n6-p45-2-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:28:"AggFT-28n6-p45-2-300x225.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"225";}s:5:"large";a:3:{s:4:"file";s:29:"AggFT-28n6-p45-2-1024x768.jpg";s:5:"width";s:4:"1024";s:6:"height";s:3:"768";}s:14:"post-thumbnail";a:3:{s:4:"file";s:29:"AggFT-28n6-p45-2-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:29:"AggFT-28n6-p45-2-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:28:"AggFT-28n6-p45-2-400x300.jpg";s:5:"width";s:3:"400";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:9:"DS-Fi1-L2";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1363278104";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:5:"0.004";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Sonia at the microscope</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/img_20140117_151959/</link>
		<pubDate>Sat, 18 Jan 2014 18:21:43 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/IMG_20140117_151959.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[This is how I spend a lot of my time.  The iPS room is a harsh mistress.]]></excerpt:encoded>
		<wp:post_id>545</wp:post_id>
		<wppost_date>2014-01-18 18:21:43</wppost_date>
		<wppost_date_gmt>2014-01-18 18:21:43</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>img_20140117_151959</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/IMG_20140117_151959.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/IMG_20140117_151959.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"2592";s:6:"height";s:4:"1944";s:14:"hwstring_small";s:23:"height='96' width='128'";s:4:"file";s:31:"2014/01/IMG_20140117_151959.jpg";s:5:"sizes";a:6:{s:9:"thumbnail";a:3:{s:4:"file";s:31:"IMG_20140117_151959-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:31:"IMG_20140117_151959-300x225.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"225";}s:5:"large";a:3:{s:4:"file";s:32:"IMG_20140117_151959-1024x768.jpg";s:5:"width";s:4:"1024";s:6:"height";s:3:"768";}s:14:"post-thumbnail";a:3:{s:4:"file";s:32:"IMG_20140117_151959-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:32:"IMG_20140117_151959-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:31:"IMG_20140117_151959-400x300.jpg";s:5:"width";s:3:"400";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:4:"2.75";s:6:"credit";s:0:"";s:6:"camera";s:12:"Galaxy Nexus";s:7:"caption";s:0:"";s:17:"created_timestamp";s:10:"1389971999";s:9:"copyright";s:0:"";s:12:"focal_length";s:4:"3.43";s:3:"iso";s:2:"64";s:13:"shutter_speed";s:8:"0.029997";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>IPS hood</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/2013-03-28_hood/</link>
		<pubDate>Sat, 18 Jan 2014 18:24:33 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-28_hood.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[It was that kind of day.]]></excerpt:encoded>
		<wp:post_id>546</wp:post_id>
		<wppost_date>2014-01-18 18:24:33</wppost_date>
		<wppost_date_gmt>2014-01-18 18:24:33</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>2013-03-28_hood</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-28_hood.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/2013-03-28_hood.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:3:"128";s:6:"height";s:2:"72";s:14:"hwstring_small";s:23:"height='72' width='128'";s:4:"file";s:27:"2014/01/2013-03-28_hood.jpg";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>2013-03-26_stacked plates</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/2013-03-26_stacked-plates/</link>
		<pubDate>Sat, 18 Jan 2014 18:27:13 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-26_stacked-plates.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>547</wp:post_id>
		<wppost_date>2014-01-18 18:27:13</wppost_date>
		<wppost_date_gmt>2014-01-18 18:27:13</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>2013-03-26_stacked-plates</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-26_stacked-plates.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/2013-03-26_stacked-plates.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"72";s:6:"height";s:3:"128";s:14:"hwstring_small";s:22:"height='96' width='54'";s:4:"file";s:37:"2014/01/2013-03-26_stacked-plates.jpg";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>stacked plates</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/2013-03-26_18-08-13_158/</link>
		<pubDate>Sat, 18 Jan 2014 18:44:51 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-26_18-08-13_158.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[At the end of the day, cell culture can be beautiful...]]></excerpt:encoded>
		<wp:post_id>548</wp:post_id>
		<wppost_date>2014-01-18 18:44:51</wppost_date>
		<wppost_date_gmt>2014-01-18 18:44:51</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>2013-03-26_18-08-13_158</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-26_18-08-13_158.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/2013-03-26_18-08-13_158.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"1840";s:6:"height";s:4:"3264";s:14:"hwstring_small";s:22:"height='96' width='54'";s:4:"file";s:35:"2014/01/2013-03-26_18-08-13_158.jpg";s:5:"sizes";a:6:{s:9:"thumbnail";a:3:{s:4:"file";s:35:"2013-03-26_18-08-13_158-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:35:"2013-03-26_18-08-13_158-169x300.jpg";s:5:"width";s:3:"169";s:6:"height";s:3:"300";}s:5:"large";a:3:{s:4:"file";s:36:"2013-03-26_18-08-13_158-577x1024.jpg";s:5:"width";s:3:"577";s:6:"height";s:4:"1024";}s:14:"post-thumbnail";a:3:{s:4:"file";s:36:"2013-03-26_18-08-13_158-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:36:"2013-03-26_18-08-13_158-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:35:"2013-03-26_18-08-13_158-169x300.jpg";s:5:"width";s:3:"169";s:6:"height";s:3:"300";}}s:10:"image_meta";a:10:{s:8:"aperture";s:3:"2.4";s:6:"credit";s:0:"";s:6:"camera";s:12:"DROID BIONIC";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:3:"4.6";s:3:"iso";s:3:"151";s:13:"shutter_speed";s:8:"0.039974";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>IPS room hood</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/2013-03-28_18-08-49_440/</link>
		<pubDate>Sat, 18 Jan 2014 19:39:41 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-28_18-08-49_440.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[It was that sort of day.]]></excerpt:encoded>
		<wp:post_id>549</wp:post_id>
		<wppost_date>2014-01-18 19:39:41</wppost_date>
		<wppost_date_gmt>2014-01-18 19:39:41</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>2013-03-28_18-08-49_440</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>537</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-28_18-08-49_440.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/01/2013-03-28_18-08-49_440.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:4:"3264";s:6:"height";s:4:"1840";s:14:"hwstring_small";s:23:"height='72' width='128'";s:4:"file";s:35:"2014/01/2013-03-28_18-08-49_440.jpg";s:5:"sizes";a:6:{s:9:"thumbnail";a:3:{s:4:"file";s:35:"2013-03-28_18-08-49_440-150x150.jpg";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:6:"medium";a:3:{s:4:"file";s:35:"2013-03-28_18-08-49_440-300x169.jpg";s:5:"width";s:3:"300";s:6:"height";s:3:"169";}s:5:"large";a:3:{s:4:"file";s:36:"2013-03-28_18-08-49_440-1024x577.jpg";s:5:"width";s:4:"1024";s:6:"height";s:3:"577";}s:14:"post-thumbnail";a:3:{s:4:"file";s:36:"2013-03-28_18-08-49_440-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:36:"2013-03-28_18-08-49_440-1000x288.jpg";s:5:"width";s:4:"1000";s:6:"height";s:3:"288";}s:13:"small-feature";a:3:{s:4:"file";s:35:"2013-03-28_18-08-49_440-500x281.jpg";s:5:"width";s:3:"500";s:6:"height";s:3:"281";}}s:10:"image_meta";a:10:{s:8:"aperture";s:3:"2.4";s:6:"credit";s:0:"";s:6:"camera";s:12:"DROID BIONIC";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:3:"4.6";s:3:"iso";s:3:"114";s:13:"shutter_speed";s:8:"0.019974";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>twitter</title>
		<link>http://www.prionalliance.org/?attachment_id=573</link>
		<pubDate>Mon, 03 Feb 2014 02:28:54 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/twitter.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>573</wp:post_id>
		<wppost_date>2014-02-03 02:28:54</wppost_date>
		<wppost_date_gmt>2014-02-03 02:28:54</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>twitter-2</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/twitter.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/twitter.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:6:{s:5:"width";s:3:"300";s:6:"height";s:3:"300";s:14:"hwstring_small";s:22:"height='96' width='96'";s:4:"file";s:19:"2014/02/twitter.png";s:5:"sizes";a:3:{s:9:"thumbnail";a:3:{s:4:"file";s:19:"twitter-150x150.png";s:5:"width";s:3:"150";s:6:"height";s:3:"150";}s:14:"post-thumbnail";a:3:{s:4:"file";s:19:"twitter-300x288.png";s:5:"width";s:3:"300";s:6:"height";s:3:"288";}s:13:"large-feature";a:3:{s:4:"file";s:19:"twitter-300x288.png";s:5:"width";s:3:"300";s:6:"height";s:3:"288";}}s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>fb</title>
		<link>http://www.prionalliance.org/?attachment_id=574</link>
		<pubDate>Mon, 03 Feb 2014 02:29:01 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/fb.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>574</wp:post_id>
		<wppost_date>2014-02-03 02:29:01</wppost_date>
		<wppost_date_gmt>2014-02-03 02:29:01</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>fb</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/fb.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/fb.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"17";s:6:"height";s:2:"15";s:14:"hwstring_small";s:22:"height='15' width='17'";s:4:"file";s:14:"2014/02/fb.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>twitter1</title>
		<link>http://www.prionalliance.org/?attachment_id=577</link>
		<pubDate>Mon, 03 Feb 2014 02:32:09 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/twitter1.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>577</wp:post_id>
		<wppost_date>2014-02-03 02:32:09</wppost_date>
		<wppost_date_gmt>2014-02-03 02:32:09</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>twitter1</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/twitter1.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/twitter1.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"22";s:6:"height";s:2:"22";s:14:"hwstring_small";s:22:"height='22' width='22'";s:4:"file";s:20:"2014/02/twitter1.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>fb1</title>
		<link>http://www.prionalliance.org/?attachment_id=580</link>
		<pubDate>Mon, 03 Feb 2014 02:37:39 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/fb1.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>580</wp:post_id>
		<wppost_date>2014-02-03 02:37:39</wppost_date>
		<wppost_date_gmt>2014-02-03 02:37:39</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>fb1</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/fb1.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/fb1.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"45";s:6:"height";s:2:"50";s:14:"hwstring_small";s:22:"height='50' width='45'";s:4:"file";s:15:"2014/02/fb1.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>fb1</title>
		<link>http://www.prionalliance.org/?attachment_id=581</link>
		<pubDate>Mon, 03 Feb 2014 02:37:45 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/fb11.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>581</wp:post_id>
		<wppost_date>2014-02-03 02:37:45</wppost_date>
		<wppost_date_gmt>2014-02-03 02:37:45</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>fb1-2</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/fb11.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/fb11.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"45";s:6:"height";s:2:"50";s:14:"hwstring_small";s:22:"height='50' width='45'";s:4:"file";s:16:"2014/02/fb11.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>tw1</title>
		<link>http://www.prionalliance.org/?attachment_id=583</link>
		<pubDate>Mon, 03 Feb 2014 02:43:02 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/tw1.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>583</wp:post_id>
		<wppost_date>2014-02-03 02:43:02</wppost_date>
		<wppost_date_gmt>2014-02-03 02:43:02</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>tw1</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/tw1.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/tw1.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"30";s:6:"height";s:2:"31";s:14:"hwstring_small";s:22:"height='31' width='30'";s:4:"file";s:15:"2014/02/tw1.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>fb2</title>
		<link>http://www.prionalliance.org/?attachment_id=585</link>
		<pubDate>Mon, 03 Feb 2014 02:44:05 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/fb2.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>585</wp:post_id>
		<wppost_date>2014-02-03 02:44:05</wppost_date>
		<wppost_date_gmt>2014-02-03 02:44:05</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>fb2</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/fb2.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/fb2.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";s:2:"29";s:6:"height";s:2:"32";s:14:"hwstring_small";s:22:"height='32' width='29'";s:4:"file";s:15:"2014/02/fb2.png";s:10:"image_meta";a:10:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2012/11/12/25/</link>
		<pubDate>Mon, 12 Nov 2012 15:38:08 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/2012/11/12/25/</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>25</wp:post_id>
		<wppost_date>2012-11-12 15:38:08</wppost_date>
		<wppost_date_gmt>2012-11-12 15:38:08</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>25</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>11</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[24]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2012/11/12/27/</link>
		<pubDate>Mon, 12 Nov 2012 15:38:08 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/2012/11/12/27/</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>27</wp:post_id>
		<wppost_date>2012-11-12 15:38:08</wppost_date>
		<wppost_date_gmt>2012-11-12 15:38:08</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>27</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>7</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[15]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Home</title>
		<link>http://www.prionalliance.org/2012/11/12/home/</link>
		<pubDate>Mon, 12 Nov 2012 15:38:08 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://69.195.124.66/~prionall/2012/11/12/home/</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>29</wp:post_id>
		<wppost_date>2012-11-12 15:38:08</wppost_date>
		<wppost_date_gmt>2012-11-12 15:38:08</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>home</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>1</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[29]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[http://www.prionalliance.org/]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2012/11/12/162/</link>
		<pubDate>Mon, 12 Nov 2012 18:37:18 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=162</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>162</wp:post_id>
		<wppost_date>2012-11-12 18:37:18</wppost_date>
		<wppost_date_gmt>2012-11-12 18:37:18</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>162</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>10</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[104]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2012/11/30/177/</link>
		<pubDate>Fri, 30 Nov 2012 17:45:37 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=177</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>177</wp:post_id>
		<wppost_date>2012-11-30 17:45:37</wppost_date>
		<wppost_date_gmt>2012-11-30 17:45:37</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>177</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>8</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[74]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2013/01/22/271/</link>
		<pubDate>Tue, 22 Jan 2013 21:47:09 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=271</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>271</wp:post_id>
		<wppost_date>2013-01-22 21:47:09</wppost_date>
		<wppost_date_gmt>2013-01-22 21:47:09</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>271</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>5</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[274]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[269]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2013/01/22/272/</link>
		<pubDate>Tue, 22 Jan 2013 21:47:09 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=272</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>272</wp:post_id>
		<wppost_date>2013-01-22 21:47:09</wppost_date>
		<wppost_date_gmt>2013-01-22 21:47:09</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>272</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>4</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[274]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[267]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2013/01/22/273/</link>
		<pubDate>Tue, 22 Jan 2013 21:47:09 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=273</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>273</wp:post_id>
		<wppost_date>2013-01-22 21:47:09</wppost_date>
		<wppost_date_gmt>2013-01-22 21:47:09</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>273</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>3</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[274]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[265]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>About</title>
		<link>http://www.prionalliance.org/2013/01/22/about/</link>
		<pubDate>Tue, 22 Jan 2013 21:47:09 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=274</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>274</wp:post_id>
		<wppost_date>2013-01-22 21:47:09</wppost_date>
		<wppost_date_gmt>2013-01-22 21:47:09</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>about</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>2</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[274]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[#]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Twitter</title>
		<link>http://www.prionalliance.org/2014/02/03/twitter/</link>
		<pubDate>Mon, 03 Feb 2014 02:09:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=571</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>571</wp:post_id>
		<wppost_date>2014-02-03 02:09:52</wppost_date>
		<wppost_date_gmt>2014-02-03 02:09:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>twitter</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>13</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[571]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:12:"menu-twitter";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[http://twitter.com/PrionAlliance]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Facebook</title>
		<link>http://www.prionalliance.org/2014/02/03/facebook/</link>
		<pubDate>Mon, 03 Feb 2014 02:09:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=572</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>572</wp:post_id>
		<wppost_date>2014-02-03 02:09:52</wppost_date>
		<wppost_date_gmt>2014-02-03 02:09:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>facebook</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>12</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[572]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[custom]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:7:"menu-fb";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[http://facebook.com/PrionAlliance]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>prionalliance</title>
		<link>http://www.prionalliance.org/?attachment_id=588</link>
		<pubDate>Mon, 03 Feb 2014 22:47:51 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/prionalliance.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>588</wp:post_id>
		<wppost_date>2014-02-03 22:47:51</wppost_date>
		<wppost_date_gmt>2014-02-03 22:47:51</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prionalliance</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/prionalliance.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/prionalliance.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:180;s:6:"height";i:180;s:4:"file";s:25:"2014/02/prionalliance.png";s:5:"sizes";a:2:{s:9:"thumbnail";a:4:{s:4:"file";s:25:"prionalliance-150x150.png";s:5:"width";i:150;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}s:16:"jmtc-small-thumb";a:4:{s:4:"file";s:25:"prionalliance-180x150.png";s:5:"width";i:180;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title></title>
		<link>http://www.prionalliance.org/2014/02/03/595/</link>
		<pubDate>Mon, 03 Feb 2014 23:50:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=595</guid>
		<description></description>
		<contentencoded><![CDATA[ ]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>595</wp:post_id>
		<wppost_date>2014-02-03 23:50:52</wppost_date>
		<wppost_date_gmt>2014-02-03 23:50:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>595</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>6</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[593]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>doxorubicin-200px</title>
		<link>http://www.prionalliance.org/?attachment_id=601</link>
		<pubDate>Tue, 04 Feb 2014 09:11:32 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/doxorubicin-200px.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[Doxorubicin, an anthracycline chemo drug.]]></excerpt:encoded>
		<wp:post_id>601</wp:post_id>
		<wppost_date>2014-02-04 09:11:32</wppost_date>
		<wppost_date_gmt>2014-02-04 09:11:32</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>doxorubicin-200px</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>600</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/doxorubicin-200px.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/doxorubicin-200px.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:200;s:6:"height";i:153;s:4:"file";s:29:"2014/02/doxorubicin-200px.png";s:5:"sizes";a:2:{s:9:"thumbnail";a:4:{s:4:"file";s:29:"doxorubicin-200px-150x150.png";s:5:"width";i:150;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}s:16:"jmtc-small-thumb";a:4:{s:4:"file";s:29:"doxorubicin-200px-200x150.png";s:5:"width";i:200;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>doxycycline-200px</title>
		<link>http://www.prionalliance.org/?attachment_id=602</link>
		<pubDate>Tue, 04 Feb 2014 09:12:04 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/02/doxycycline-200px.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[Doxycycline, a tetracycline antibiotic.]]></excerpt:encoded>
		<wp:post_id>602</wp:post_id>
		<wppost_date>2014-02-04 09:12:04</wppost_date>
		<wppost_date_gmt>2014-02-04 09:12:04</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>doxycycline-200px</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>600</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/02/doxycycline-200px.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/02/doxycycline-200px.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:200;s:6:"height";i:102;s:4:"file";s:29:"2014/02/doxycycline-200px.png";s:5:"sizes";a:1:{s:9:"thumbnail";a:4:{s:4:"file";s:29:"doxycycline-200px-150x102.png";s:5:"width";i:150;s:6:"height";i:102;s:9:"mime-type";s:9:"image/png";}}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>prion-drug-progress</title>
		<link>http://www.prionalliance.org/2014/03/03/when-will-treatments-be-available-for-prion-disease/prion-drug-progress/</link>
		<pubDate>Sat, 01 Mar 2014 23:26:59 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/03/prion-drug-progress.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[There are potential treatments for prion disease at many different stages of development.]]></excerpt:encoded>
		<wp:post_id>617</wp:post_id>
		<wppost_date>2014-03-01 23:26:59</wppost_date>
		<wppost_date_gmt>2014-03-01 23:26:59</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-drug-progress</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>611</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/03/prion-drug-progress.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/03/prion-drug-progress.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:553;s:6:"height";i:432;s:4:"file";s:31:"2014/03/prion-drug-progress.png";s:5:"sizes";a:8:{s:9:"thumbnail";a:4:{s:4:"file";s:31:"prion-drug-progress-150x150.png";s:5:"width";i:150;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}s:6:"medium";a:4:{s:4:"file";s:31:"prion-drug-progress-300x234.png";s:5:"width";i:300;s:6:"height";i:234;s:9:"mime-type";s:9:"image/png";}s:14:"post-thumbnail";a:4:{s:4:"file";s:31:"prion-drug-progress-553x288.png";s:5:"width";i:553;s:6:"height";i:288;s:9:"mime-type";s:9:"image/png";}s:13:"large-feature";a:4:{s:4:"file";s:31:"prion-drug-progress-553x288.png";s:5:"width";i:553;s:6:"height";i:288;s:9:"mime-type";s:9:"image/png";}s:13:"small-feature";a:4:{s:4:"file";s:31:"prion-drug-progress-384x300.png";s:5:"width";i:384;s:6:"height";i:300;s:9:"mime-type";s:9:"image/png";}s:16:"jmtc-small-thumb";a:4:{s:4:"file";s:31:"prion-drug-progress-280x150.png";s:5:"width";i:280;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}s:18:"jmtc-max-web-thumb";a:4:{s:4:"file";s:31:"prion-drug-progress-435x375.png";s:5:"width";i:435;s:6:"height";i:375;s:9:"mime-type";s:9:"image/png";}s:32:"jmtc-max-mobile-non-retina-thumb";a:4:{s:4:"file";s:31:"prion-drug-progress-280x375.png";s:5:"width";i:280;s:6:"height";i:375;s:9:"mime-type";s:9:"image/png";}}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>trieste-at-night-600px</title>
		<link>http://www.prionalliance.org/2014/06/22/prion2014-recap/trieste-at-night-600px/</link>
		<pubDate>Sun, 22 Jun 2014 21:19:28 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/06/trieste-at-night-600px.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[The Piazza Unit&agrave; D'Italia in central Trieste.]]></excerpt:encoded>
		<wp:post_id>629</wp:post_id>
		<wppost_date>2014-06-22 21:19:28</wppost_date>
		<wppost_date_gmt>2014-06-22 21:19:28</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>trieste-at-night-600px</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>628</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/06/trieste-at-night-600px.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/06/trieste-at-night-600px.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:600;s:6:"height";i:450;s:4:"file";s:34:"2014/06/trieste-at-night-600px.jpg";s:5:"sizes";a:9:{s:9:"thumbnail";a:4:{s:4:"file";s:34:"trieste-at-night-600px-150x150.jpg";s:5:"width";i:150;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:34:"trieste-at-night-600px-300x225.jpg";s:5:"width";i:300;s:6:"height";i:225;s:9:"mime-type";s:10:"image/jpeg";}s:14:"post-thumbnail";a:4:{s:4:"file";s:34:"trieste-at-night-600px-600x288.jpg";s:5:"width";i:600;s:6:"height";i:288;s:9:"mime-type";s:10:"image/jpeg";}s:13:"large-feature";a:4:{s:4:"file";s:34:"trieste-at-night-600px-600x288.jpg";s:5:"width";i:600;s:6:"height";i:288;s:9:"mime-type";s:10:"image/jpeg";}s:13:"small-feature";a:4:{s:4:"file";s:34:"trieste-at-night-600px-400x300.jpg";s:5:"width";i:400;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:16:"jmtc-small-thumb";a:4:{s:4:"file";s:34:"trieste-at-night-600px-280x150.jpg";s:5:"width";i:280;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}s:18:"jmtc-max-web-thumb";a:4:{s:4:"file";s:34:"trieste-at-night-600px-435x375.jpg";s:5:"width";i:435;s:6:"height";i:375;s:9:"mime-type";s:10:"image/jpeg";}s:32:"jmtc-max-mobile-non-retina-thumb";a:4:{s:4:"file";s:34:"trieste-at-night-600px-280x375.jpg";s:5:"width";i:280;s:6:"height";i:375;s:9:"mime-type";s:10:"image/jpeg";}s:28:"jmtc-max-mobile-retina-thumb";a:4:{s:4:"file";s:34:"trieste-at-night-600px-560x450.jpg";s:5:"width";i:560;s:6:"height";i:450;s:9:"mime-type";s:10:"image/jpeg";}}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>sonia-and-eric-presenting-at-prion2014</title>
		<link>http://www.prionalliance.org/2014/06/22/prion2014-recap/sonia-and-eric-presenting-at-prion2014/</link>
		<pubDate>Sun, 22 Jun 2014 21:26:48 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/06/sonia-and-eric-presenting-at-prion2014.jpg</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA["Proteinaceous Infectious Optimism." We present our story at Prion2014. <em>Photo by Ekaterina Kochegurova.</em>]]></excerpt:encoded>
		<wp:post_id>630</wp:post_id>
		<wppost_date>2014-06-22 21:26:48</wppost_date>
		<wppost_date_gmt>2014-06-22 21:26:48</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>sonia-and-eric-presenting-at-prion2014</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>628</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/06/sonia-and-eric-presenting-at-prion2014.jpg</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/06/sonia-and-eric-presenting-at-prion2014.jpg]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:600;s:6:"height";i:450;s:4:"file";s:50:"2014/06/sonia-and-eric-presenting-at-prion2014.jpg";s:5:"sizes";a:9:{s:9:"thumbnail";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-150x150.jpg";s:5:"width";i:150;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-300x225.jpg";s:5:"width";i:300;s:6:"height";i:225;s:9:"mime-type";s:10:"image/jpeg";}s:14:"post-thumbnail";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-600x288.jpg";s:5:"width";i:600;s:6:"height";i:288;s:9:"mime-type";s:10:"image/jpeg";}s:13:"large-feature";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-600x288.jpg";s:5:"width";i:600;s:6:"height";i:288;s:9:"mime-type";s:10:"image/jpeg";}s:13:"small-feature";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-400x300.jpg";s:5:"width";i:400;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:16:"jmtc-small-thumb";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-280x150.jpg";s:5:"width";i:280;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}s:18:"jmtc-max-web-thumb";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-435x375.jpg";s:5:"width";i:435;s:6:"height";i:375;s:9:"mime-type";s:10:"image/jpeg";}s:32:"jmtc-max-mobile-non-retina-thumb";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-280x375.jpg";s:5:"width";i:280;s:6:"height";i:375;s:9:"mime-type";s:10:"image/jpeg";}s:28:"jmtc-max-mobile-retina-thumb";a:4:{s:4:"file";s:50:"sonia-and-eric-presenting-at-prion2014-560x450.jpg";s:5:"width";i:560;s:6:"height";i:450;s:9:"mime-type";s:10:"image/jpeg";}}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>trieste-at-night-100px</title>
		<link>http://www.prionalliance.org/2014/06/22/prion2014-recap/trieste-at-night-100px/</link>
		<pubDate>Sun, 22 Jun 2014 21:36:37 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/06/trieste-at-night-100px.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>632</wp:post_id>
		<wppost_date>2014-06-22 21:36:37</wppost_date>
		<wppost_date_gmt>2014-06-22 21:36:37</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>trieste-at-night-100px</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>628</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/06/trieste-at-night-100px.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/06/trieste-at-night-100px.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:100;s:6:"height";i:100;s:4:"file";s:34:"2014/06/trieste-at-night-100px.png";s:5:"sizes";a:0:{}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>e200k-paper-ajhg-title</title>
		<link>http://www.prionalliance.org/2014/10/02/no-anticipation-in-e200k-prion-disease/e200k-paper-ajhg-title/</link>
		<pubDate>Thu, 02 Oct 2014 16:41:54 +0000</pubDate>
		<dccreator><![CDATA[eric]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/wp-content/uploads/2014/10/e200k-paper-ajhg-title.png</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>642</wp:post_id>
		<wppost_date>2014-10-02 16:41:54</wppost_date>
		<wppost_date_gmt>2014-10-02 16:41:54</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>e200k-paper-ajhg-title</wp:post_name>
		<wpstatus>inherit</wpstatus>
		<wp:post_parent>641</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>attachment</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:attachment_url>http://www.prionalliance.org/wp-content/uploads/2014/10/e200k-paper-ajhg-title.png</wp:attachment_url>
		<wp:postmeta>
			<wp:meta_key>_wp_attached_file</wp:meta_key>
			<wp:meta_value><![CDATA[2014/10/e200k-paper-ajhg-title.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_attachment_metadata</wp:meta_key>
			<wp:meta_value><![CDATA[a:5:{s:5:"width";i:750;s:6:"height";i:196;s:4:"file";s:34:"2014/10/e200k-paper-ajhg-title.png";s:5:"sizes";a:7:{s:9:"thumbnail";a:4:{s:4:"file";s:34:"e200k-paper-ajhg-title-150x150.png";s:5:"width";i:150;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}s:6:"medium";a:4:{s:4:"file";s:33:"e200k-paper-ajhg-title-300x78.png";s:5:"width";i:300;s:6:"height";i:78;s:9:"mime-type";s:9:"image/png";}s:13:"small-feature";a:4:{s:4:"file";s:34:"e200k-paper-ajhg-title-500x130.png";s:5:"width";i:500;s:6:"height";i:130;s:9:"mime-type";s:9:"image/png";}s:16:"jmtc-small-thumb";a:4:{s:4:"file";s:34:"e200k-paper-ajhg-title-280x150.png";s:5:"width";i:280;s:6:"height";i:150;s:9:"mime-type";s:9:"image/png";}s:18:"jmtc-max-web-thumb";a:4:{s:4:"file";s:34:"e200k-paper-ajhg-title-435x196.png";s:5:"width";i:435;s:6:"height";i:196;s:9:"mime-type";s:9:"image/png";}s:32:"jmtc-max-mobile-non-retina-thumb";a:4:{s:4:"file";s:34:"e200k-paper-ajhg-title-280x196.png";s:5:"width";i:280;s:6:"height";i:196;s:9:"mime-type";s:9:"image/png";}s:28:"jmtc-max-mobile-retina-thumb";a:4:{s:4:"file";s:34:"e200k-paper-ajhg-title-560x196.png";s:5:"width";i:560;s:6:"height";i:196;s:9:"mime-type";s:9:"image/png";}}s:10:"image_meta";a:10:{s:8:"aperture";i:0;s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";i:0;s:9:"copyright";s:0:"";s:12:"focal_length";i:0;s:3:"iso";i:0;s:13:"shutter_speed";i:0;s:5:"title";s:0:"";}}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Contact</title>
		<link>http://www.prionalliance.org/contact/</link>
		<pubDate>Sun, 07 Oct 2012 16:38:15 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=15</guid>
		<description></description>
		<contentencoded><![CDATA[Whether you've got a question, an idea, a proposal or just to say hello, we would love to hear from you.  Just note that we are not medical professionals and cannot provide medical advice.  To send us an email, please use this form:

[contact_form]

To send us snail mail or a donation, please send letters to:

PRION ALLIANCE
P.O. BOX 391953
CAMBRIDGE, MA 02139

Our official business address is:

PRION ALLIANCE INC
270 DORCHESTER AVE
BOSTON MA 02127]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>15</wp:post_id>
		<wppost_date>2012-10-07 16:38:15</wppost_date>
		<wppost_date_gmt>2012-10-07 16:38:15</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>contact</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Get Involved</title>
		<link>http://www.prionalliance.org/get-involved/</link>
		<pubDate>Sun, 07 Oct 2012 17:21:15 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=20</guid>
		<description></description>
		<contentencoded><![CDATA[Want to help us cure human prion diseases?  There are several ways you can help.

<a title="Donate" href="http://www.prionalliance.org/donate/"><strong>Donate</strong></a>

To make a tax deductible donation online or by check, please visit our <a title="Donate" href="http://www.prionalliance.org/donate/">donations</a> page.  We were awarded 501(c)(3) tax exempt status from the IRS on October 23, 2012, so your contribution will be fully tax deductible.

We have already developed, and are continuing to improve upon, a detailed plan for the <a title="Research" href="http://www.prionalliance.org/research/">research we would like to support</a>, so that we can tell you exactly where your donation will go.  In the meantime, if you have ideas or opinions, please <a title="Contact Us" href="http://www.prionalliance.org/contact/">contact us</a> and let us know what you think we should prioritize!

<strong>Fundraise</strong>

Want to use your network, your charisma and your impeccable sense of style to help us raise funds for research?  You can organize a walk, run, gala, date auction or any other event you can dream up.  We would be thrilled and we'll support you in any way we can.  <a title="Contact Us" href="http://www.prionalliance.org/contact/">contact us</a> with your idea and together we'll work out the details.

<strong>Collaborate</strong>

If you're a scientist -- or a budding scientist -- with an interest in prion research, let's talk.  You can get a sense of our current research interests on the <a title="Research" href="http://www.prionalliance.org/research/">research</a> page, but even if your area of study doesn't match what we've been working on so far, don't hesitate to <a href="http://www.prionalliance.org/contact/">contact us</a>.  We'd love to hear your brilliant idea, or share our ideas.  You can help shape our research agenda, propose an experiment, share data, offer your help, ask for our help, or simply make the connection so that we can stay on one another's radar.

<strong>Keep in touch</strong>

Stay informed on what we're up to and share it with your friends. Follow <a href="https://twitter.com/intent/user?screen_name=PrionAlliance">@PrionAlliance</a> and <a href="https://twitter.com/intent/user?screen_name=cureffi">@cureffi</a> on Twitter and visit <a href="http://www.facebook.com/PrionAlliance/">Prion Alliance on Facebook</a>.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>20</wp:post_id>
		<wppost_date>2012-10-07 17:21:15</wppost_date>
		<wppost_date_gmt>2012-10-07 17:21:15</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>get-involved</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Research Goals</title>
		<link>http://www.prionalliance.org/research/</link>
		<pubDate>Sun, 07 Oct 2012 17:43:01 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=24</guid>
		<description></description>
		<contentencoded><![CDATA[Prion Alliance exists to promote research leading to a treatment or cure for human prion diseases.  We are currently focused on the following research goals.  <em>Updated August 2013</em>

<strong>Development of strategies to deplete PrP<sup>C</sup></strong>

PrP knockout mice are resistant to prion disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8100741">Bueler 1993</a>], and Cre-mediated conditional knockout of PrP  after the onset of symptoms reverses disease in prion-infected mice [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14593181">Mallucci 2003</a>].  Abolishing expression of PrP is the only approach that has ever reversed symptomatic prion disease in any animal model.  For this and <a href="http://www.cureffi.org/2013/04/08/the-case-for-depleting-prp-as-a-therapeutic-strategy-against-prion-diseases/">several other reasons</a>, we believe that depleting PrP is the most promising route to a cure for prion diseases.

We are interested in several research areas focused on the ultimate goal of depleting PrP therapeutically:
<ul>
	<li>Development of new assays to discover small molecules capable of depleting PrP.</li>
	<li>Identifying the most effective siRNAs against PrP mRNA and developing improved delivery systems for therapeutic gene silencing in the brain.</li>
	<li>Understanding the pathways by which PrP transcription, translation, metabolism and degradation are regulated.</li>
	<li>Illuminating the mechanisms by which mutant PrP is selectively degraded in the cell and finding ways to enhance this degradative process.</li>
</ul>
<strong>Validation of experimental treatments in models of genetic prion disease</strong>

To date over a hundred <a href="http://www.cureffi.org/prion-therapeutic-review">experimental treatments</a> - small molecules, antibodies, vaccination protocols, and gene silencing vectors - have been tested in animal models of prion disease.  Virtually all of these <em>in vivo</em> experiments have used animals infected with exogenously introduced prions.  Treatments effective in infected models may have greater or lesser effects in genetic models due to differences in prion conformation, PrP primary structure, and timepoints available for therapeutic intervention.  For those treatments most effective in prion-infected animal models, we are interested in conducting trials in knock-in and transgenic animal models carrying mutations that cause genetic prion disease in humans.

<strong>Identifying early biomarkers of prion disease</strong>

Genetic prion diseases cause illness in mid-life even though the mutation is present from conception.   Does mid-life onset result from a life-long slow buildup of infectious material, or from a decades-long silent phase followed by a stochastic misfolding event and a subsequent rapid disease course?  The answer to this question bears on how early potential treatments must be started to be effective, and on whether early biomarkers in asymptomatic carriers of genetic prion disease mutations could possibly exist.

In sporadic prion disease, 2/3 of the disease course from first symptoms to death is spent in reaching a correct diagnosis [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23007691">Paterson 2012</a>].  Early diagnosis and early intervention will be crucial in maximizing the effectiveness of future treatments.

<strong>Developing tools for prion research and advancing basic science</strong>

Improved tools for researching prions and a better understanding of fundamental questions about prions will ultimately pave the way for smarter therapeutic development.  A few of the needs we view as most urgent are:
<ul>
	<li>Development of human cell lines capable of propagating human prion strains.</li>
	<li>Elucidating the mechanisms of prion strain evolution and drug resistance.</li>
	<li>Understanding the kinetics of prion propagation.</li>
	<li>Identifying the mechanisms of prion neurotoxicity.</li>
	<li>Clarifying phenotypes resulting from PrP knockout and the potential side effects of PrP depletion as a therapeutic strategy.</li>
</ul>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>24</wp:post_id>
		<wppost_date>2012-10-07 17:43:01</wppost_date>
		<wppost_date_gmt>2012-10-07 17:43:01</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>research</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Thank You</title>
		<link>http://www.prionalliance.org/thank-you/</link>
		<pubDate>Sat, 03 Nov 2012 20:27:19 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=65</guid>
		<description></description>
		<contentencoded><![CDATA[Thank you for supporting Prion Alliance. You are awesome.

Next step: boast about how awesome you are (and help us get the word out) by telling your friends you donated by <a class="twitter-mention-button" href="https://twitter.com/intent/tweet?screen_name=PrionAlliance&amp;text=I%20just%20donated%20http://www.prionalliance.org/donate/.">Tweeting at us</a> or commenting on <a href="http://www.facebook.com/PrionAlliance">our Facebook page</a>.

You should receive your donation receipt within two business days; if you do not, please <a title="Contact" href="http://www.prionalliance.org/contact/">contact us</a>.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>65</wp:post_id>
		<wppost_date>2012-11-03 20:27:19</wppost_date>
		<wppost_date_gmt>2012-11-03 20:27:19</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>thank-you</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Donate</title>
		<link>http://www.prionalliance.org/donate/</link>
		<pubDate>Sat, 03 Nov 2012 21:13:30 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=74</guid>
		<description></description>
		<contentencoded><![CDATA[Prion Alliance is a 501(c)(3) non-profit devoted exclusively to raising funds to support research into a treatment or cure for human prion diseases including Creutzfeldt-Jakob disease, fatal familial insomnia and Gerstmann-Straussler-Scheinker syndrome. Prion Alliance gladly accepts tax-deductible donations of all shapes and sizes, whether <a href="#online">online</a>, <a href="#recurring">monthly</a> or <a href="#snailmail">by check</a>:

<a name="online"></a><strong>Online</strong>

We accept donations through two online services: Amazon SimplePay and PayPal.  If you've already got an account with one of these companies, this is incredibly quick and easy.  Just use the links below.


<!-- noformat on -->
<div style="width:20em;padding-left:10px;padding-top:10px;padding-right:10px;padding-bottom:10px;">
	<table class="table" border="0" cellpadding="0" cellspacing="0" width="100%">
	<tr>
	<form action="https://authorize.payments.amazon.com/pba/paypipeline" method="post">
	  <input type="hidden" name="returnUrl" value="http://www.prionalliance.org/thank-you/" >
	  <input type="hidden" name="processImmediate" value="1" >
	  <input type="hidden" name="accessKey" value="11SEM03K88SD016FS1G2" >
	  <input type="hidden" name="signatureMethod" value="HmacSHA256" >
	  <input type="hidden" name="collectShippingAddress" value="1" >
	  <input type="hidden" name="isDonationWidget" value="1" >
	  <input type="hidden" name="amazonPaymentsAccountId" value="GDCOXCPEINODC2XVSVG935ZLE4N95F9AZQRRG4" >
	  <input type="hidden" name="referenceId" value="prion-alliance-amazon-donations" >
	  <input type="hidden" name="cobrandingStyle" value="logo" >
	  <input type="hidden" name="immediateReturn" value="0" >
	  <input type="hidden" name="description" value="Support research to treat or cure human prion diseases." >
	  <input type="hidden" name="abandonUrl" value="http://www.prionalliance.org/cancel/" >
	  <input type="hidden" name="signatureVersion" value="2" >
	  <input type="hidden" name="signature" value="pt7FFgeCYNioJtqql4oPZCEntWO1SD+uQSGcr4nATag=" >
	
	<td>$&nbsp;
	<input type="text" name="amount" size="8" 
		value=""></td>
	<td>&nbsp;</td>  
	<td><input type="image" src="http://g-ecx.images-amazon.com/images/G/01/asp/beige_small_donate_withmsg_whitebg.gif" border="0"></td>
	</form>
	</tr>
	</table>
	</div>
<!-- noformat off -->

<!-- noformat on -->
<img title="paypal" src="http://69.195.124.66/~prionall/wp-content/uploads/2012/11/paypal.gif" alt="PayPal logo" width="200" height="50" />
<div style="float: left;"><form action="https://www.paypal.com/cgi-bin/webscr" method="post"><input type="hidden" name="cmd" value="_s-xclick" />
<input type="hidden" name="hosted_button_id" value="9FU3LLRQXKYYL" />
<input type="image" name="submit" src="https://www.paypalobjects.com/en_US/i/btn/btn_donateCC_LG.gif" alt="PayPal - The safer, easier way to pay online!" />
<img src="https://www.paypalobjects.com/en_US/i/scr/pixel.gif" alt="" width="1" height="1" border="0" /></form></div>
<div style="clear: both;"></div>
<!-- noformat off -->


<br>
These companies and their awesome cybersecurity staff just deposit the money into our account&mdash;we here at Prion Alliance never see your credit card information, which is a relief for you and us.

<a name="recurring"></a><strong>Recurring</strong>

If you want to make a recurring donation to Prion Alliance each month, first of all, you're awesome.  Second of all, you can use this handy PayPal button:

<!-- noformat on -->

<form action="https://www.paypal.com/cgi-bin/webscr" method="post">
<input type="hidden" name="cmd" value="_xclick-subscriptions">
<input type="hidden" name="business" value="R2W28GE3HDRYG">
<input type="hidden" name="lc" value="US">
<input type="hidden" name="item_name" value="Recurring donation to Prion Alliance">
<input type="hidden" name="item_number" value="prion-alliance-paypal-recurring">
<input type="hidden" name="no_note" value="1">
<input type="hidden" name="no_shipping" value="2">
<input type="hidden" name="rm" value="1">
<input type="hidden" name="return" value="http://www.prionalliance.org/thank-you/">
<input type="hidden" name="cancel_return" value="http://www.prionalliance.org/cancel/">
<input type="hidden" name="src" value="1">
<input type="hidden" name="a3" value="1.00">
<input type="hidden" name="p3" value="1">
<input type="hidden" name="t3" value="M">
<input type="hidden" name="currency_code" value="USD">
<input type="hidden" name="bn" value="PP-SubscriptionsBF:btn_donateCC_LG.gif:NonHosted">
<table>
<tr><td>Monthly Donation Amount:</td></tr>
<tr><td><input type="text" name="a3" maxlength="60"></td></tr>
</table>
<input type="image" src="https://www.paypal.com/en_US/i/btn/btn_donateCC_LG.gif" border="0" name="submit" alt="PayPal - The safer, easier way to pay online!">
<img alt="" border="0" src="https://www.paypalobjects.com/en_US/i/scr/pixel.gif" width="1" height="1">
</form>
<br>
<br>
<!-- noformat off -->


<a name="snailmail"></a><strong>By mail</strong>

Send a check made out to Prion Alliance to:

PRION ALLIANCE
P.O. BOX 391953
CAMBRIDGE, MA 02139

Just make sure your return address is legible or that you include a note with your email address, so that we can send you a donation receipt so that you can deduct this donation on your tax return. For tax deduction purposes, our EIN is 46-0732060.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>74</wp:post_id>
		<wppost_date>2012-11-03 21:13:30</wppost_date>
		<wppost_date_gmt>2012-11-03 21:13:30</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>donate</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Cancel</title>
		<link>http://www.prionalliance.org/cancel/</link>
		<pubDate>Tue, 06 Nov 2012 19:42:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=86</guid>
		<description></description>
		<contentencoded><![CDATA[You have cancelled your donation.  You will not be charged.

Return to the <a href="http://www.prionalliance.org/">homepage</a>.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>86</wp:post_id>
		<wppost_date>2012-11-06 19:42:52</wppost_date>
		<wppost_date_gmt>2012-11-06 19:42:52</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>cancel</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>People</title>
		<link>http://www.prionalliance.org/people/</link>
		<pubDate>Sat, 10 Nov 2012 23:31:20 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=104</guid>
		<description></description>
		<contentencoded><![CDATA[<!-- noformat on -->
<strong>Directors</strong>
<div style="display: block;">
<div style="width: 20%; float: left;"><img class="alignnone size-medium wp-image-141" title="sonia-vallabh" src="http://69.195.124.66/~prionall/wp-content/uploads/2012/11/sonia-vallabh-232x300.jpg" alt="" width="232" height="300" />
<a href="http://www.linkedin.com/pub/sonia-vallabh/81/b39/275"><img class="alignnone size-full wp-image-163" title="in" src="http://www.prionalliance.org/wp-content/uploads/2012/11/in.png" alt="" width="16" height="16" /></a></div>
<div style="float: left important!; width: 80% important!; padding-left: 25%;"><strong>Sonia Vallabh</strong> is president and co-founder of Prion Alliance. She currently works at the Center for Human Genetic Research at Massachusetts General Hospital, where her responsibilities include experiments querying the role of splicing and epigenetic dysregulation in Huntington’s disease, using human induced pluripotent stem cell and mouse embryonic stem cell systems. Sonia also brings to Prion Alliance leadership and organizational expertise from her pre-scientific career, in which she earned a J.D. cum laude from Harvard Law School, specializing in negotiation and mediation. As president of Prion Alliance she is responsible for fundraising, outreach, collaboration, and setting research goals.</div>
<div style="clear: both;"></div>
<br/>
<div style="width: 20%; float: left;"><img class="alignnone size-medium wp-image-140" title="eric-minikel" src="http://69.195.124.66/~prionall/wp-content/uploads/2012/11/eric-minikel-244x300.jpg" alt="" width="244" height="300" />
<a href="http://www.linkedin.com/in/ericminikel"><img class="alignnone size-full wp-image-163" title="in" src="http://www.prionalliance.org/wp-content/uploads/2012/11/in.png" alt="" width="16" height="16" /></a></div>
<div style="float: left important!; width: 80% important!; padding-left: 25%;"><strong>Eric Minikel</strong> co-founded Prion Alliance with Sonia Vallabh and also serves as the organization's Treasurer and Clerk. He works as a Computational Scientist at Massachusetts General Hospital's Center for Human Genetic Research, where he is responsible for analyzing large genetic datasets to illuminate the biology of Huntington's Disease. Eric is a major contributor to CureFFI.org and is responsible for maintaining PrionAlliance.org, managing the organization's finances and helping to set research goals. Before becoming interested in applying his computational skill set to prion diseases, Eric received dual Master's degrees in City Planning and Transportation '10 from the Massachusetts Institute of Technology, specializing in the analysis of large, complex urban data sets.</div>
<div style="clear: both;"></div>
<br/>
<div style="width: 20%; float: left;"><img class="alignnone size-full wp-image-110" title="greta" src="http://69.195.124.66/~prionall/wp-content/uploads/2012/11/greta.png" alt="" width="135" height="133" /></div>
<div style="float: left important!; width: 80% important!; padding-left: 25%;"><strong>Greta Beekhuis</strong> joins Sonia and Eric on the Prion Alliance Board of Directors. Greta currently works as a Technical Writer and Editor for the Department of Neurosurgery at Stanford School of Medicine. At Prion Alliance she is instrumental in developing new relationships and setting long-term strategy. Greta has over 20 years experience in project management and business development consulting in the biotechnology industry. Greta holds a B.A. degree in Art Therapy with a social justice and advocacy focus from Guilford College, and has more than 25 years of advocacy experience with the developmental disabilities community.</div>
</div>
<div style="clear: both;"></div>
<br/>

<!-- noformat off -->]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>104</wp:post_id>
		<wppost_date>2012-11-10 23:31:20</wppost_date>
		<wppost_date_gmt>2012-11-10 23:31:20</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>people</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>I Just Donated</title>
		<link>http://www.prionalliance.org/i-just-donated/</link>
		<pubDate>Mon, 17 Dec 2012 21:27:34 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=206</guid>
		<description></description>
		<contentencoded><![CDATA[Congratulations: you're on the right side of history. 2012 is a bad time to be a rare disease, thanks to people like you.

You should receive your donation receipt within two business days; if you do not, please <a title="Contact" href="http://www.prionalliance.org/contact/">contact us</a>.

In the meantime, use the social buttons below to tell your friends that you owned it.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>206</wp:post_id>
		<wppost_date>2012-12-17 21:27:34</wppost_date>
		<wppost_date_gmt>2012-12-17 21:27:34</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>i-just-donated</wp:post_name>
		<wpstatus>private</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Donation Sandbox</title>
		<link>http://www.prionalliance.org/donation-sandbox/</link>
		<pubDate>Mon, 07 Jan 2013 01:13:28 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=251</guid>
		<description></description>
		<contentencoded><![CDATA[To make a recurring donation:

<!-- noformat on -->

<form action="https://www.paypal.com/cgi-bin/webscr" method="post">
<input type="hidden" name="cmd" value="_xclick-subscriptions">
<input type="hidden" name="business" value="R2W28GE3HDRYG">
<input type="hidden" name="lc" value="US">
<input type="hidden" name="item_name" value="Recurring donation to Prion Alliance">
<input type="hidden" name="item_number" value="prion-alliance-paypal-recurring">
<input type="hidden" name="no_note" value="1">
<input type="hidden" name="no_shipping" value="2">
<input type="hidden" name="rm" value="1">
<input type="hidden" name="return" value="http://www.prionalliance.org/thank-you/">
<input type="hidden" name="cancel_return" value="http://www.prionalliance.org/cancel/">
<input type="hidden" name="src" value="1">
<input type="hidden" name="a3" value="1.00">
<input type="hidden" name="p3" value="1">
<input type="hidden" name="t3" value="M">
<input type="hidden" name="currency_code" value="USD">
<input type="hidden" name="bn" value="PP-SubscriptionsBF:btn_subscribeCC_LG.gif:NonHosted">
<table>
<tr><td>Enter Your Donation Amount</td></tr>
<tr><td><input type="text" name="a3" maxlength="60"></td></tr>
</table>
<input type="image" src="https://www.paypal.com/en_US/i/btn/btn_donateCC_LG.gif" border="0" name="submit" alt="PayPal - The safer, easier way to pay online!">
<img alt="" border="0" src="https://www.paypalobjects.com/en_US/i/scr/pixel.gif" width="1" height="1">
</form>

<!-- noformat off -->]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>251</wp:post_id>
		<wppost_date>2013-01-07 01:13:28</wppost_date>
		<wppost_date_gmt>2013-01-07 01:13:28</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>donation-sandbox</wp:post_name>
		<wpstatus>private</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Our Story</title>
		<link>http://www.prionalliance.org/our-story/</link>
		<pubDate>Tue, 22 Jan 2013 21:41:11 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=265</guid>
		<description></description>
		<contentencoded><![CDATA[<a href="http://www.prionalliance.org/wp-content/uploads/2013/01/43crop.jpg"><img class="alignnone size-full wp-image-387" title="43crop" src="http://www.prionalliance.org/wp-content/uploads/2013/01/43crop.jpg" alt="" width="600" height="431" />
</a><em>Photo by Aditi Mehta (<a href="http://creativecommons.org/licenses/by/3.0/">CC BY</a>).</em>

We're in love, and since learning that Sonia carries a fatal genetic disease, we've changed everything in our lives.  Next, we want to change history.

Fatal Familial Insomnia (FFI) is a genetic prion disease closely related to Creutzfeldt-Jakob Disease (CJD) and mad cow disease.  The disease is caused by a mutation in the human prion protein gene (PRNP) which gives rise to misfolded proteins that kill neurons.  The average age of onset for FFI is 50, and most patients die within one year.  The disease is currently incurable and untreatable.  Learn more about prion diseases in our <a title="Frequently Asked Questions" href="http://www.prionalliance.org/faq/">FAQ</a>.

Sonia's mother passed away of a mysterious neurodegenerative disease in 2010, and we later learned from autopsy that the cause was FFI.  In December 2011 genetic test results showed that Sonia inherited the disease gene from her mother.  We didn't seem to be in that much of a position to do anything about it.  FFI is currently incurable and untreatable, our degrees in law and city planning were not relevant to finding a cure, nor was our bank account up to the task of funding any research.  But it's not our nature to take bad news sitting down.  We decided that ending FFI would be our life's work.

Within a few days of getting the news we started reading papers, calling researchers, and asking our scientist friends for guidance.  In January 2012 we started our scientific blog, <a href="http://www.cureffi.org/">CureFFI.org</a>.  Sonia quit her job in consulting and started taking science classes at MIT and Harvard Extension School. By April she had found a new job in stem cell research at Massachusetts General Hospital, and Eric followed in July, retooling his data analysis skillset towards bioinformatics.

In parallel with beginning to retrain ourselves as scientists, we also founded a non-profit organization to serve as our fundraising arm.  Prion Alliance raises funds exclusively to fund scientific research towards a cure for human prion diseases.  Along the way, we hope to make the prion research field more open by publicizing everything we learn and encouraging the open sharing of datasets and methodologies.  At present, 100% of funds go to science: we pay no salaries and we pay all administrative expenses out of our own pockets.

Read more about our story in <a href="http://www.newyorker.com/online/blogs/books/2013/09/a-prion-love-story.html">The New Yorker</a> and <a href="http://www.thetimes.co.uk/tto/health/article3955060.ece">The Times of London</a> (<a href="http://www.prionalliance.org/wp-content/uploads/2014/01/the-times-2013-12-23-unless-we-find-a-cure-insomnia-will-kill-me.pdf">full text</a>).]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>265</wp:post_id>
		<wppost_date>2013-01-22 21:41:11</wppost_date>
		<wppost_date_gmt>2013-01-22 21:41:11</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>our-story</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>641</wp:comment_id>
			<wp:comment_author><![CDATA[nidhan]]></wp:comment_author>
			<wp:comment_author_email>nidhan@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>14.139.220.49</wp:comment_author_IP>
			<wp:comment_date>2013-03-28 14:23:47</wp:comment_date>
			<wp:comment_date_gmt>2013-03-28 14:23:47</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Great.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1364480627.33";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>278</wp:comment_id>
			<wp:comment_author><![CDATA[Ratna Radhakrishna]]></wp:comment_author>
			<wp:comment_author_email>ratnarockstar@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>64.216.106.77</wp:comment_author_IP>
			<wp:comment_date>2013-03-02 04:21:57</wp:comment_date>
			<wp:comment_date_gmt>2013-03-02 04:21:57</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Good peeps.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1362198117.48";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>1314</wp:comment_id>
			<wp:comment_author><![CDATA[John Paul Glaves]]></wp:comment_author>
			<wp:comment_author_email>glavesy@hotmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>199.126.130.222</wp:comment_author_IP>
			<wp:comment_date>2013-06-01 17:52:28</wp:comment_date>
			<wp:comment_date_gmt>2013-06-01 17:52:28</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[It was a pleasure meeting the both of you at Prion 2013. Keep up the tremendous work!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:12:"1370109148.7";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>4382</wp:comment_id>
			<wp:comment_author><![CDATA[Philippe]]></wp:comment_author>
			<wp:comment_author_email>pcampeau@hotmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>108.245.174.68</wp:comment_author_IP>
			<wp:comment_date>2013-08-25 00:21:00</wp:comment_date>
			<wp:comment_date_gmt>2013-08-25 00:21:00</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Great blog. Best of luck with your research.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1377390060.74";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17422</wp:comment_id>
			<wp:comment_author><![CDATA[Naveen]]></wp:comment_author>
			<wp:comment_author_email>kondru@iastate.edu</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>129.186.252.211</wp:comment_author_IP>
			<wp:comment_date>2014-05-27 01:46:20</wp:comment_date>
			<wp:comment_date_gmt>2014-05-27 01:46:20</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Love u guys &amp; your initiative! Good bless you with all good luck! 
.. Naveen]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1401155180.9814551;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17443</wp:comment_id>
			<wp:comment_author><![CDATA[Evelien]]></wp:comment_author>
			<wp:comment_author_email>evelienboskma@yahoo.co.uk</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>80.60.252.56</wp:comment_author_IP>
			<wp:comment_date>2015-02-21 18:53:04</wp:comment_date>
			<wp:comment_date_gmt>2015-02-21 18:53:04</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[actress75, please contact me. I read your comment but I can't find it on this website anymore. My email is evelienboskma@yahoo.co.uk]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1424544784.8941541;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17444</wp:comment_id>
			<wp:comment_author><![CDATA[Evelien]]></wp:comment_author>
			<wp:comment_author_email>evelienboskma@yahoo.co.uk</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>80.60.252.56</wp:comment_author_IP>
			<wp:comment_date>2015-02-21 18:55:38</wp:comment_date>
			<wp:comment_date_gmt>2015-02-21 18:55:38</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[actress75, please contact me. I read your comment but can't find it on this website anymore. My email is evelienboskma@yahoo.co.uk]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>17422</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1424544938.137913;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Our Mission</title>
		<link>http://www.prionalliance.org/our-mission/</link>
		<pubDate>Tue, 22 Jan 2013 21:42:10 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=267</guid>
		<description></description>
		<contentencoded><![CDATA[Prion Alliance, Inc. is a nonprofit organization devoted to catalyzing scientific research towards a treatment or cure for human prion diseases.  We aim to achieve this goal by:
<ul>
	<li>Raising and disbursing funds to support research into prion disease biology and therapeutics</li>
	<li>Facilitating collaboration among top scientific minds</li>
	<li>Developing and open sourcing novel methodologies and datasets</li>
</ul>
Prion Alliance was incorporated in the state of Massachusetts on June 14, 2012 and awarded 501(c)(3) tax exempt status by the Internal Revenue Service on October 23, 2012.  Our EIN is 46-0732060.  We accept <a title="Donate" href="http://www.prionalliance.org/donate/">donations</a> online and by check.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>267</wp:post_id>
		<wppost_date>2013-01-22 21:42:10</wppost_date>
		<wppost_date_gmt>2013-01-22 21:42:10</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>our-mission</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Our Scientific Philosophy</title>
		<link>http://www.prionalliance.org/our-scientific-philosophy/</link>
		<pubDate>Tue, 22 Jan 2013 21:42:54 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=269</guid>
		<description></description>
		<contentencoded><![CDATA[Science moves faster when people collaborate.  We're huge believers in open source science, and that's why some of our members share their research on <a title="CureFFI.org" href="http://www.cureffi.org/">CureFFI.org</a>.

We recognize that science is a competitive field — being the first one to a new discovery can make or break your career — and we respect our collaborators' need for secrecy.  We also have a profound respect for patient privacy and do not publicize people's personal information.  However, within these constraints, we believe there is still a lot of room to make science more open than it is today.  Here are some goals that we strive towards:
<ul>
	<li>Making the literature more accessible.  We work to understand the latest advances and repackage them in straightforward language.</li>
	<li>Sharing methodologies.  Without giving away results or data, it's possible to share code, protocols, and approaches and save others from having to re-invent the wheel.</li>
	<li>Publicizing what didn't work.  It is a shame that experiments only get published when they work: telling the world what <em>didn't</em> work will let others build on, rather than duplicate, what you've done.  We intend to publicize the results of all our work, even that which isn't publication-worthy.</li>
	<li>Opening up the discussion.  Two scientists may not agree on everything -- or anything -- but opening up the debate so that more people can understand the evidence for each side will help us all make progress toward finding the truth.</li>
</ul>
As scientists ourselves, we aim to promote these goals in our work every day.  In running the nonprofit Prion Alliance, we also aim to promote these goals in the research that we fund and support.  All research funded by Prion Alliance is required to be published whether the results are positive or not. All publications funded in whole or part by Prion Alliance, conducted in collaboration with Prion Alliance or by Prion Alliance members are required to be made freely available to the public either as a pre-print or as an Open Access article.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>269</wp:post_id>
		<wppost_date>2013-01-22 21:42:54</wppost_date>
		<wppost_date_gmt>2013-01-22 21:42:54</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>our-scientific-philosophy</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Frequently Asked Questions</title>
		<link>http://www.prionalliance.org/faq/</link>
		<pubDate>Tue, 26 Nov 2013 02:40:32 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=377</guid>
		<description></description>
		<contentencoded><![CDATA[We're currently rolling out a series of blog posts introducing the basics of prions and prion disease. This is a work in progress. This page will link to all of the posts.
<ul>
	<li><strong><a href="http://www.prionalliance.org/2013/11/26/what-are-prions/">What are prions?</a></strong></li>
	<li><a title="What are human prion diseases?" href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/"><strong>What are human prion diseases?</strong> What is Creutzfeldt-Jakob disease (CJD)? What is fatal familial insomnia (FFI)? What is Gerstmann-Straussler-Scheinker syndrome (GSS)?</a></li>
	<li><a title="What does it mean to have a genetic prion disease?" href="http://www.prionalliance.org/2013/12/09/what-does-it-mean-to-have-a-genetic-prion-disease/"><strong>What does it mean to have a genetic prion disease?</strong></a></li>
	<li><strong><a title="What are the potential treatments for prion disease?" href="http://www.prionalliance.org/2014/02/04/what-are-the-potential-treatments-for-prion-disease/">What are the potential treatments for prion disease?</a></strong></li>
	<li><strong><a title="When will treatments be available for prion disease?" href="http://www.prionalliance.org/2014/03/03/when-will-treatments-be-available-for-prion-disease/">When will treatments be available for prion disease?</a></strong></li>
</ul>
&nbsp;]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>377</wp:post_id>
		<wppost_date>2013-11-26 02:40:32</wppost_date>
		<wppost_date_gmt>2013-11-26 02:40:32</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>faq</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>16058</wp:comment_id>
			<wp:comment_author><![CDATA[ahrpainthorses@msn,com]]></wp:comment_author>
			<wp:comment_author_email>ahrpainthorses@msn.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>66.226.52.112</wp:comment_author_IP>
			<wp:comment_date>2013-12-15 17:06:31</wp:comment_date>
			<wp:comment_date_gmt>2013-12-15 17:06:31</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[how does this jacobs disease manifest in a child 7 years old. What are the symtoms.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1387127191.92";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Fundraising</title>
		<link>http://www.prionalliance.org/fundraising/</link>
		<pubDate>Wed, 25 Sep 2013 17:37:14 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=392</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>392</wp:post_id>
		<wppost_date>2013-09-25 17:37:14</wppost_date>
		<wppost_date_gmt>2013-09-25 17:37:14</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>fundraising</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_gdd_speedy_page_redirect</wp:meta_key>
			<wp:meta_value><![CDATA[a:2:{s:3:"url";s:89:"https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease/";s:6:"status";s:3:"302";}]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Microryza</title>
		<link>http://www.prionalliance.org/microryza/</link>
		<pubDate>Wed, 25 Sep 2013 17:38:01 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=394</guid>
		<description></description>
		<contentencoded><![CDATA[<iframe width="600" height="900" src="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease"></iframe>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>394</wp:post_id>
		<wppost_date>2013-09-25 17:38:01</wppost_date>
		<wppost_date_gmt>2013-09-25 17:38:01</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>microryza</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Fundraising campaign test sandbox</title>
		<link>http://www.prionalliance.org/fundraising-campaign-test-sandbox/</link>
		<pubDate>Wed, 25 Sep 2013 18:05:03 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=400</guid>
		<description></description>
		<contentencoded><![CDATA[Our Microryza campaign was a success.  Now help us reach our next goal.

[sdprogress]1[/sdprogress]

With a lot of work we could probably get these things to line up properly:
Raised Goal Donors
[sdprogress]3[/sdprogress]

<iframe src="//www.youtube.com/embed/pA5xUT4Nq3o?rel=0" frameborder="0" width="420" height="315"></iframe>

[sdonations]2[/sdonations]

And by the way, here's the progress toward a second, unrelated goal!

[sdprogress]2[/sdprogress]

&nbsp;]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>400</wp:post_id>
		<wppost_date>2013-09-25 18:05:03</wppost_date>
		<wppost_date_gmt>2013-09-25 18:05:03</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>fundraising-campaign-test-sandbox</wp:post_name>
		<wpstatus>private</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>cms-sandbox</title>
		<link>http://www.prionalliance.org/cms-sandbox/</link>
		<pubDate>Wed, 25 Sep 2013 20:59:54 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=411</guid>
		<description></description>
		<contentencoded><![CDATA[[wpdonatebuy cid=001]

[wpdonatemeter cid=001]

[wpdonategoal cid=001]

[wpdonatecollected cid=001]

[wpdonatorlist cid=001]]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>411</wp:post_id>
		<wppost_date>2013-09-25 20:59:54</wppost_date>
		<wppost_date_gmt>2013-09-25 20:59:54</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>cms-sandbox</wp:post_name>
		<wpstatus>private</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Home</title>
		<link>http://www.prionalliance.org/</link>
		<pubDate>Sun, 02 Feb 2014 22:44:32 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=559</guid>
		<description></description>
		<contentencoded><![CDATA[Prion Alliance is a non-profit scientific research foundation devoted to discovering a treatment or cure for human prion diseases: Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia.  We aim to achieve this by fundraising to support therapeutic research, and by promoting open science and collaboration within the prion research field.  Here you can learn more about <a title="Research Goals" href="http://www.prionalliance.org/research/">our research goals</a>, our <a title="Our Story" href="http://www.prionalliance.org/our-story/">personal story</a> of testing positive for the genetic mutation that causes fatal familial insomnia, the <a title="Frequently Asked Questions" href="http://www.prionalliance.org/faq/">basics of prion diseases</a>,  and you can <a title="Donate" href="http://www.prionalliance.org/donate/">support our research</a> by making a tax-deductible donation.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>559</wp:post_id>
		<wppost_date>2014-02-02 22:44:32</wppost_date>
		<wppost_date_gmt>2014-02-02 22:44:32</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>home</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[pahome.php]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Blog</title>
		<link>http://www.prionalliance.org/blog/</link>
		<pubDate>Mon, 03 Feb 2014 23:49:20 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=593</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>593</wp:post_id>
		<wppost_date>2014-02-03 23:49:20</wppost_date>
		<wppost_date_gmt>2014-02-03 23:49:20</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>blog</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[default]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>FAQ</title>
		<link>http://www.prionalliance.org/2014/02/03/faq/</link>
		<pubDate>Mon, 03 Feb 2014 23:50:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=596</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>596</wp:post_id>
		<wppost_date>2014-02-03 23:50:52</wppost_date>
		<wppost_date_gmt>2014-02-03 23:50:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>faq</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>9</wp:menu_order>
		<wppost_type>nav_menu_item</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="nav_menu" nicename="the-menu"><![CDATA[The Menu]]></category>
		<wp:postmeta>
			<wp:meta_key>_menu_item_type</wp:meta_key>
			<wp:meta_value><![CDATA[post_type]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_menu_item_parent</wp:meta_key>
			<wp:meta_value><![CDATA[0]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object_id</wp:meta_key>
			<wp:meta_value><![CDATA[377]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_object</wp:meta_key>
			<wp:meta_value><![CDATA[page]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_target</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_classes</wp:meta_key>
			<wp:meta_value><![CDATA[a:1:{i:0;s:0:"";}]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_xfn</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_menu_item_url</wp:meta_key>
			<wp:meta_value><![CDATA[]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Welcome to PrionAlliance.org</title>
		<link>http://www.prionalliance.org/2012/10/23/welcome-to-prionalliance-org-2/</link>
		<pubDate>Tue, 23 Oct 2012 16:04:11 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=48</guid>
		<description></description>
		<contentencoded><![CDATA[Welcome to our new website.  We are a newly formed nonprofit devoted to finding a treatment or cure for human prion diseases.  We've just added a rough draft of our current research goals, please <a title="Research" href="http://www.prionalliance.org/research/">check it out</a> and <a title="Contact" href="http://www.prionalliance.org/contact/">let us know your thoughts</a>!]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>48</wp:post_id>
		<wppost_date>2012-10-23 16:04:11</wppost_date>
		<wppost_date_gmt>2012-10-23 16:04:11</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>open</wp:ping_status>
		<wp:post_name>welcome-to-prionalliance-org-2</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>CureFFI.org is back</title>
		<link>http://www.prionalliance.org/2012/11/11/cureffi-org-is-back/</link>
		<pubDate>Sun, 11 Nov 2012 15:57:55 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=119</guid>
		<description></description>
		<contentencoded><![CDATA[After a couple weeks of struggling to restore the site following a malware infection, <a title="CureFFI.org" href="http://www.cureffi.org/">CureFFI.org</a> is back and better than ever. Subscribe to the <a title="CureFFI.org Posts RSS Feed" href="http://www.cureffi.org/feed/">posts RSS</a> and <a title="CureFFI.org Comments RSS Feed" href="http://www.cureffi.org/comments/feed/">comments RSS</a> to keep tabs on all the science we're doing and learning about over there.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>119</wp:post_id>
		<wppost_date>2012-11-11 15:57:55</wppost_date>
		<wppost_date_gmt>2012-11-11 15:57:55</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>cureffi-org-is-back</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Prion Alliance receives 501(c)(3) status</title>
		<link>http://www.prionalliance.org/2012/11/11/prion-alliance-receives-501c3-status/</link>
		<pubDate>Sun, 11 Nov 2012 16:00:13 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=122</guid>
		<description></description>
		<contentencoded><![CDATA[Good news: in a Letter of Determination dated October 23, 2012, the Internal Revenue Service has granted 501(c)(3) tax exempt status to Prion Alliance, Inc.!  We are now a federally recognized non profit organization and your donation to us will be tax-deductible.  We are almost ready to receive online donations and will begin fundraising this month.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>122</wp:post_id>
		<wppost_date>2012-11-11 16:00:13</wppost_date>
		<wppost_date_gmt>2012-11-11 16:00:13</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-receives-501c3-status</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Prion Alliance seeking research partners for Rare Disease Challenge</title>
		<link>http://www.prionalliance.org/2012/11/11/prion-alliance-seeking-research-partners-for-rare-disease-challenge/</link>
		<pubDate>Sun, 11 Nov 2012 16:04:30 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=124</guid>
		<description></description>
		<contentencoded><![CDATA[<a href="http://challenge.assaydepot.com/rare-disease-challenge/">Rare Disease Challenge</a> is a contest put on by Assay Depot and Rare Genomics Institute to win $10,000 cash and a total of <a href="http://challenge.assaydepot.com/detailed-list-services/">$400,000 in in-kind donated services from biotech companies</a>.  The idea is that a non-profit group of advocates (that's us) team with a group of researchers (that's you) to put together a one-page proposal for each prize we want to compete for.  So: a one-pager on what we'd do with the $10,000, another one-pager on what we'd do with each donated service that we could use.  <a href="http://challenge.assaydepot.com/rare-disease-science-challenge-submission-form/">The application process</a> is quite simple—it's just these short proposals, the principal investigator's CV and some contact info.  Once applications are submitted (the deadline is Dec 15) there will be a round of Facebook voting to decide the winner.  Here at Prion Alliance we would love to use this as a chance to further <a title="Research" href="http://www.prionalliance.org/research/">our research goals</a>, and we're happy to do most of the work putting together the proposal and mobilizing our supporters for the voting-- we just need a research partner.  If you're interested in joining us, please <a title="Contact" href="http://www.prionalliance.org/contact/">get in touch</a>.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>124</wp:post_id>
		<wppost_date>2012-11-11 16:04:30</wppost_date>
		<wppost_date_gmt>2012-11-11 16:04:30</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-seeking-research-partners-for-rare-disease-challenge</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Prion Alliance launches first fundraising campaign</title>
		<link>http://www.prionalliance.org/2012/11/30/prion-alliance-launches-first-fundraising-campaign/</link>
		<pubDate>Fri, 30 Nov 2012 19:06:23 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=184</guid>
		<description></description>
		<contentencoded><![CDATA[We are proud to announce that Prion Alliance has launched its first fundraising campaign and we are accepting <a title="Donate" href="http://www.prionalliance.org/donate/">donations</a> online or by check.  Broadly, our goal is to fund research towards a treatment or cure for human prion diseases.  We've been doing our homework over the last several months to understand the current state of prion disease research and what is needed to move the field forward, we have adpoted five <a title="Research" href="http://www.prionalliance.org/research/">research goals</a> including the testing of potential therapeutics and the development of new disease models and early diagnostic tools.  In the immediate term, our interest is in moving forward our first research goal: validating several potential drugs that have shown efficacy in other mouse models by testing them in FFI knock-in mice, a faithful model of genetic prion disease.  Read more about this research goal <a href="http://www.prionalliance.org/research/#kimice">here</a>.

We received 501(c)(3) status from the IRS on October 23, so donations are fully tax-deductible.  Thanks in advance for your support.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>184</wp:post_id>
		<wppost_date>2012-11-30 19:06:23</wppost_date>
		<wppost_date_gmt>2012-11-30 19:06:23</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>open</wp:ping_status>
		<wp:post_name>prion-alliance-launches-first-fundraising-campaign</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>New links to Parkinson&#039;s spur interest in prion diseases</title>
		<link>http://www.prionalliance.org/2012/12/10/new-links-to-parkinsons-spur-interest-in-prion-diseases/</link>
		<pubDate>Mon, 10 Dec 2012 14:47:11 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=196</guid>
		<description></description>
		<contentencoded><![CDATA[For years, prion diseases like fatal familial insomnia were considered to be pretty unique: one diseased prion protein (PrP) molecule can transmit disease to another PrP molecule, with no virus, no bacterium—no DNA—required.  Before <a href="http://en.wikipedia.org/wiki/Stanley_B._Prusiner">Stanley Prusiner</a>'s Nobel Prize-winning work showing this was really how diseased PrP spreads, this sort of thing was unheard of in all of human (and animal) disease.

In the past few years, researchers have found <a href="http://www.nature.com/nature/journal/v482/n7385/full/nature10875.html">proteins that behave similarly in yeast</a>, and new clues that the Aβ protein involved in Alzheimer's <a href="http://www.ncbi.nlm.nih.gov/pubmed/22711819">may also spread by protein-to-protein interactions</a>.

The big news this past week has been <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552321/">an impressive new study</a> from UPenn showing the same for Parkinson's disease as well.  A protein called <a href="http://en.wikipedia.org/wiki/Alpha-synuclein">α-synuclein</a> is central to Parkinson's disease: plaques of this protein are found in the brains of Parkinson's patients, and mutations in the SNCA gene encoding this protein can lead to a genetic form of the disease.  In this new study, researchers injected pre-formed α-synuclein fibrils into the brains of mice and then demonstrated that protein aggregation spreads through the brain from this point of the initial "seeding".  The authors posit that this is how Parkinson's disease spreads in the human brain as well.

The notion that Parkinson's may spread throughout the brain just like prion disease—that α-synuclein can act, in short, as a prion—is a huge link between the two diseases.  Last week <a href="http://online.wsj.com/article/SB10001424127887324020804578151291509136144.html">the Wall Street Journal explained</a> why mad cow disease (a prion disease caused by diseased PrP) might hold the clues to unraveling Parkinson's, and the Michael J. Fox Foundation for Parkinson's Research <a href="https://www.michaeljfox.org/foundation/news-detail.php?wsj-mad-cow-disease-provides-insight-into-parkinson-protein-folding">reported on this message as well</a>.

For those of us interested in a cure for prion disease, this is hopeful news.  The discovery of more similarities between prion diseases and the more common neurodegenerative diseases—Alzheimer's and Parkinson's—makes it more likely that scientific advances in one disease will help explain things about all of these diseases, and that a treatment strategies developed for one disease might work for others as well.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>196</wp:post_id>
		<wppost_date>2012-12-10 14:47:11</wppost_date>
		<wppost_date_gmt>2012-12-10 14:47:11</wppost_date_gmt>
		<wp:comment_status>closed</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>new-links-to-parkinsons-spur-interest-in-prion-diseases</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[New links to Parkinson's spur interest in prion diseases #prion #FFI #parkinsons]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Prion Alliance partners with all-star team for Rare Disease Challenge</title>
		<link>http://www.prionalliance.org/2012/12/17/prion-alliance-partners-with-all-star-team-for-rare-disease-challenge/</link>
		<pubDate>Mon, 17 Dec 2012 19:22:52 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=199</guid>
		<description></description>
		<contentencoded><![CDATA[We're proud to announce that this weekend we submitted our proposal to the <a href="http://challenge.assaydepot.com/rare-disease-challenge/">Assay Depot Rare Disease Challenge</a>, partnering with an outstanding team of researchers to propose the creation of stem cell lines that will be instrumental in achieving <a title="Research" href="http://www.prionalliance.org/research/">our research goals</a>.

Here's the essence of our proposal.  Prion Alliance President Sonia Vallabh, a carrier of the FFI mutation, will donate skin cells to be transformed into <a title="cells from an adult, reprogrammed to 'forget' which tissue they are and be able to turn into anything" href="http://en.wikipedia.org/wiki/Induced_pluripotent_stem_cell">induced pluripotent stem cells</a>.  Then we'll use a <a title="a technology for targeted editing of the genome" href="http://en.wikipedia.org/wiki/Zinc_finger_nuclease">zinc finger nuclease</a> to correct the single base (G-&gt;A) mutation that causes FFI.  This way we'll have two stem cell lines that are completely genetically identical except for this one base, which gives us an incredibly well-controlled platform to explore how this mutation causes disease.  We also plan to create two other variations on these stem cell lines: one which is homozygous for the FFI mutation and so presumably more prone to disease, and one which has the entire PRNP gene knocked out, so that we can study the effects of this knockout in human cells - something that has never been studied before.  We also plan to create similar sets of stem cell lines from the existing FFI knock-in mice so that we can study human and mouse cells in parallel.

We estimate that if we win the competition, the $10,000 cash prize plus the free custom-designed zinc finger nuclease being donated by Sigma Life Science (normally $25,000), along with several other donated services, will be enough to get all these stem cell lines created, differentiate them into neurons and do a few basic experiments to demonstrate how they behave differently.  All that should position us well to win further grants and build on this early success.

Which brings us to the awesome part.  Creating these stem cell lines is just the beginning of our broader research agenda.  We want to measure everything we can about these cells - <a title="how much RNA is produced for a particular gene.  a proxy for how 'active' the gene is." href="http://en.wikipedia.org/wiki/Gene_expression">gene expression</a>, <a title="shape, size, intensity, curvature - anything you can see under a microscope" href="http://en.wikipedia.org/wiki/Morphology_(biology)">morphology</a>, <a title="heritable genetic information that's _not_ encoded in the DNA sequence itself" href="http://en.wikipedia.org/wiki/Epigenetics">epigenetics</a> and more - to find subtle ways that the FFI stem cells are different from their healthy counterparts.  That will give us clues as to the molecular mechanisms by which the FFI mutation causes disease and, perhaps more importantly, will give us ways to measure the efficacy of different potential drugs we'd like to test.  And once we've developed hypotheses or identified drugs we think might work, we'll be able to test them in <a href="http://www.cureffi.org/2012/11/16/an-introduction-to-walker-jacksons-fatal-familial-insomnia-knock-in-mice/">FFI knock-in mice</a>.

This is all cutting-edge stuff and we believe what we're doing will prove useful not just for advancing science on FFI but for all prion diseases and hopefully other neurodegenerative diseases as well.  Most people who study prion disease in cell culture today use mouse brain cancer cells infected with rodent strains of scrapie.  This model has been a useful tool so far, but it's limited, for instance because it relies on infection rather than spontaneous disease and on rodent rather than human strains of prions.  We believe that studying human stem cells in tightly controlled experiments will give us much better insight into what's really going on in prion disease.  In order to make our impact as broad as possible, we also plan to open source this project, providing the stem cell lines as a tool for other researchers to use and opening up our data for others to analyze.

Hats off to Prion Alliance Director Greta Beekhuis, who pulled together an amazing team to do this research:

<a href="http://www.montana.edu/wwwmri/carlson.html">Dr. George Carlson</a>, director of the <a href="http://mclaughlinresearch.org/">McLaughlin Research Institute</a> in Great Falls, Montana has signed on as Principal Investigator for this project.  Dr. Carlson has been doing valuable prion research for three decades - in the 1980s he teamed with <a href="http://en.wikipedia.org/wiki/Stanley_B._Prusiner">Stanley Prusiner</a> to provide some of the earliest evidence for the 'prion hypothesis' - the now widely accepted idea that infectious proteins are the cause of disease in animal scrapie and in human CJD, FFI, etc.  He's been an innovator in using stem cells for this research and in 2005 he created the first mouse embryonic brain cell model of prion disease.  We admire his research and we also love that he's a big believer in open source - he co-led the team that did the first large systems biology study of prion disease [<a href="http://www.nature.com/msb/journal/v5/n1/synopsis/msb200910.html">Hwang 2009</a>] and open sourced all of its data at <a href="http://prion.systemsbiology.net/">prion.systemsbiology.net</a>.  In this project Dr. Carlson will oversee all of the experiments to tease out the molecular differences between FFI and control stem cells and see how they respond to different stresses and drugs.  He'll also house the FFI knock-in mice - McLaughlin has one of the best and most efficient mouse facilities in the United States - and oversee all of the followup experiments on them.

<a href="http://stemcell.stanford.edu/about/Laboratories/weissman/index.html">Dr. Irving Weissman</a>, director of the <a href="http://stemcell.stanford.edu/">Stanford School of Medicine Institute for Stem Cell Biology and Regenerative Medicine</a>, is on board to create and differentiate the stem cell lines.  Dr. Weissman is in fact a founding father of the whole stem cell field: he was the first to isolate blood-producing stem cells from mice and from humans and to chart out the lineage of how these cells differentiate into different types of blood cells, laying the groundwork for much of stem cell science today.  He has continued to innovate and is now at the leading edge of figuring out how to use reprogrammed stem cells in therapeutic transplants.

<a href="http://www.cincinnatichildrens.org/bio/a/bruce-aronow/">Dr. Bruce Aronow</a>, co-director of the <a href="http://www.cincinnatichildrens.org/research/divisions/b/bmi/labs/pestian/computational-medical-center/">Computational Medicine Center at Cincinnati Children's Hospital</a>, is a leader in using big data to advance biomedical research.  His work fuses genetic, systems biology and high-content image analysis approaches to uncovering the roots of human disease.  This entire research project has been his vision, and he will lead the work of analyzing all the data we gather from the cells.

<a href="http://www.dzne.de/en/centers/bonn-cologne-juelich/research-groups/jackson.html">Dr. Walker Jackson</a>, group leader at <a title="stands for the German Center for Neurodegenerative Disease, except in German." href="http://www.dzne.de/en/">DZNE</a>, is the creator of the FFI knock-in mice and a master molecular biologist and mouse geneticist with decades of experience in neurodegenerative disease.  He will provide mice for this project and participate in efforts to characterize the differences between the FFI and control cells and mice.

We are incredibly honored to be part of such an outstanding group of researchers.  Going forward, this project will be our focus and top priority.

This competition is a perfect start for us for two reasons.  First, it presents us with a great opportunity to mobilize you, our supporters, to help us out.  The scientific judges for the Rare Disease Challenge will choose finalists by February 28, 2013 and the winner of the cash prize will then ultimately be chosen by Facebook voting, for which we'll ask for your support once it gets started.

Second, if we win, this competition will provide us with enough seed money to get this project off the ground and make us competitive for grants.  But more importantly, it's already gotten us organized and teamed with a crack team of researchers, and now we are determined to move this project forward whether we win or not.

The cash prize is $10,000 and we've also applied for a number of donated services, all of which would be a huge boost to our project.  The cornerstone of our plan, though, is the use of a custom zinc finger nuclease which will let us target and edit the exact part of the genome that we want to change.  These sell for $25,000 normally.  Our goal, then, will be to raise $35,000 by the end of March 2013 so we can get these stem cell lines started no matter what - and if we do win, then we can move that much faster and do that much more.

Cheers to everyone who has chipped in already - you guys are amazing - and to those who have promised to send checks before the end of FY2012.  If you haven't donated yet, and if you think this research project sounds awesome, then <a title="Donate" href="http://www.prionalliance.org/donate/">donate now</a> to help make it a reality.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>199</wp:post_id>
		<wppost_date>2012-12-17 19:22:52</wppost_date>
		<wppost_date_gmt>2012-12-17 19:22:52</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-partners-with-all-star-team-for-rare-disease-challenge</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Prion Alliance partners with all-star team for Rare Disease Challenge http://wp.me/p2WBWF-3d #prion #CJD #FFI #GSS]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>11</wp:comment_id>
			<wp:comment_author><![CDATA[Julie Minikel-Lacocque]]></wp:comment_author>
			<wp:comment_author_email>jtminikel@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>108.233.159.68</wp:comment_author_IP>
			<wp:comment_date>2012-12-18 14:58:03</wp:comment_date>
			<wp:comment_date_gmt>2012-12-18 14:58:03</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Go, go, go guys!!  Great work and I am excited to hear the results of the contest!  Off to donate...
-Julie]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1355846442.67";s:7:"message";s:44:"admin changed the comment status to approved";s:5:"event";s:15:"status-approved";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1355842683.08";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>14</wp:comment_id>
			<wp:comment_author><![CDATA[Greta Beekhuis]]></wp:comment_author>
			<wp:comment_author_email>glbeekhuis@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>173.95.181.38</wp:comment_author_IP>
			<wp:comment_date>2012-12-19 19:30:42</wp:comment_date>
			<wp:comment_date_gmt>2012-12-19 19:30:42</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[SO incredibly proud to be part of this team! It is truly an honor and a privilege. Here's to a CURE!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1355945442.93";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1355945953.64";s:7:"message";s:44:"admin changed the comment status to approved";s:5:"event";s:15:"status-approved";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Donations to Prion Alliance matched 1:1 through end of 2012</title>
		<link>http://www.prionalliance.org/2012/12/20/donations-to-prion-alliance-matched-11-through-end-of-2012/</link>
		<pubDate>Thu, 20 Dec 2012 01:47:35 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=220</guid>
		<description></description>
		<contentencoded><![CDATA[Following <a title="Prion Alliance partners with all-star team for Rare Disease Challenge" href="http://www.prionalliance.org/2012/12/17/prion-alliance-partners-with-all-star-team-for-rare-disease-challenge/">the good news from earlier this week</a>, we now have an amazing donor who will be matching your donations dollar for dollar through midnight on New Year's Eve 2012, up to $10,000 matched (i.e. $20,000 total). <a title="Donate" href="http://www.prionalliance.org/donate/">Donate now</a> before the year is over, and double your donation.

We've already applied the match to all the donations received in the last two weeks (thanks everyone!), and we'll apply it to any other online donations or checks we get before year's end.

We would love to use every cent of this opportunity, so our new ambitious goal is to use all $10,000 of match, raising $20,000 in total, by the end of the year. If we do it, we'll already be more than halfway to our longer-term goal of $35,000 by the end of March.

The time is now: <a title="Donate" href="http://www.prionalliance.org/donate/">donate</a>, and tell your friends about it too using the social media links below.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>220</wp:post_id>
		<wppost_date>2012-12-20 01:47:35</wppost_date>
		<wppost_date_gmt>2012-12-20 01:47:35</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>donations-to-prion-alliance-matched-11-through-end-of-2012</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Donations to Prion Alliance matched 1:1 through end of 2012 http://wp.me/p2WBWF-3y]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Plot of awesomeness vs. time</title>
		<link>http://www.prionalliance.org/?p=227</link>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=227</guid>
		<description></description>
		<contentencoded><![CDATA[If you've wondered what Prion Alliance's logo represents, it's the direction of progress, which as everyone knows is up and to the right.  More specifically, think of it as an abstract representation of this graph which we hold to be a quick overview of our species' past, present and future:

<a href="http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future.png"><img class="alignnone size-full wp-image-228" title="our view of human history" src="http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future.png" alt="" width="212" height="204" /></a>

&nbsp;]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>227</wp:post_id>
		<wppost_date>2012-12-21 21:26:39</wppost_date>
		<wppost_date_gmt>0000-00-00 00:00:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>plot-of-awesomeness-vs-time</wp:post_name>
		<wpstatus>draft</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Our view of human history http://wp.me/p2WBWF-3F]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>20% of the way there</title>
		<link>http://www.prionalliance.org/2012/12/22/20-of-the-way-there/</link>
		<pubDate>Sat, 22 Dec 2012 04:52:14 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=233</guid>
		<description></description>
		<contentencoded><![CDATA[It has been 48 hours since we announced that <a title="Donations to Prion Alliance matched 1:1 through end of 2012" href="http://www.prionalliance.org/2012/12/20/donations-to-prion-alliance-matched-11-through-end-of-2012/">donations will be matched 1:1 through Dec 31</a>, and we've raised $1,970 so far - that's $3,940 with matching - and so we're about 20% of the way to our goal for the end of the year.  Friends, we are humbled by the outpouring of support and encouragement we've received from everyone over the past several days, evident both in these donations and in the outpouring of kind words we've received from all corners.  Thank you so much.

Here is a quick token of our optimism for the future:

<a href="http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future1.png"><img class="alignnone size-full wp-image-234" title="our view of human history" src="http://www.prionalliance.org/wp-content/uploads/2012/12/prion-alliance-the-future1.png" alt="our view of human history" width="227" height="227" /></a>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>233</wp:post_id>
		<wppost_date>2012-12-22 04:52:14</wppost_date>
		<wppost_date_gmt>2012-12-22 04:52:14</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>20-of-the-way-there</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[20% of the way to our fundraising goal #prion #FFI #CJD #GSS]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>40% of the way there</title>
		<link>http://www.prionalliance.org/2012/12/28/40-of-the-way-there/</link>
		<pubDate>Fri, 28 Dec 2012 23:14:49 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=239</guid>
		<description></description>
		<contentencoded><![CDATA[Exciting news: we've now raised over $4,000 - that's <strong>$8,000</strong> with our <a title="Donations to Prion Alliance matched 1:1 through end of 2012" href="http://www.prionalliance.org/2012/12/20/donations-to-prion-alliance-matched-11-through-end-of-2012/">1:1 match</a>.  We're 40% of the way to our goal of matching $10,000 by the end of the year.  Our hearts are full of gratitude toward everyone who has chipped in - many of you have been incredibly generous, and we don't know how to thank you enough.

Today is the last day of 2012 that we'll be able to receive snail mail, but we've worked it out that if any checks trickle in during January that are postmarked Dec 31 or earlier, we'll be able to apply the match.  In the meantime, <a title="Donate" href="http://www.prionalliance.org/donate/">online donations</a> will continue to be matched 1:1 for the next three days - and by the way, we've added Google Wallet as another payment method.

As a treat to reward all of your generosity, we'd now like to share what we think may be the funniest thing that happened in 2012.  The backstory is this: about a month ago, many of you got an email from us announcing that we'd launched Prion Alliance and asking for your support.  A few days earlier, when Sonia first sat down to start drafting that email, she tried to do so on Swype on her Android phone while waiting outside for an MBTA train in the Boston winter.  Both the phone and her fingers were extremely cold and if you've ever used Swype before, you know how it can suddenly freak out for no reason and start adding all kinds of random words you didn't even type, and then when you go to hit backspace it gets even more excited and interprets the backspaces as whole new words.  On that fateful day, this series of events gave rise to the following text:
<blockquote> Dear friends and family,
As most of you know, Eric and I learned about a year ago that I am a carrier of FFI, the genetic prion disease of which my mom died in December 2010.
Since receiving this news we jabber both been hard at work retooling in order to best address plop I r lloml lMm loololoo ml mollusk mml mml mml mmmml Mloloo LOLml lololoo ml,</blockquote>
If you agree with us that having a sense of humor about even the hardest things in life is awesome, then please <a title="Donate" href="http://www.prionalliance.org/donate/">donate</a>, <a href="https://www.facebook.com/PrionAlliance">like</a> and/or share!  Thank you!!]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>239</wp:post_id>
		<wppost_date>2012-12-28 23:14:49</wppost_date>
		<wppost_date_gmt>2012-12-28 23:14:49</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>40-of-the-way-there</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[40% of the way to our fundraising goal http://wp.me/p2WBWF-3R]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>26</wp:comment_id>
			<wp:comment_author><![CDATA[Greta]]></wp:comment_author>
			<wp:comment_author_email>glbeekhuis@mac.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>70.10.35.87</wp:comment_author_IP>
			<wp:comment_date>2012-12-29 02:03:45</wp:comment_date>
			<wp:comment_date_gmt>2012-12-29 02:03:45</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I laughed out loud, and then tweeted, and retweeted, thanks!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1356746625.95";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:12:"1358890646.8";s:7:"message";s:44:"admin changed the comment status to approved";s:5:"event";s:15:"status-approved";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Happy new year and thank you</title>
		<link>http://www.prionalliance.org/2013/01/02/happy-new-year-and-thank-you/</link>
		<pubDate>Wed, 02 Jan 2013 02:59:28 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=246</guid>
		<description></description>
		<contentencoded><![CDATA[The results of our end-of-the-year push are in, and we raised a total of $5,700 in December - that's $11,400 with our <a title="Donations to Prion Alliance matched 1:1 through end of 2012" href="http://www.prionalliance.org/2012/12/20/donations-to-prion-alliance-matched-11-through-end-of-2012/">1:1 match</a>.  Amazing!  Thank you so much to everyone who contributed!  You have blown us away with your generosity.  Thanks to your help, we are now well on our way to being able to fund some early efforts on <a title="Prion Alliance partners with all-star team for Rare Disease Challenge" href="http://www.prionalliance.org/2012/12/17/prion-alliance-partners-with-all-star-team-for-rare-disease-challenge/">our stem cell project for the Rare Disease Challenge</a> and more broadly being able to kick off some of our <a title="Research" href="http://www.prionalliance.org/research/">research goals</a>.  This early money is going to be crucial in helping us do enough to position ourselves competitively for larger grants over the next several months.

We're a bit behind on thank yous and receipts but we'll catch up in the next couple of days.    In the meantime, we want to let you know we're starting the new year on a note of unbridled optimism and that we are incredibly grateful for all of your support.

2012 was an incredible year. We got Sonia's genetic test results in December 2011 - just over a year ago.  By January 2012 we had embarked on our new adventure of becoming scientists, had enrolled in night classes and started CureFFI.org.  We soon found new jobs in science (Sonia in April, Eric in July), founded Prion Alliance (June), got 501(c)(3) status (October), and in just the past month we've started <a title="Prion Alliance seeking research partners for Rare Disease Challenge" href="http://www.prionalliance.org/2012/11/11/prion-alliance-seeking-research-partners-for-rare-disease-challenge/">a new research project with a new team</a> and raised $11,400 in our first month of fundraising thanks to generous people like you.

Here's to 2013: an even awesomer year. Thanks for being with us.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>246</wp:post_id>
		<wppost_date>2013-01-02 02:59:28</wppost_date>
		<wppost_date_gmt>2013-01-02 02:59:28</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>happy-new-year-and-thank-you</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Our story, recurring donations and recent updates</title>
		<link>http://www.prionalliance.org/2013/01/22/our-story-recurring-donations-and-recent-updates/</link>
		<pubDate>Tue, 22 Jan 2013 22:05:01 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=281</guid>
		<description></description>
		<contentencoded><![CDATA[2013 is off to a good start.  Here are a few updates from the past few weeks:
<ul>
	<li>We received the <a title="Donations to Prion Alliance matched 1:1 through end of 2012" href="http://www.prionalliance.org/2012/12/20/donations-to-prion-alliance-matched-11-through-end-of-2012/">match</a> for all of your generous December donations, and more donations have continued to come in throughout January pushing us above $12,000 total.  Thanks everyone!</li>
	<li>We've added <a title="Our Story" href="http://www.prionalliance.org/our-story/">our story</a> to the Prion Alliance website.  It proved to be a surprisingly difficult story to actually sit down and write, but now we've finally got something down on the page so people know why we started all of this.</li>
	<li>We are now able to accept <a href="http://www.prionalliance.org/donate/#recurring">recurring monthly donations</a> via PayPal.  It's slightly trickier to set up with Amazon, so we haven't gotten around to that yet, but if you want to donate each month through Amazon <a title="Contact" href="http://www.prionalliance.org/contact/">let us know</a> and we'll make it a priority!</li>
	<li>This month we have been hard at work understanding the science of modeling human diseases using <a href="http://www.cureffi.org/2013/01/21/advances-in-cell-reprogramming/">adult skin cells reprogrammed to neurons</a> and of editing genomes using the 'molecular scissors' known as <a href="http://www.cureffi.org/2013/01/19/talens-and-zfns/">TALENs and ZFNs</a>.  This is amazing stuff and we are excited to put it into action for studying prion diseases!</li>
</ul>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>281</wp:post_id>
		<wppost_date>2013-01-22 22:05:01</wppost_date>
		<wppost_date_gmt>2013-01-22 22:05:01</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>our-story-recurring-donations-and-recent-updates</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Our story, recurring donations and recent updates http://wp.me/p2WBWF-4x #prion #CJD #FFI #GSS]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Anle138b studies funded. Here&#039;s what&#039;s next</title>
		<link>http://www.prionalliance.org/?p=415</link>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=415</guid>
		<description></description>
		<contentencoded><![CDATA[Good news: with one day to spare, <a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease/">our Microryza campaign</a> has reached its third goal, raising over $16,800.

<a href="http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-goal3-now-reached.png"><img class="alignnone size-full wp-image-417" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-goal3-now-reached.png" alt="" width="600" height="276" />
</a><em>Above: our campaign as of the morning of Friday, 9/27</em>

The campaign went on for an epic six weeks.  We initially set a conservative goal of $8,000, aiming only to raise enough for the study of anle138b against one genetic prion disease, A117V GSS.  We <a title="GSS study funded! Now fundraising for FFI and E200K" href="http://www.prionalliance.org/2013/09/17/gss-study-funded-now-fundraising-for-ffi-and-e200k/">met that goal</a> with 10 days to spare, and in the meantime, our efforts to import models of fatal familial insomnia and E200K Creutzfeldt-Jakob disease had <a title="FFI and E200K mice arrive in U.S." href="http://www.prionalliance.org/2013/08/23/ffi-and-e200k-mice-arrive-in-u-s/">finally succeeded</a>, so we ambitiously set out to raise funds for these studies in just the final week and half.  Thanks to you, our contributors, for making this ambitious goal a reality.

We ought also credit much of our success to the amazing project video made by supporters Chelsea Groves Kuhnle and Alan Ransil:

<iframe src="//www.youtube.com/embed/pA5xUT4Nq3o?rel=0" frameborder="0" width="420" height="315"></iframe>

With this, our studies of the new drug candidate anle138b in three models of genetic prion disease are fully funded.  We couldn't be more thrilled.  From the beginning, it has been our goal that any promising new potential drugs should be validated in models of genetic forms of prion disease.  At first we didn't have any models ready for therapeutic studies, nor any drug candidates worth testing nor any funds with which to test them.  A lot has changed in just two years.  Thank you, thanks to all of you, for making this happen.

We'll be in touch with updates over the coming months as things get rolling.  In the meantime, we have <a title="Research Goals" href="http://www.prionalliance.org/research/">lots of other research goals</a> as well. We would like to help develop other potentially therapeutic compounds into drugs, understand how prion protein is regulated in the cell, test gene silencing approaches for reducing prion protein, understand why some drugs are prion strain-specific and develop new assays to find drugs that are universal.  There is much work to be done, and we're only beginning.  Please help us make these other goals a reality too, by <a href="http://www.prionalliance.org/donate/">donating</a> today!]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>415</wp:post_id>
		<wppost_date>2013-09-27 16:24:56</wppost_date>
		<wppost_date_gmt>0000-00-00 00:00:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>microryza-campaign-successful-anle138b-studies-funded</wp:post_name>
		<wpstatus>draft</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Are prion diseases infectious?</title>
		<link>http://www.prionalliance.org/?p=472</link>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=472</guid>
		<description></description>
		<contentencoded><![CDATA[&nbsp;

In fact, it's not entirely clear whether prions can even be passed by blood transfusion, though the answer is probably "yes, but rarely". A review of potential transfusion cases in Britain found just 3 cases in which it looked like prions had probably been transmitted by blood transfusion [<a href="http://www.ncbi.nlm.nih.gov/pubmed/16958834">Hewitt 2006</a>].  All 3 suspect transfusions were from donors infected with variant Creutzfeldt-Jakob disease (vCJD), which is the human form of mad cow disease or bovine spongiform encephalopathy (BSE). Another case was reported later which was almost certainly linked to transfusion from a vCJD blood donor, though the recipient had only a prion infection of the spleen, which had never reached his brain to cause disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20070383">Peden 2010</a>].

So far there's no evidence that vCJD (or any other prion disease) can be transmitted from parent to child [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19401289">Murray 2011</a>], or that health care workers exposed to prion disease patients have been infected [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22516047">Alcalde-Cabero 2012</a>].

It's important to note that because vCJD is acquired from the diet, prions are present first in the peripheral tissues (including blood) and only later in the brain. That's different from sporadic or genetic prion diseases which, as far as we know, probably start in the brain.

&nbsp;]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>472</wp:post_id>
		<wppost_date>2014-01-21 14:52:16</wppost_date>
		<wppost_date_gmt>0000-00-00 00:00:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name></wp:post_name>
		<wpstatus>draft</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>I read an article about ___ as a treatment for prion diseases. How promising is it?</title>
		<link>http://www.prionalliance.org/?p=523</link>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=523</guid>
		<description></description>
		<contentencoded><![CDATA[<em>This post is part of a series introducing the basics of prion disease. Read the full series <a href="http://www.prionalliance.org/faq/">here</a>.</em>

In general, here are a few questions to ask. Unfortunately, sometimes the news article will not even address all of these issues, but these are still important issues to keep in mind.
<ul>
	<li><strong>Is the article reporting the results of a published study?</strong>  In scientific research, new discoveries are expected to be published in peer-reviewed journals. "Peer review" means that other scientists - often the authors' fiercest competitors - have to read their work and decide how good their evidence is. This process isn't perfect, but it does force scientists to make the best argument they can as to why their treatment works or why their discovery is important. It also means that all of the evidence is laid out in print for everyone to see and debate. Occasionally, scientific discoveries that are presented at conferences or announced in a press release will reach mainstream media outlets. When this happens, it is difficult to debate the merits of the scientific work because</li>
	<li><strong>Was the study about prions?</strong>  Prion diseases are pretty special, and one shouldn't get too excited about a treatment that isn't directed at prion diseases in particular. Here we're referring to <a title="What are human prion diseases?" href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/">the human diseases</a> caused by prions made of prion protein (PrP). While it is increasingly common to hear the term "prion" used in reference to Alzheimer's or Parkinson's disease, those diseases involve different proteins.  These and other neurodegenerative diseases do have certain things in common with prion diseases, but in general, when a new treatment is being investigated for Alzheimer's, the chances it will work for prion diseases are fairly low, and one shouldn't get too excited about such a treatment until or unless it is shown to work against prion diseases.</li>
	<li><strong>Was the study in test tubes or in animals?  </strong>The research pipeline usually begins with a test tube ("<em>in vitro</em>"), and when a treatment seems to work well in a test tube it gets tested in animals.  Testing in animals is in turn only the beginning of the road towards a treatment reaching humans.  Only a handful of treatments that work in vitro will turn out to work in animals, for a variety of reasons. Some treatments turn out to be too toxic, other treatments can't get into the brain, sometimes prions can develop resistance to treatments, and other treatments we never even know why they turn out not to work in animals.  In general, if a treatment has only been tested in cells in a test tube it is quite a long way from being used in humans.</li>
	<li><strong>How effective was the treatment in animals?</strong>  If a potential drug was tested in animals, an important question is how well it worked. Researchers may ask a variety of different questions about their drug - did it reduce prion accumulation in the spleen? Did it reach the brain? Did it change the way the brain looked when examined after death? And so on. Many of these are really important questions for understanding how a drug works. However, if you want to evaluate how successful a drug was in an animal study, there is one main question to ask: how long did the animals survive?  Prion diseases are deadly in other animals just as they are in humans, and if we want a treatment to make humans live longer,</li>
</ul>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>523</wp:post_id>
		<wppost_date>2013-12-17 00:17:49</wppost_date>
		<wppost_date_gmt>0000-00-00 00:00:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name></wp:post_name>
		<wpstatus>draft</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Why are you optimists?</title>
		<link>http://www.prionalliance.org/?p=591</link>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=591</guid>
		<description></description>
		<contentencoded><![CDATA[First, the scale of these operations has increased tremendously in the past decade. Throughout the 1990s, the only candidate anti-prion drugs that any scientists had written about were things they stumbled upon, almost accidentally, in the lab. While pop fiction may make it seem like these accidental "Eureka!" moments are what scientific progress is made of, most scientists and drug companies today would agree that if you want to discover a drug, you need to be very organized and look very hard for one.  In particular, it helps to use <strong>high-throughput screening</strong>, in which robotics are used to test thousands or even hundreds of thousands of potential drugs in parallel.  The first effort to apply high-throughput screening to prions came just ten short years ago, and even then, it tested only about 2,000 chemical compounds [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC228499/">Kocisko 2003</a>]. By contrast, the most recent effort to be published in the scientific literature tested over 50,000 compounds [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24183589">Silber 2013</a>].

Second, while no one has yet found a drug that works against human prion strains, there have now been a few successes in treating mice, which demonstrates that finding a small molecule drug for prions should be possible in principle. Just a few years ago, it would have been accurate to say that no drug had ever slowed down the progression of prion disease by more than about 10%, in any animal, ever. Today we know of three small molecules (compound B, IND24 and anle138b) that can <em>double</em> how long prion-infected mice survive [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169081/">Kawasaki 2007</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/23965382">Lu &amp; Giles 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661926/">Wagner 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24128760">Berry 2013</a>]. Unfortunately none of these compounds have yet been shown to be effective against any <a title="What are human prion diseases?" href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/">human prion strain</a>, and in some cases they have been shown to be ineffective [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23965382">Lu &amp; Giles 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24128760">Berry 2013</a>]. That's why we still don't have a treatment today - but nonetheless, these successes prove it's not impossible to treat prions with a small molecule.

Third, despite not succeeding yet, scientists have learned a whole lot from failures along the way. For instance, we now know that prions can evolve and develop drug resistance [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777304/">Ghaemmaghami &amp; Ahn 2009</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848070/">Li 2010</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24128760">Berry 2013</a>], and we know that drugs effective against mouse prions won't necessarily work against human prions [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23965382">Lu &amp; Giles 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24128760">Berry 2013</a>].  While each of these discoveries may seem like a setback at the time, in the long run knowledge is power. Each discovery makes us better prepared to be smarter about discovering new drugs the next time around.

As of now, none of the possible new drugs from these research efforts are ready to be tested in humans. At the moment, we believe that the most promising potential drug is <a href="http://www.cureffi.org/2013/04/26/anle138b-the-new-most-promising-experimental-compound-for-treating-prion-diseases/">anle138b</a>, which worked powerfully against mouse prions and which also worked against a few human prion strains in a test tube [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661926/">Wagner 2013</a>]. We've <a title="Microryza project closes at $17,217" href="http://www.prionalliance.org/2013/09/28/microryza-project-closes-at-17217/">funded</a> experiments to test this compound against three different forms of genetic prion disease, and those experiments are ongoing. But even if everything goes perfectly - which is a big if - it would still be a few years before anle138b could reach clinical trials in humans.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>591</wp:post_id>
		<wppost_date>2014-02-03 23:48:42</wppost_date>
		<wppost_date_gmt>0000-00-00 00:00:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name></wp:post_name>
		<wpstatus>draft</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>What is the blood-brain barrier?</title>
		<link>http://www.prionalliance.org/?p=597</link>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=597</guid>
		<description></description>
		<contentencoded><![CDATA[In the original mouse study that showed how antibodies could be effective, some groups of mice were infected with prions <strong>peripherally</strong>, meaning outside of the brain [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12621436">White 2003</a>]. When these mice were treated early on with antibodies, the antibodies were able to cure the infection before it ever reached the brain, and the mice never got sick. That's an amazing result, and to this day, antibodies are the only treatment shown to completely cure peripheral prion infections in mice. However, when mice were infected directly in their brain or when they weren't treated until after the infection had reached the brain, the antibodies had no detectable effect: the mice died at the same time as mice that weren't treated with any antibodies.

As far as we know, sporadic and genetic prion diseases in humans <em>start</em> in the brain, so there's no opportunity to treat them in the periphery.  And even for the small fraction of human prion disease cases that are acquired, as far as we're aware, no one has ever known they were infected with prions until it had already reached their brain and they had started showing symptoms. So unfortunately, antibodies aren't going to do anyone much good unless we can get them into the brain.

The folks at MRC Prion Unit have pointed to evidence that the blood-brain barrier may be broken down in prion disease patients anyway [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7583685">Chung 1995</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/9458163">Brandner 1998</a>], which would help the antibodies to get across, and as noted <a href="http://www.cureffi.org/2013/07/31/mrc-prion-unit-discusses-possible-clinical-trial-of-prn100-antibody/">here</a> they've also raised the possibility of eventually administering antibodies directly into the brain instead of into the bloodstream. In animal studies, direct injections of antibodies into the brain have been shown to have some small effect (survival was extended by ~8%) though the animals were not cured [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18474571">Song 2008</a> (<a href="http://vir.sgmjournals.org/content/89/6/1533.long">ft</a>)].]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>597</wp:post_id>
		<wppost_date>2014-02-03 23:53:59</wppost_date>
		<wppost_date_gmt>0000-00-00 00:00:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name></wp:post_name>
		<wpstatus>draft</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>New tetracycline post for CureFFI</title>
		<link>http://www.prionalliance.org/?p=600</link>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=600</guid>
		<description></description>
		<contentencoded><![CDATA[title TBD

Last month, clinical research teams from France and Italy jointly reported on the long-awaited results of double-blind clinical trials of doxycycline for sporadic Creutzfeldt-Jakob disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24411709">Haik &amp; Marcon 2014</a>].  The result in two words: no efficacy.  But before I dissect the results of this particular study further, it's worth a lengthy digression to explain some history: how did doxycycline, originally an antibiotic, come to be tested in a clinical trial for prion disease in the first place?

I did walk through some of this backstory in a previous post, but that was when I was just getting started at this, and now I have the perspective of another year and a half of reading the prion disease literature, so I think the subject is worth revisiting.

The story begins with an anti-cancer chemo drug candidate called 4'-iodo-4'-deoxydoxorubicin (IDOX for short).  IDOX was intended as a replacement for <a href="http://en.wikipedia.org/wiki/Doxorubicin">doxorubicin</a> (Doxil), a very old chemo drug used for several blood cancers, including myeloma.  Myeloma is often associated with <a href="http://en.wikipedia.org/wiki/AL_amyloidosis">AL amyloidosis</a>, a condition where the light chains of antibodies in the blood aggregate into amyloid fibrils.  In treating myeloma patients with IDOX in the mid-1990s, one Italian research group noticed, apparently serendipitously, that IDOX didn't just fight myeloma, it also seemed to help alleviate the clinical signs of amyloidosis [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7620181">Gianni 1995</a> (<a href="http://bloodjournal.hematologylibrary.org/content/86/3/855.full.pdf">ft</a>)].  Further investigation revealed that IDOX could bind not only to AL amyloid fibrils, but also to several other types of amyloid, including amyloid beta and transthyretin, all apparently with picomolar affinity (kD reported as 5.9e-11 M) [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7708755/">Merlini 1995</a>].

Along the way, IDOX also underwent a sort of testing for

IDOX eventually underwent <a href="http://clinicaltrials.gov/ct2/show/NCT00003853">a clinical trial for primary systemic amyloidosis</a> but, as far as I can tell, it never made it to FDA approval for any indication.  One limitation of IDOX was that, like doxorubicin, it is seriously toxic. IDOX and doxorubicin belong to a class of drugs called <a href="http://en.wikipedia.org/wiki/Anthracycline">anthracyclines</a> which are known to cause cardiac arrhythmia and cardiomyopathy.  This motivated the question of whether less toxic, structurally similar molecules might have the same effect.  As it happens, anthracyclines have a 4-cycle core structure reminiscent of that of a class of antibiotics called tetracyclines.

[caption id="attachment_601" align="alignleft" width="200"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/02/doxorubicin-200px.png"><img class="size-full wp-image-601 alignleft" alt="Doxorubicin, an anthracycline chemo drug." src="http://www.prionalliance.org/wp-content/uploads/2014/02/doxorubicin-200px.png" width="200" height="153" /></a> Doxorubicin, an anthracycline chemo drug.[/caption]

[caption id="attachment_602" align="alignright" width="200"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/02/doxycycline-200px.png"><img class="size-full wp-image-602 alignright" alt="Doxycycline, a tetracycline antibiotic." src="http://www.prionalliance.org/wp-content/uploads/2014/02/doxycycline-200px.png" width="200" height="102" /></a> Doxycycline, a tetracycline antibiotic.[/caption]

<div style="clear: both;"></div>
And

&nbsp;

original post below

The goals of this post are to review the evidence for tetracyclines as prion therapeutics, document the nature and results of studies that led to doxycycline making it to the human clinical trial stage, and ultimately come to understand how promising these drugs are.  <em>Important note: this blog does not provide opinions on the efficacy of any medical treatment and nothing said here should be construed as medical advice.</em>

<a href="http://www.marionegri.it/mn/en/sezioni/istituto/storia/biografie/forloni.html">Gianluigi Forloni</a> of the Mario Negri Institute in Milan gave <a href="http://www.neuroprion.org/en/videos-cjd2011-forloni.html">a 20-minute talk</a> on this subject at the 2011 CJD Family Foundation Conference, <a href="http://www.cureffi.org/2012/01/18/clinical-trial-for-doxycycline-in-ffi-carriers-will-run-from-2011-2022/">as we've mentioned previously</a>.  Watching his talk, I went through and dug up several of the original papers he referred to, as a starting point for my review of the literature.

Interest in tetracyclines for prion diseases arose in 1995 when <a href="http://bloodjournal.hematologylibrary.org/content/86/3/855.long">Gianni</a> and <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC42338/pdf/pnas01485-0551.pdf">Merlini</a> each discovered that 4'-iodo-4'-deoxydoxorubicin (aka IDX or IDOX), an anthracycline then under study for anti-cancer properties, inhibited amyloid fibril formation.  By 1997, a team (including Forloni) had shown that PrP<sup>Sc</sup>-infected brain homogenate was less infectious (i.e. prolonged incubation time) in Syrian hamsters if it was coincubated with IDX before injection into the hamsters [<a href="http://www.ncbi.nlm.nih.gov/pubmed/9148807">Tagliavini 1997</a>].  As far as I can tell, IDX eventually underwent <a href="http://clinicaltrials.gov/ct2/show/NCT00003853">clinical trials for primary systemic amyloidosis</a> but never made it to FDA approval.  Its parent drug, <a href="http://en.wikipedia.org/wiki/Doxorubicin">regular-old doxorubicin</a>, is a widely-used cancer drug (read: "chemo") and the side effects are awful (again: think "chemo"). Forloni alludes to this in the video, and states that because patients cannot tolerate doxorubicin for long, the above discoveries touched off a search for chemically similar compounds that might be more benign while still having antiprion properties.  This search led quickly to <a href="http://en.wikipedia.org/wiki/Tetracycline_antibiotics">tetracyclines</a>.  A note here: tetracyclines are a class of compounds (including <a href="http://en.wikipedia.org/wiki/Tetracycline">tetracycline</a> itself as well as <a href="http://en.wikipedia.org/wiki/Doxycycline">doxycycline</a> and many others) often used as antibiotics, <a href="http://www.nytimes.com/2012/03/24/health/fda-is-ordered-to-restrict-use-of-antibiotics-in-livestock.html">including in livestock</a>.

By 2002 Forloni had managed to repeat his 1997 Syrian hamster experiment but with tetracycline instead of IDX, with the same result: "a significant delay in the onset of clinical signs of disease and prolonged survival time" [<a href="http://www.pnas.org/content/99/16/10849.full">Forloni 2002</a>].  In a separate study, he and colleagues also used several in vitro models (synthetic PrP-like peptides; actual PrP from brains of human CJD patients; rat neuron and astrocyte cultures in the presence of PrP 106-126) to demonstrate several anti-prion properties of tetracycline: it inhibits amyloid fibril formation, reverses PrP<sup>Sc</sup>'s <a href="http://en.wikipedia.org/wiki/Proteinase_K">proteinase K</a> resistance, prevents neuronal death and astrocyte proliferation, and can be shown by NMR spectroscopy to bind to hydrophobic residues of PrP between residue 106 and 126, a region "which is thought to undergo a profound conformational change in PrP<sup>C</sup> to PrP<sup>Sc</sup> conversion" [<a href="http://www.ncbi.nlm.nih.gov/pubmed/10903871">Tagliavini 2000</a>].  All of these findings were taken as signs of the drug's potential therapeutic value.  Even though amyloid formation and proteinase K resistance now appear not to be necessary conditions for prion pathogenesis, these in vitro findings do tell a molecular story: in the presence of tetracycline, PrP<sup>Sc </sup>acts more like regular PrP<sup>C</sup>.  <a href="http://jvi.asm.org/content/77/15/8462.full">Barret 2003</a> validated Tagliavini's findings by confirming that tetracycline reduces PrP<sup>Sc</sup>'s <a href="http://en.wikipedia.org/wiki/Proteinase_K">proteinase K</a> resistance and binds to PrP 106-126; moreover, he also found that tetracycline inhibits the amplification of PrPres (i.e. <a href="http://en.wikipedia.org/wiki/Proteinase_K">proteinase K</a> resistant PrP) in vitro.  (In contrast, quinacrine, which was the focus of Barret's study, had less or no effect in each of these experiments.)  Though Forloni doesn't mention them, there have been a number of other in vivo and in vitro studies of tetracyclines.

A few pieces are missing for me: Forloni touches on the stronger antiprion and weaker antibiotic properties of other tetracyclines such as 4-epitetracycline and <a href="http://en.wikipedia.org/wiki/Rolitetracycline">rolitetracycline</a>, but says no more on the subject, and a Google search doesn't reveal any articles about these in relation to PrP.  At 6:54 in the <a href="http://www.neuroprion.org/en/videos-cjd2011-forloni.html">video</a> he also shows preliminary results from a patient preference human trial of doxycycline for CJD (10 years old at the time, so it must have started in 2001), with 21 treated and 77 untreated patients.  I understand that these were symptomatic CJD patients and so what he's discussing is survivability <em>after onset</em>.  He actually shows a chart with an <em>earlier</em> age of onset for the treatment group, but I infer that these are just descriptive statistics on who the (already symptomatic) patients were going into the study, because his message is clear: doxycycline improved survivability compared to the untreated group.  (I say "untreated" rather than "control" because these don't quite count as controls since they didn't get a placebo.)  It looks like the results are as yet unpublished, but they appear to be referenced by a collaborator of Forloni's, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268013/">Luigi 2008</a>:
<blockquote>In the last five years, a small group of CJD patients has received compassionate treatment with daily doses of 100 mg/kg <strong><a href="http://www.cureffi.org/2012/09/14/the-history-of-tetracyclines-as-treatments-for-prion-disease/#comment-89">[sic]</a></strong> doxycycline, and retrospective analysis showed significantly longer survival than untreated patients (Tagliavini F, et al., manuscript in preparation). Once again whether this effect is related to anti-prion activity or to protection of patients from bacterial infection is yet to be established. A major limitation of this study is that the results are not the outcome of a formal clinical trial but are based on open observations. The data reported in this paper provided the experimental basis for an ongoing Italian phase II, multicenter, randomized, double-blind, placebo-controlled efficacy study of doxycycline in CJD patients funded by the Italian Drug Agency.</blockquote>
<strong>Update 2012-09-16: the 100mg/kg figure is almost certainly an error on Luigi's part and probably is intended to state "100mg/day".  See <a href="http://www.cureffi.org/2012/09/14/the-history-of-tetracyclines-as-treatments-for-prion-disease/#comment-89">comment</a> below.</strong>

Forloni also mentions the double-blind study that Luigi introduces above, which began in 2006.  The results also appear to be unpublished-- the only reference I found online was under the heading of "Unpublished Studies" in a review of potential prion treatments [<a href="http://www.neurology.org/content/70/15/1272.full">Stewart 2008</a>].  Forloni also cites a German study of 51 patients whose results I did manage to find online in a review.  That study found "a delay in disease progression and a significant (p=0.005) prolongation in survival time from onset in patients treated with doxycycline  (median: 292d, range: 162d-635d, treated group) compared to historical data in untreated patients (median: 167d, range: 33d-1448d)" [<a href="http://www.benthamscience.com/cdtid/samples/iddt9-1/0011S.pdf">Zerr 2009</a>].  Another French study of doxycycline also began in 2009, again with no relevant hits on Google as of today.

As far as I can tell all of those human clinical results are on already-symptomatic patients.  Forloni introduces a new project, a trial of doxycycline on 11 asymptomatic FFI carriers in one pedigree, <a href="http://www.cureffi.org/2012/01/18/clinical-trial-for-doxycycline-in-ffi-carriers-will-run-from-2011-2022/">mentioned previously on this blog</a>, set to run through 2022.

There have been a whole host of other studies on tetracyclines which Forloni doesn't have time to mention in the talk. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15046864">Gu &amp; Singh 2004</a> found an apparently complete reversal of pathology in a cell culture model of CJD using doxycycline; <a href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001888">Luigi 2008</a> showed that scrapie onset in Syrian hamsters can be delayed by injecting the hamsters themselves (as opposed to coinoculating the infectious brain homogenate) with doxycycline, tetracycline or <a href="http://en.wikipedia.org/wiki/Minocycline">minocycline</a>.  Forloni mentions still other studies in a 2009 <a href="http://www.benthamscience.com/cdtid/samples/iddt9-1/0004S.pdf">review</a>.  Curiously, though, it appears that doxycycline has never been tested on an animal knock-in model of a genetic prion disease.  There have been purified peptide models, cell culture models and human trials on symptomatic patients, but all of the animal studies I've found were based on infection with scrapie rather than a prion disease genotype.

Tetracyclines don't have much in the way of side effects and they can cross the blood-brain barrier, though apparently only if administered in the right way.  In a review of tetracyclines as prion drugs, Forloni wrote: "Tetracyclines have limited toxicity and some derivatives, such as doxycycline and minocycline, cross the BBB efficiently <em>when an appropriate route is used</em>" (my italics; his citation is <a href="http://www.amazon.com/Goodman-Gilmans-Pharmacological-Therapeutics-Twelfth/dp/0071624422/ref=sr_1_1?ie=UTF8&amp;qid=1347659980&amp;sr=8-1&amp;keywords=9780071624428">Goodman and Gilman's <span style="text-decoration: underline;">The Pharmacological Basis of Therapeutics</span></a>), and in reference to the drug's apparently disappointing performance against Huntington's disease in vivo, he wrote "The lack of in vivo effect of doxycycline has different explanations including the unfavorable pharmacokinetics when the drug is administered in the drinking water"  [<a href="http://www.benthamscience.com/cdtid/samples/iddt9-1/0004S.pdf">Forloni 2009</a>].

One critique I have heard of doxycycline as a prion therapeutic is touched on by <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268013/">Luigi 2008</a> and elaborated further by the <a href="http://www.prion.ucl.ac.uk/clinic-services/research/drug-treatments/">UK's MRC Prion Unit:</a>
<blockquote>Early results of these trials show that there may be a modest survival benefit in treated patients, but this is far from conclusive, and any benefit may be related to the antibiotic preventing terminal chest infections.</blockquote>
But while this fact could plausibly explain away the extension of lifespan in symptomatic CJD patients in the trials mentioned above, it doesn't explain away the results from animal studies.  In the initial Syrian hamster study [<a href="http://www.pnas.org/content/99/16/10849.full">Forloni 2002</a>], the hamsters were never treated with doxycycline or tetracycline, rather, the drugs were merely coincubated with the PrP<sup>Sc</sup> brain homogenate before the animals were infected, with the total amount of drug used for each animal (doxycycline: <a href="http://en.wikipedia.org/wiki/Doxycycline">444g/mol</a>*1mM*30μL = 13μg/hamster) far from being clinically significant.  The hamsters (in both control and treatment groups) lived for hundreds of days after inoculation, long after any antibiotic effect would have passed, and the authors reported a delay in disease onset commensurate to the extension of lifespan (though unfortunately they seem not to have published the data for that claim).  Moreover, <a href="http://www.pnas.org/content/99/16/10849/F3.expansion.html">MRI</a> and <a href="http://www.pnas.org/content/99/16/10849/F4.expansion.html">PrP immunoblo</a>t data showed differences in thalamic activity and PrP accumulation that should not have been present if the effect was due to antibiotic activity.  And if you're a Bayesian, the in vitro studies demonstrating antiprion properties of tetracyclines give us a stronger prior belief that doxycycline's observed effects might be due to antiprion activity in vivo and not just an artifact of their antibiotic properties.

A comparison to <a href="http://en.wikipedia.org/wiki/Quinacrine">quinacrine</a> is also merited.  In 2005 Quinacrine became the first would-be prion therapeutic to make it to <a href="http://clinicaltrials.gov/ct2/show/NCT00104663">a clinical trial</a> in the U.S., but ultimately it was not found effective [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660392/">Collinge 2009</a>].  Perhaps in the future I'll devote a whole post to quinacrine, but for now, from the little bit of searching I have done on the web, it seems that quinacrine went straight from in vitro studies to humans without any successful tests in animal models.  In fact, even before it entered clinical trials, it was already shown to have only limited antiprion properties (as compared to tetracyclins) at the biochemical level [<a href="http://jvi.asm.org/content/77/15/8462.full">Barret 2003</a>].  Flupirtine and <a href="http://www.cureffi.org/2012/06/24/pentosan-polysulfate/">pentosan polysulfate</a> have been similarly <a href="http://www.prion.ucl.ac.uk/clinic-services/research/drug-treatments/">panned</a>.  By contrast, in all the searching I did while writing this post, I didn't find a single study that tested tetracyclines-- whether in vitro, in animals or in humans-- and failed to find an effect.  That doesn't mean it works, but it is certainly not to be dismissed.

<strong>update 2013-06-04: see <a title="Updates on clinical trials of doxycycline for CJD at Prion2013" href="http://www.cureffi.org/2013/06/01/updates-on-clinical-trials-of-doxycycline-for-cjd-at-prion2013/">latest update from Prion2013</a>.  Human trials look negative after all.</strong>]]&gt;]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>600</wp:post_id>
		<wppost_date>2014-02-04 09:32:18</wppost_date>
		<wppost_date_gmt>0000-00-00 00:00:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>new-tetracycline-post-for-cureffi</wp:post_name>
		<wpstatus>draft</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Archives</title>
		<link>http://www.prionalliance.org/archives/</link>
		<pubDate>Sun, 02 Mar 2014 20:41:24 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?page_id=619</guid>
		<description></description>
		<contentencoded><![CDATA[]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>619</wp:post_id>
		<wppost_date>2014-03-02 20:41:24</wppost_date>
		<wppost_date_gmt>2014-03-02 20:41:24</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>archives</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>page</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wp_page_template</wp:meta_key>
			<wp:meta_value><![CDATA[custom-archives.php]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Vote for us to win the Rare Disease Challenge</title>
		<link>http://www.prionalliance.org/2013/02/28/vote-for-us-to-win-the-rare-disease-challenge/</link>
		<pubDate>Thu, 28 Feb 2013 17:45:34 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=287</guid>
		<description></description>
		<contentencoded><![CDATA[Good news: <strong><a title="vote now" href="https://apps.facebook.com/whcontests/rare-disease-science-challenge/entries/view/12765/1116553">Facebook voting for the Rare Disease Challenge is open! Vote for us here!</a></strong>  <strong><span style="text-decoration: underline;">update: you can vote every 24 hours.  please do!</span>  </strong>If we win we'll be awarded $10,000 in seed money to get started on our research goals.  This early money will be really helpful for us in getting preliminary results that will help us compete for grants in the near future.

<a href="https://apps.facebook.com/whcontests/rare-disease-science-challenge"><img class="alignnone size-full wp-image-293" title="Vote for us to win the Rare Disease Challenge" src="http://www.prionalliance.org/wp-content/uploads/2013/02/prion-alliance-1.jpg" alt="" width="885" height="767" /></a>

<a title="Prion Alliance partners with all-star team for Rare Disease Challenge" href="http://www.prionalliance.org/2012/12/17/prion-alliance-partners-with-all-star-team-for-rare-disease-challenge/">Our proposal</a>, submitted late last year with a research team led by <a title="Director of McLaughlin Research Institute, Great Falls, MT" href="http://www.montana.edu/wwwmri/carlson.html">George Carlson</a>, is to convert a sample of Sonia's skin cells to <a href="http://www.cureffi.org/2013/01/21/advances-in-cell-reprogramming/">induced pluripotent stem cells</a> and use 'molecular scissors' called <a href="http://www.cureffi.org/2013/01/19/talens-and-zfns/">zinc finger nucleases</a> to create a batch of them that is genetically identical except for the single DNA base mutation that causes <a href="http://www.cureffi.org/2012/12/03/introduction-to-fatal-familial-insomnia/">fatal familial insomnia</a>.  With this tight experimental control in hand, we can study the appearance and gene expression of the cells in great detail to see what is going wrong in the FFI cells, and eventually be able to screen for drugs that make the FFI cells act more like the healthy 'corrected' cells.

Surprisingly, according to the <a href="http://challenge.assaydepot.com/rare-disease-awards/">list of winners</a> we weren't the only fatal familial insomnia project in the competition!  Christina Chao, we Googled you and couldn't find you - if you see this drop us a line to let us know who you are - we should combine forces!

We're already a Gold winner and will get some of the donated biotech services - <a href="http://www.prnewswire.com/news-releases/assay-depot-and-rare-genomics-institute-award-prizes-to-study-26-rare-diseases-193848181.html">see the full press release</a> and <a href="http://challenge.assaydepot.com/rare-disease-awards/">list of winners</a> - but we need your vote to win the cash prize.  <strong><a href="https://apps.facebook.com/whcontests/rare-disease-science-challenge/entries/view/12765/1116553">Vote for us now!</a></strong>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>287</wp:post_id>
		<wppost_date>2013-02-28 17:45:34</wppost_date>
		<wppost_date_gmt>2013-02-28 17:45:34</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>vote-for-us-to-win-the-rare-disease-challenge</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Vote for us to win the Rare Disease Challenge for #prion disease research http://wp.me/p2WBWF-4D]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>258</wp:comment_id>
			<wp:comment_author><![CDATA[Jean Yates]]></wp:comment_author>
			<wp:comment_author_email>jyatesnewyork@aol.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>74.89.151.48</wp:comment_author_IP>
			<wp:comment_date>2013-02-28 18:02:39</wp:comment_date>
			<wp:comment_date_gmt>2013-02-28 18:02:39</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I am voting for you!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1362074852.92";s:7:"message";s:44:"admin changed the comment status to approved";s:5:"event";s:15:"status-approved";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1362074559.22";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>259</wp:comment_id>
			<wp:comment_author><![CDATA[admin]]></wp:comment_author>
			<wp:comment_author_email>prionalliance@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>12.150.171.253</wp:comment_author_IP>
			<wp:comment_date>2013-02-28 18:07:39</wp:comment_date>
			<wp:comment_date_gmt>2013-02-28 18:07:39</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Thank you!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>258</wp:comment_parent>
			<wp:comment_user_id>1</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1362074859.76";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Prion Alliance finalists in Rare Disease Challenge</title>
		<link>http://www.prionalliance.org/2013/02/28/prion-alliance-finalists-in-rare-disease-challenge/</link>
		<pubDate>Thu, 28 Feb 2013 16:50:16 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=290</guid>
		<description></description>
		<contentencoded><![CDATA[Good news: Prion Alliance and our research team led by <a title="Director of McLaughlin Research Institute, Great Falls, MT" href="http://www.montana.edu/wwwmri/carlson.html">George Carlson</a> have been selected as finalists in the <a href="http://challenge.assaydepot.com/rare-disease-challenge/">Rare Disease Challenge</a>!  Rare Genomics is expected to make an official announcement at Rare Disease Day in D.C. today, kicking off Facebook voting to determine the final winner of the $10,000 prize!  Check back later today to learn how to vote for us to win.  In the meantime, if you haven't yet, don't forget to <a href="https://www.facebook.com/PrionAlliance">like us on Facebook</a>.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>290</wp:post_id>
		<wppost_date>2013-02-28 16:50:16</wppost_date>
		<wppost_date_gmt>2013-02-28 16:50:16</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-finalists-in-rare-disease-challenge</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Rare Disease Challenge recap: no $10K, but plenty of other good things</title>
		<link>http://www.prionalliance.org/2013/03/15/rare-disease-challenge-recap-no-10k-but-plenty-of-other-good-things/</link>
		<pubDate>Fri, 15 Mar 2013 17:40:41 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=299</guid>
		<description></description>
		<contentencoded><![CDATA[The <a href="https://apps.facebook.com/whcontests/rare-disease-science-challenge/entries/view/12765/1116553">Rare Disease Challenge voting</a> ended at 1:00 am this morning, with the Rett Syndrome team taking 1st place with 15,607 votes.  Our team placed 4th out of 10, with 1,414 votes:

<img class="alignnone size-full wp-image-300" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/03/rare-disease-challenge-final-counts.jpg" alt="" width="688" height="490" />

We'd like to extend a huge thanks to everyone who voted for us - repeatedly!  It's a lot to ask to have people remember to log on and vote every day, yet by the end we found that over a hundred people were voting for us every day, which is pretty awesome.  We really appreciate all of your support and help in getting the word out to your extended circles.

Though we didn't end up winning 1st place for the $10,000 cash prize, these were a really great couple of weeks nonetheless.  This competition was a good motivation to step up our outreach efforts, and it paid off.  Through Facebook we reached out and met several other families affected by genetic prion disease, and we are really grateful to be able to connect with people in the same boat!  Even besides the other families, we just met a lot of really wonderful people who wanted to support us - we tripled our number of Facebook Likes, received donations from new folks, and kind words and emails from all around.  Our story was told on <a href="http://colabradio.mit.edu/in-face-of-rare-disease-an-ode-to-bostons-biotech-hub/">MIT's CoLab Radio</a> and in <a href="http://daily.swarthmore.edu/2013/03/07/alumna-with-genetic-disease-quits-job-and-dedicates-life-to-finding-cure/">Swarthmore's Daily Gazette</a>, leading to people we had never met getting in touch to tell us they are excited about what we're doing!

Rare Disease Challenge aside, we are moving forward with our research goals and are well on our way to meeting our fundraising goal for this month - <a title="Donate" href="http://www.prionalliance.org/donate/">donate here</a> if you haven't yet (thank you!)

By the way - don't miss the interesting new posts at <a href="http://www.cureffi.org/">CureFFI.org</a>.  Those of you who've heard us expound on the value of personal genomics (and aren't tired of hearing about it yet!) will enjoy <a href="http://www.cureffi.org/2013/03/12/why-we-recommend-23andme-to-everyone-we-know/">our post on our experience with 23andMe</a> (preview: we strongly recommend it).  And if you're in the mood for a brainteaser and reminiscing about the days you used to read Parade Magazine, check out <a href="http://www.cureffi.org/2013/03/14/fatal-familial-insomnia-and-the-boy-girl-paradox/">fatal familial insomnia and the boy girl paradox</a>.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>299</wp:post_id>
		<wppost_date>2013-03-15 17:40:41</wppost_date>
		<wppost_date_gmt>2013-03-15 17:40:41</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>rare-disease-challenge-recap-no-10k-but-plenty-of-other-good-things</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Reflections on the GET2013 conference</title>
		<link>http://www.prionalliance.org/2013/04/26/reflections-on-the-get2013-conference/</link>
		<pubDate>Fri, 26 Apr 2013 15:19:08 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=307</guid>
		<description></description>
		<contentencoded><![CDATA[This week we've had the pleasure of attending the <a href="http://www.getconference.org/GET2013/">2013 Genomes, Environments and Traits (GET) conference</a> put on by the <a href="http://www.personalgenomes.org/">Personal Genome Project</a> here in Boston.  It's been a fascinating chance to reflect, both as scientists and patients, on the role of genomics in society.

<img class="alignnone size-full wp-image-310" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/04/get2013conf.png" alt="" width="294" height="170" />

The better part of the morning sessions yesterday were spent discussing the sticky issues of how much it is appropriate - or possible - to involve patients in research and inform them about the results of research and even clinical work being done on their genomes.  The new 'ome' of the day was the <em>incidentalome</em>, the set of incidental findings that come up when you do genotyping or sequencing on a person.  <a href="http://en.wikipedia.org/wiki/Stephen_W._Scherer">Steve Scherer</a> estimated that 50% of clinically relevant findings from genomics are incidental, meaning unrelated to the condition for which the patient was originally referred.  The question of how, and even <em>whether</em>, such findings should be returned to patients is hugely controversial.  Robert Green and Heidi Rehm discussed the <a href="http://news.sciencemag.org/scienceinsider/2013/03/patients-should-get-all-dna-info-1.html">new set of recommendations</a> they had helped to produce, which in essence say that patients should receive <em>all</em> clinically relevant findings, incidental or otherwise.  The GET conference was by far the most pro-genomics group of people we've ever been in a room with, and so the audience was wholly on board, but Green noted that another group is right now preparing a scathing retort to the recommendations, claiming that returning incidental findings takes away patient autonomy.

Why? After all, Green pointed out that in all other medical tests - X-rays for example - the reporting of incidental findings is <em>mandatory</em>.  Amidst all the supposed controversy, no one has presented a good reason why genomics should be any different.  What's really different, we think, is simply that genomics is new and scary, while people have long been used to X-rays.  Just a year and a half ago we, too, were terrified of the genome, but we've changed our lives based on what we learned.  Genomics is the future, and it's a future where people can take action.

The tragic Boston marathon bombings last week were a sobering reminder that not everyone gets 20 years advance warning that their life is in danger.  Danger can strike at any time.  We are renewedly grateful to live in an era where information wants to be free, where genomics makes it possible to glimpse - and change - the future.

On the subject of human violence, one of the real treats of the conference was getting to see Stephen Pinker speak.  It was only marginally related to genomics, but he is such a fantastic speaker that everyone was riveted:

<a href="http://fora.tv/2013/04/25/Conversation_Steven_Pinker_on_Decline_of_Human_Violence"><img src="http://www.prionalliance.org/wp-content/uploads/2013/04/pinker.png" alt="" title="" width="401" height="261" class="alignnone size-full wp-image-319" /></a>

<a href="http://fora.tv/v/c17735">Conversation: Steven Pinker on Decline of Human Violence</a> from <a href="http://fora.tv/partner/Personal_Genome_Project">The Personal Genome Project</a> on <a href="http://fora.tv">FORA.tv</a>

But above all, the singular highlight of the conference was getting to see <a href="http://en.hdbuzz.net/">HDBuzz</a>'s Jeff Carroll and Ed Wild speak.  Jeff Carroll's story is uplifting and inspiring: he was 19 years old and serving in the U.S. military in Kosovo when he learned that his mom had Huntington's Disease.  He got tested, found that he had the mutant allele, went back to school, and is now a scientist researching Huntington's.  He's a role model for us, and he paved our way in more than one sense - he used to work in our lab at MGH, and his brilliance and dedication convinced his colleagues of the value of hiring scientists with a personal motivation to find a cure.

<a href="http://fora.tv/2013/04/25/Radical_Participant_Access_to_Health_Research_Data"><img src="http://www.prionalliance.org/wp-content/uploads/2013/04/hdbuzz.png" alt="" title="" width="400" height="260" class="alignnone size-full wp-image-320" /></a>

<a href="http://fora.tv/v/c17730">Radical Participant Access to Health Research Data</a> from <a href="http://fora.tv/partner/Personal_Genome_Project">The Personal Genome Project</a> on <a href="http://fora.tv">FORA.tv</a>

Carroll and Wild spoke about <a href="http://en.hdbuzz.net/">HDBuzz</a>, their project that seeks to educate patients on the results and significance of scientific research in Huntintgon's Disease.  "A scientific work is not complete until it has been understood by those who need it most", said Jeff.  Both spoke beautifully about the relationship between science and hope.  Showing an image of natural gas being flared at an oil rig (circa 11:00 in the above video), Ed said:
<blockquote>Hope is an automatic by-product of scientific research, and we have a forced choice as scientists: we can either let it evaporate uselessly into the air by not engaging with the public whom we serve, or, with a small amount of reprocessing, we can turn it into something incredibly useful, that no other thing can achieve.</blockquote>
This is what motivates their effort to educate the public about scientific progress through <a href="http://en.hdbuzz.net/">HDBuzz</a>.  The goal is to provide "substantive hope": not reassurances that everything will just work out, nor blind faith that science will cure all, but rather hope grounded in real knowledge of the progress being made.  That's a hope we can believe in.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>307</wp:post_id>
		<wppost_date>2013-04-26 15:19:08</wppost_date>
		<wppost_date_gmt>2013-04-26 15:19:08</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>reflections-on-the-get2013-conference</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Reflections on the #GET2013 conference http://wp.me/p2WBWF-4X]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>857</wp:comment_id>
			<wp:comment_author><![CDATA[greta]]></wp:comment_author>
			<wp:comment_author_email>glbeekhuis@mac.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>184.194.157.176</wp:comment_author_IP>
			<wp:comment_date>2013-04-26 19:01:18</wp:comment_date>
			<wp:comment_date_gmt>2013-04-26 19:01:18</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[When is your book coming out?
I want to be first in line for an autographef copy!
Well written and inspirational post, as always.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:12:"1367002878.7";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Astemizole and anle138b: no &quot;effective therapy&quot; yet, but lots to be optimistic about</title>
		<link>http://www.prionalliance.org/2013/05/07/no-effective-therapy-yet-but-lots-to-be-optimistic-about/</link>
		<pubDate>Tue, 07 May 2013 18:29:40 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=322</guid>
		<description></description>
		<contentencoded><![CDATA[The past month has been a hot time for therapeutic research in prion disease.  Two new studies have announced positive results in animal models and have proposed that these treatments may eventually be evaluated for possible use in humans.  The media coverage hasn't always been as good as the science, so here's the lowdown.

<img class="alignnone size-full wp-image-324" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/05/96-well-plate-600px.jpg" alt="" width="600" height="410" />

<em>Above: The new studies on astemizole and anle138b both relied on high-throughput screening using tools like these 96-well plates to test thousands of compounds.  High-throughput screening used to be exclusive to pharmaceutical companies, but today more and more academic research institutions are using it too, helping to discover potential ways to treat rare diseases like CJD, FFI and GSS.</em>

<strong>astemizole</strong>

The first announcement concerned a drug called <a href="http://en.wikipedia.org/wiki/Astemizole">astemizole</a>.  Scientists at Scripps Florida discovered that this drug can increase reduce the amount of prion protein produced by cells, potentially delaying disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23576755">Karapetyan &amp; Sferrazza 2013</a>].  Astemizole used to be an FDA-approved antihistamine.  It was later pulled from the market due to very rare cardiac complications.  On balance, though, it's actually got a good safety record - the adverse effects were deemed enough to make the drug obsolete in the face of newer and better antihistamines developed in the 1990s, but are not common enough to preclude its use in this case.  After all, prion disease is a lot more serious than seasonal allergies.

So the astemizole finding could turn out to be promising.  But Scripps' <a href="http://www.scripps.edu/news/press/2013/20130403lasmezas.html">own press release</a> described the finding as the "first potentially effective therapy for human prion disease."   Whoa!  Let's back up a minute here.  In the mouse model used in this study, astemizole only delayed onset of disease by 4%, and the effect was of borderline statistical significance (p = .06).  Further work will be needed to even know for sure that the effect is real.  Moreover, several other drugs and supplements have delayed disease by more than 4% in animal models - <a href="http://www.cureffi.org/2012/09/28/statins-as-prion-therapeutics/">statins</a>, <a href="http://www.cureffi.org/2012/11/24/curcumin-as-prion-therapeutic/">curcumin</a>, <a href="http://www.cureffi.org/2012/12/01/memantine/">memantine</a>, <a href="http://www.cureffi.org/2012/09/13/rapamycin-delays-disease-onset-in-gss-mice/">rapamycin</a> and <em><a href="http://www.cureffi.org/2012/10/23/scutellaria-lateriflora/">Scutellaria lateriflora</a></em> to name a few.  Measurable effects in an animal model don't necessarily imply an "effective therapy" for humans.  Moreover, both astemizole and <a href="http://en.wikipedia.org/wiki/Tacrolimus">tacrolimus</a> (a second candidate drug identified in the Scripps study), had already been investigated as potential treatments for prion disease years ago [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC228499/">Kocisko 2003</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143673/">Bertsch 2005</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951383/">Mukherjee 2010</a>].

Future work may yet show that astemizole is indeed effective and could be brought back onto the U.S. market.  For now it's too early to say.  But actually, what's most exciting about the Scripps study is not astemizole in particular, but the new assay that the scientists used to discover astemizole's effects.

Most past efforts at discovering drugs for prion disease have focused on trying to prevent the conversion of healthy prion protein to diseased prion protein.  That's a dodgy business because prion diseases come in several different strains - fatal familial insomnia, Gerstmann-Straussler-Scheinker syndrome, and multiple subtypes of Creutzfeldt-Jakob Disease - and so far all of the treatments that target prion <em>conversion</em> have found effects to be strain-specific even among mouse prion strains, making it a longshot that they'll work in human prion strains.  In contrast, the Scripps researchers focused on reducing the amount of healthy prion protein produced by cells to begin with.  That's a more universal approach, because <em>all</em> prion strains rely on having healthy prion protein available in order to convert it and spread throughout the brain.  We've argued that <a href="http://www.cureffi.org/2013/04/08/the-case-for-depleting-prp-as-a-therapeutic-strategy-against-prion-diseases/">reducing prion protein levels is the best therapeutic strategy</a>, and the Scripps study is evidence that other scientists are starting to think this way as well.  Hopefully this will lead to more exciting therapeutic leads in the future.  To learn more about the Scripps study and why we think it's good news - but definitely not a "first potentially effective therapy" - read <a href="http://www.cureffi.org/2013/04/04/tacrolimus-astemizole-and-a-new-screening-approach-for-drugs-that-reduce-prp/">our review of the study on CureFFI.org</a>.

<strong>anle138b</strong>

The second piece of news is the discovery of a completely new molecule dubbed anle138b [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23604588">Wagner 2013</a> (<a href="http://link.springer.com/content/pdf/10.1007%2Fs00401-013-1114-9.pdf">full text here</a>)].  A group of scientists in Germany had been working on this and related compounds for several years.  They <a href="http://www.google.com/patents/US20110293520">patented anle138b back in 2009</a> and published some related results in 2011 [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21755599">Geissen 2011</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/21746938">Leidel 2011</a>] but were apparently waiting to finish more experiments before publishing their results on anle138b last month.

The researchers provided a variety of biochemical evidence to argue that anle138b inhibits the formation of infectious particles composed of multiple prion protein molecules, and that its effects appear to be equal across multiple strains of prions.  They also tested it in a Parkinson's disease mouse model and found evidence of therapeutic effects, suggesting the effects might be applicable to more than one protein-folding neurodegenerative disease.  But the most impressive part of the study is the survival evidence from prion-infected mice.  When mice were treated with a large dose of this compound starting right at the beginning of prion infection, it nearly doubled their survival time.  Even more impressively, it extended survival by about 30% even when it was administered pretty late in prion infection.

That sort of effect is <em>almost</em> unprecedented.  As <a href="http://www.cureffi.org/2013/04/26/translating-timepoints-from-mouse-trials-into-human-clinical-trials/">we've pointed out</a>, similarly large effects late in disease were seen years ago for <a href="http://www.cureffi.org/2012/12/13/the-rise-and-fall-of-pentosan-polysulfate-in-prion-disease/">pentosan polysulfate</a>, which nevertheless turned out not to work in humans [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18355301">Bone 2008</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/19788637">Tsuboi 2009</a>].  For that reason, it's too early to get excited that anle138b will necessarily prove effective.  Still, it has a lot going for it: anle138b can be taken orally and find its way into the brain, whereas pentosan polysulfate had to be infused directly into the brain, which led to some nasty complications.  And though it's too early to say, the evidence so far suggests anle138b's effects might be fairly consistent across different prion strains.

As a novel molecule, anle138b is still a long ways from becoming a drug - more work will be needed to demonstrate its safety and efficacy before it can advance to a clinical trial in humans.  And it didn't prevent or reverse disease, only delay it, so even at best it won't be a cure.  Still, it <em>is</em> the most promising candidate developed so far.  Therefore it's been slightly surprising that it has received almost no media coverage, especially when compared to astemizole.  On the other hand, the little coverage we have seen has been pretty inflated.  <a href="http://scitechdaily.com/anle138b-slows-down-the-onset-and-progression-of-parkinsons-disease/">SciTechDaily reported</a> that anle138b "Slows Down the Onset and Progression of Parkinson’s Disease".  That statement needs two additional very important words: "<em>in mice</em>."

To learn more about the details of anle138b, check out <a href="http://www.cureffi.org/2013/04/26/anle138b-the-new-most-promising-experimental-compound-for-treating-prion-diseases/">our review on CureFFI.org</a>.  It's too early to know if it will prove effective, but this compound is nevertheless exciting news, and another sign that progress is being made.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>322</wp:post_id>
		<wppost_date>2013-05-07 18:29:40</wppost_date>
		<wppost_date_gmt>2013-05-07 18:29:40</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>no-effective-therapy-yet-but-lots-to-be-optimistic-about</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_thumbnail_id</wp:meta_key>
			<wp:meta_value><![CDATA[324]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>17437</wp:comment_id>
			<wp:comment_author><![CDATA[PAUL]]></wp:comment_author>
			<wp:comment_author_email>STAROPOLI@OPTIMUM.NET</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>173.220.181.254</wp:comment_author_IP>
			<wp:comment_date>2014-12-28 15:10:13</wp:comment_date>
			<wp:comment_date_gmt>2014-12-28 15:10:13</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[hi Eric and Sonia and Happy and Healthy New Year. While it is definately exciting news, I have not heard anything additional regarding ANLE 138B or Astemizole other than original info.  Are there any current clinical trials or plans for trials in the works. 

Thanks]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1419779413.717315;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Highlights of Prion2013</title>
		<link>http://www.prionalliance.org/2013/06/02/highlights-of-prion2013/</link>
		<pubDate>Sun, 02 Jun 2013 00:18:08 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=330</guid>
		<description></description>
		<contentencoded><![CDATA[This past week we had the privilege of going to Banff to attend <a href="http://prion2013.ca">Prion2013</a>, the biggest annual conference on prions.  We were truly impressed and humbled by the wealth of progress being made on understanding the basic science of prions and on developing therapeutics.  We also got to meet many top scientists including several of our own collaborators who we'd never met face-to-face.

<a href="http://www.prionalliance.org/wp-content/uploads/2013/06/banff-fairmont-prion2013.jpg"><img class="alignnone size-medium wp-image-331" title="The conference was at this big expensive castle in the mountains." src="http://www.prionalliance.org/wp-content/uploads/2013/06/banff-fairmont-prion2013-300x177.jpg" alt="" width="300" height="177" /></a>

Here are a few of the major themes of the conference.

<strong>de novo prions in a test tube</strong>

It's been three decades since Stanley Prusiner coined the term <em>prion</em>, ushering in our modern understanding that misfolding can induce misfolding [<a href="http://www.ncbi.nlm.nih.gov/pubmed/6801762">Prusiner 1982</a>].  The 'prion hypothesis' - in short, the notion that proteins can be infectious and cause disease - has long since ceased to be controversial.  But it has long been held that the "final final final" proof of the prion hypothesis would be to generate synthetic prions from purified proteins in a test tube and show that they're infectious.

This has proven surprisingly difficult to do.  Until recently, all of the <em>de novo</em> prions anyone had managed to create all had one or another Shakespearan flaw that made them "not count" - they used mutant prion protein [<a href="http://www.ncbi.nlm.nih.gov/pubmed/15286374">Legname 2004</a>], used existing infectious prions to seed the reaction [<a href="http://www.ncbi.nlm.nih.gov/pubmed/15851027/">Castilla 2005</a>] or used cells rather than purified protein [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20660771">Edgeworth 2010</a>].  Finally a few years ago, Fei Wang and Jiyan Ma managed to pull it off [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893558/">Wang 2010</a>], but people still doubted them.  Wang and Ma had used an extremely sensitive amplification technique, so people wondered if maybe they hadn't created anything new but had just inadvertently amplified a single prion particle that had floated into the test tube from their lab, where they'd done prion research for years.

To disprove the doubters, Prof. Ma set up a brand new lab at East China Normal University in Shanghai, where no one had ever done prion research before and no prions would be just lying around, and he repeated the experiment there (with success).  This seems to have finally done the trick: everyone was convinced enough that they gave Ma's protege, Fei Wang, the conference's annual prize for best research.

<strong>they're all prions</strong>

The conference wasn't just about Creutzfeldt-Jakob Disease, fatal familial insomnia, BSE, and the other 'classical' prion diseases.  There were also several talks on Alzheimer's, Parkinson's, and ALS, with the unifying theme that each of these diseases involves a misfolded protein that, on contact, can induce a correctly folded copy of itself to misfold.  In short: these are prion diseases too.  This seems increasingly well-accepted - hypotheses that seemed controversial even a year ago have gained currency, with big-name scientists like <a href="http://www.med.upenn.edu/cndr/VMYLeebio.shtml">Virginia Lee</a>, <a href="http://www.chrcrm.org/en/rotm/dr-neil-cashman">Neil Cashman</a>, and <a href="http://www.cin.uni-tuebingen.de/research/cin-members-detail.php?tx_pxemployee%5Bemployee%5D=108">Mathias Jucker</a> leading the way.  Stanley Prusiner showed a slide listing a couple dozen disorders that he now considers to be prion diseases.

This is all bad news for Googleability: if just about every neurodegenerative disease is a prion disease, then how are we going to find relevant search results for <em>actual </em>prion diseases?  We're not changing our name to "Transmissible Spongiform Encephalopathy Alliance", that's for sure.

But in seriousness, this is all a huge leap forward in our understanding of these other diseases, and perhaps ultimately in our understanding and treatment of, er, PrP diseases, if you will.  <a href="http://www.ch.cam.ac.uk/person/cmd44">Chris Dobson</a> gave a brilliant talk about the structural similarities of amyloid between a wide range of different proteins and diseases and noted his hope of finding a drug that can act against all of them - "the equivalent of a statin for heart disease".  As of today this is science fiction, but there is no doubt that there are similarities between these diseases, and advances in one promise to shed light on all.

<strong>strain selection, evolution and drug resistance</strong>

Prions come in different strains.  In humans, FFI, GSS, familial CJD, vCJD, kuru, and several subtypes of CJD (MM1, MM2, VV1, etc.) are considered to be distinct strains of prion, meaning distinct misfolded conformations of prion protein.  But that's not all - it turns out that each one of these is not just a single strain, but most probably a collection of different strains (some call them 'quasi-species') each with its own properties.  This is a huge challenge for developing prion therapeutics.  The Prusiner lab's work on <a href="http://www.cureffi.org/2013/06/01/2-aminothiazoles-exciting-progress-and-lessons-for-the-field/">2-aminothiazoles</a> as potential drugs, revealed at the conference, showed that drugs effective against mouse prion strains used in the lab aren't necessarily effective against Creutzfeldt-Jakob Disease prions.  Not only that, but even the mouse prion strains eventually develop resistance as the drug selects for the few conformations of the protein that can form even in the presence of the drug.

That's a big challenge, but it's also a big relief that the scientific community has now uncovered this problem.  In retrospect, strain selection and drug resistance probably explain why <a href="http://www.cureffi.org/2012/10/23/quinacrine/">quinacrine</a> never worked in animals or humans even though it worked brilliantly in a test tube.  Armed with this new information, you can bet that the UCSF folks and many other groups will be working hard to find drugs that apply universally across all strains of prions.  Dr. Prusiner briefly flashed a slide touting some of the new compounds they've discovered and are currently following up on.  Hopefully this will mean that by the time we finally do see a new drug in clinical trials, it will work a whole lot better than quinacrine did.  Having things not work is disappointing - but learning why they didn't work is a huge step forward.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>330</wp:post_id>
		<wppost_date>2013-06-02 00:18:08</wppost_date>
		<wppost_date_gmt>2013-06-02 00:18:08</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>highlights-of-prion2013</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_thumbnail_id</wp:meta_key>
			<wp:meta_value><![CDATA[331]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Highlights of #Prion2013]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Cannabidiol for prion disease? Not so fast.</title>
		<link>http://www.prionalliance.org/2013/06/09/cannabidiol-for-prion-disease-not-so-fast/</link>
		<pubDate>Sun, 09 Jun 2013 01:49:29 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=334</guid>
		<description></description>
		<contentencoded><![CDATA[In the past few weeks we've seen user comments on CureFFI.org and posts on Facebook by people wondering whether cannabidiol might be a promising treatment for prion disease.

<img class="alignnone size-full wp-image-335" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/06/cannabis-520px.jpg" alt="" width="520" height="480" />

<em>Above: cannabis, from which cannabidiol is derived.  Source: <a href="http://en.wikipedia.org/wiki/File:Kolkata-Kut.jpg">Wikimedia Commons</a>.</em>

<a href="http://en.wikipedia.org/wiki/Cannabidiol">Cannabidiol</a> is a non-psychoactive derivative of cannabis.  Unlike THC, the foremost "active ingredient" in marijuana, cannabidiol doesn't make you high.  But it can cross the blood-brain barrier to get into the brain [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21796370">Deiana 2012</a>] and it appears to have some other, non-intoxicating effects on the nervous system.  A pharmacological preparation of cannabidiol marketed as Sativex<sup>®</sup> is <a href="http://webprod5.hc-sc.gc.ca/dpd-bdpp/item-iteme.do?pm-mp=00016162">approved for sale in Canada</a> as a treatment of certain symptoms of multiple sclerosis.  Researchers have also tested cannabidiol in animal and cell culture models of several neurodegenerative diseases, including Parkinson's [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17196181">Garcia-Arencibia 2007</a>] and Alzheimer's [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102548/">Martin-Moreno 2011</a>].

There has been exactly one published study examining the effect of cannabidiol on prion disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17804615">Dirikoc 2007</a> (<a href="http://www.jneurosci.org/content/27/36/9537.long">ft</a>)]  In the group of mice receiving a high dose immediately upon prion infection, symptoms and death were each delayed by about 6%.  The effect was not seen when the drug was administered later or in a lower dose.

The study was criticized in a subsequent letter [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18338806">Dicou 2008</a>] for failing to clarify the mechanism of action of the drug, in particular, whether cannabinoid receptors were involved.  Dicou also noted that the drug was only shown effective in a high dose immediately after infection, whereas prion diseases in humans are not diagnosed until late stages of disease when symptoms appear.  These points were also mentioned in a subsequent review article [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19228180">Iuvone 2009</a>].

But that's not all that's wrong with Dirikoc's study.  The most important point is that the mice were infected "intraperitoneally", meaning by injection into the body cavity.  This is often abbreviated "i.p." and, along with oral and subcutaneous infections, might be called a peripheral infection, meaning the prions are in the body but not yet in the brain.

In the sporadic and genetic forms of Creutzfeldt-Jakob Disease, fatal familial insomnia and Gerstmann-Straussler-Scheinker syndrome, the disease starts in the <em>brain</em>, not in the body cavity.  Even in variant or iatrogenic Creutzfeldt-Jakob Disease, acquired by food or surgery, patients don't know they're infected until they start to have neurological symptoms, meaning that prions have long since entered the brain.

So there's really no human equivalent to the notion of treating mice from the very instant they're infected with prions in the gut.  One could imagine a scenario where a researcher accidentally sticks themselves with a contaminated needle, but no case of prion disease from this sort of accident on the job has ever been reported.  If there were such cases, odds are we already have the tools to treat them.  A decade ago, researchers at the MRC Prion Unit in London showed that, in mice with peripheral prion infections, injections of antibodies against prion protein can delay disease a very long time, probably indefinitely [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12621436">White 2003</a>].  If prion diseases all started in the body and gave us plenty of advance warning, they'd already be cured.  The trouble is that the antibody treatment didn't work in mice that were already sick or that had infections in the brain.

Cannabidiol has never been shown effective - indeed never even been tested - in a scenario that realistically reflects the treatment opportunities available for prion diseases in humans - namely, treatment late in the disease course when prions are already in the brain.

Could cannabidiol still have some effect against prion disease anyway?  We have no evidence to say it <em>couldn't</em>, but in science, the answer to every question is "no" until someone proves "yes".  Dozens of drugs have shown <em>some</em> effect in <em>some</em> model of prion disease at <em>some</em> point in time [reviewed in <a href="http://www.ncbi.nlm.nih.gov/pubmed/16816391">Trevitt &amp; Collinge 2006</a> (<a href="http://brain.oxfordjournals.org/content/129/9/2241.long">full text here</a>)], but even the one that was most effective of all in treating mice, <a href="http://www.cureffi.org/2012/12/13/the-rise-and-fall-of-pentosan-polysulfate-in-prion-disease/">pentosan polysulfate</a>, ultimately proved to have no effect at all in humans [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18355301">Bone 2008</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/19788637">Tsuboi 2009</a>].  So it's worth taking all studies of anti-prion drugs with a good dose of skepticism.  When we prioritize drugs for further research, we need to consider how rigorous were the studies that showed therapeutic effects.  The strongest bets are drugs that have been shown effective even late in the disease course, in animals with prion infections of the brain, and across multiple prion strains - ideally including human prion strains.  Cannabidiol meets none of these criteria.

But luckily, several groups around the world have undertaken large-scale drug discovery efforts to find anti-prion treatments and are testing their drugs in animal models that much more realistically reflect what treatment in human disease will look like.  The recently-announced new compound <a title="Astemizole and anle138b: no “effective therapy” yet, but lots to be optimistic about" href="http://www.prionalliance.org/2013/05/07/no-effective-therapy-yet-but-lots-to-be-optimistic-about/">anle138b</a> extends life in mice even late in disease course.  Even if it's years away from clinical trials, this compound is an exciting possibility which appears to have some effects across more than one neurodegenerative disease.  And at <a title="Highlights of Prion2013" href="http://www.prionalliance.org/2013/06/02/highlights-of-prion2013/">Prion2013</a> we learned that Prusiner's lab at UCSF had a new compound that looked extremely promising, but ultimately proved not to work against human CJD. That's disappointing, but at least they were smart enough to test their drug on CJD in the lab - it's better to know this result now than needing to wait for an unsuccessful clinical trial.  They have dozens of other compounds in their pipeline and are committed to the most rigorous possible testing of their drugs before they move for anything to be tested in humans.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>334</wp:post_id>
		<wppost_date>2013-06-09 01:49:29</wppost_date>
		<wppost_date_gmt>2013-06-09 01:49:29</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>cannabidiol-for-prion-disease-not-so-fast</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Cannabidiol for #prion disease? Not so fast. http://wp.me/p2WBWF-5o]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>1563</wp:comment_id>
			<wp:comment_author><![CDATA[Robert H.]]></wp:comment_author>
			<wp:comment_author_email>Rhigh@psc.gov</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>108.45.183.70</wp:comment_author_IP>
			<wp:comment_date>2013-06-12 23:51:54</wp:comment_date>
			<wp:comment_date_gmt>2013-06-12 23:51:54</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Enjoyed the artical.  Thank you very much!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1371081114.85";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>1515</wp:comment_id>
			<wp:comment_author><![CDATA[Terry]]></wp:comment_author>
			<wp:comment_author_email>flounder9@verizon.net</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>108.12.104.81</wp:comment_author_IP>
			<wp:comment_date>2013-06-11 13:08:07</wp:comment_date>
			<wp:comment_date_gmt>2013-06-11 13:08:07</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[re-Marijuana USA 
 
http://www.cnbc.com/id/39617671/Marijuana_USA
 
 
bottom line, big brother and pharmaceutical companies i.e. $$$ 
 
 
please see ; 
 
 
 
 
National Cancer Institute at the National Institutes of Health 
 
 
Cannabis and Cannabinoids (PDQ®), Cancer Antitumor Effects, Prion prevention, Pain management, muscle relaxer, and Palliative Medicine 
 
 
Cannabis and Cannabinoids (PDQ®) 
 
Laboratory/Animal/Preclinical Studies
 
Antitumor Effects Appetite Stimulation Analgesia 
 
Laboratory/Animal/Preclinical Studies
 
Antitumor Effects 
 
Appetite Stimulation 
 
Analgesia 
 
 
 
Cannabinoids are a group of 21-carbon–containing terpenophenolic compounds produced uniquely by Cannabis sativa and Cannabis indica species.[1,2] These plant-derived compounds may be referred to as phytocannabinoids. Although delta-9-tetrahydrocannabinol (THC) is the primary psychoactive ingredient, other known compounds with biologic activity are cannabinol, cannabidiol (CBD), cannabichromene, cannabigerol, tetrahydrocannabivarin, and delta-8-THC. CBD, in particular, is thought to have significant analgesic and anti-inflammatory activity without the psychoactive effect (high) of delta-9-THC.
 
Antitumor Effects One study in mice and rats suggested that cannabinoids may have a protective effect against the development of certain types of tumors.[3] During this 2-year study, groups of mice and rats were given various doses of THC by gavage. A dose-related decrease in the incidence of hepatic adenoma tumors and hepatocellular carcinoma was observed in the mice. Decreased incidences of benign tumors (polyps and adenomas) in other organs (mammary gland, uterus, pituitary, testis, and pancreas) were also noted in the rats. In another study, delta-9-THC, delta-8-THC, and cannabinol were found to inhibit the growth of Lewis lung adenocarcinoma cells in vitro and in vivo .[4] In addition, other tumors have been shown to be sensitive to cannabinoid-induced growth inhibition.[5-8]
 
Cannabinoids may cause antitumor effects by various mechanisms, including induction of cell death, inhibition of cell growth, and inhibition of tumor angiogenesis invasion and metastasis.[9-12] One review summarizes the molecular mechanisms of action of cannabinoids as antitumor agents.[13] Cannabinoids appear to kill tumor cells but do not affect their nontransformed counterparts and may even protect them from cell death. These compounds have been shown to induce apoptosis in glioma cells in culture and induce regression of glioma tumors in mice and rats. Cannabinoids protect normal glial cells of astroglial and oligodendroglial lineages from apoptosis mediated by the CB1 receptor.[14]
 
The effects of delta-9-THC and a synthetic agonist of the CB2 receptor were investigated in hepatocellular carcinoma (HCC).[15] Both agents reduced the viability of hepatocellular carcinoma cells in vitro and demonstrated antitumor effects in hepatocellular carcinoma subcutaneous xenografts in nude mice. The investigations documented that the anti-HCC effects are mediated by way of the CB2 receptor. Similar to findings in glioma cells, the cannabinoids were shown to trigger cell death through stimulation of an endoplasmic reticulum stress pathway that activates autophagy and promotes apoptosis. Other investigations have confirmed that CB1 and CB2 receptors may be potential targets in non-small cell lung carcinoma [16] and breast cancer.[17]
 
An in vitro study of the effect of CBD on programmed cell death in breast cancer cell lines found that CBD induced programmed cell death, independent of the CB1, CB2, or vanilloid receptors. CBD inhibited the survival of both estrogen receptor–positive and estrogen receptor–negative breast cancer cell lines, inducing apoptosis in a concentration-dependent manner while having little effect on nontumorigenic, mammary cells.[18]
 
CBD has also been demonstrated to exert a chemopreventive effect in a mouse model of colon cancer.[19] In the experimental system, azoxymethane increased premalignant and malignant lesions in the mouse colon. Animals treated with azoxymethane and CBD concurrently were protected from developing premalignant and malignant lesions. In in vitro experiments involving colorectal cancer cell lines, the investigators found that CBD protected DNA from oxidative damage, increased endocannabinoid levels, and reduced cell proliferation.
 
Another investigation into the antitumor effects of CBD examined the role of intercellular adhesion molecule-1 (ICAM-1).[12] ICAM-1 expression has been reported to be negatively correlated with cancer metastasis. In lung cancer cell lines, CBD upregulated ICAM-1, leading to decreased cancer cell invasiveness.
 
In an in vivo model using severe combined immunodeficient mice, subcutaneous tumors were generated by inoculating the animals with cells from human non-small cell lung carcinoma cell lines.[20] Tumor growth was inhibited by 60% in THC-treated mice compared with vehicle-treated control mice. Tumor specimens revealed that THC had antiangiogenic and antiproliferative effects. However, research with immunocompetent murine tumor models has demonstrated immunosuppression and enhanced tumor growth in mice treated with THC.[21,22]
 
In addition, both plant-derived and endogenous cannabinoids have been studied for anti-inflammatory effects. A mouse study demonstrated that endogenous cannabinoid system signaling is likely to provide intrinsic protection against colonic inflammation.[23] As a result, a hypothesis that phytocannabinoids and endocannabinoids may be useful in the risk reduction and treatment of colorectal cancer has been developed.[24-27]
 
Appetite Stimulation Many animal studies have previously demonstrated that delta-9-THC and other cannabinoids have a stimulatory effect on appetite and increase food intake. It is believed that the endogenous cannabinoid system may serve as a regulator of feeding behavior. The endogenous cannabinoid anandamide potently enhances appetite in mice.[28] Moreover, CB1 receptors in the hypothalamus may be involved in the motivational or reward aspects of eating.[29]
 
Analgesia Understanding the mechanism of cannabinoid-induced analgesia has been increased through the study of cannabinoid receptors, endocannabinoids, and synthetic agonists and antagonists. The CB1 receptor is found in both the central nervous system (CNS) and in peripheral nerve terminals. Similar to opioid receptors, increased levels of the CB1 receptor are found in regions of the brain that regulate nociceptive processing.[30] CB2 receptors, located predominantly in peripheral tissue, exist at very low levels in the CNS. With the development of receptor-specific antagonists, additional information about the roles of the receptors and endogenous cannabinoids in the modulation of pain has been obtained.[31,32]
 
Cannabinoids may also contribute to pain modulation through an anti-inflammatory mechanism; a CB2 effect with cannabinoids acting on mast cell receptors to attenuate the release of inflammatory agents, such as histamine and serotonin, and on keratinocytes to enhance the release of analgesic opioids has been described.[33-35] One study reported that the efficacy of synthetic CB1- and CB2-receptor agonists were comparable with the efficacy of morphine in a murine model of tumor pain.[36]
 
References 
 
snip... 
 
 
 
http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page4 
 
 
 
 
Original Contribution| January 11, 2012 Association Between Marijuana Exposure and Pulmonary Function Over 20 Years 
 
Conclusion Occasional and low cumulative marijuana use was not associated with adverse effects on pulmonary function. 
 
http://jama.ama-assn.org/content/307/2/173.short 
 
 
 
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1 
 
Cannabinoids inhibit cancer cell invasion via increasing tissue inhibitor of matrix metalloproteinases-1 (TIMP-1). 
 
http://www.fasebj.org/content/early/2011/12/21/fj.11-198184.abstract 
 
http://www.ncbi.nlm.nih.gov/pubmed/22198381 
 
 
 
 
Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Rel­ated Morbidity 
 
Published online before print March 28, 2011, J HOSP PALLIAT CARE August 2011 vol. 28 no. 5 297-303 
 
http://ajh.sagepub.com/content/early/2011/03/26/1049909111402318.abstract 
 
 
 
 
Published online ahead of print August 30, 2010 CMAJ 10.1503/cm­aj.091414
 
Smoked cannabis for chronic neuropathi­c pain: a randomized controlled trial 
 
Conclusion 
 
Our results support the claim that smoked cannabis reduces pain, improves mood and helps sleep. We believe that our trial provides a methodological approach that may be considered for further research. Clinical studies using inhaled delivery systems, such as vaporizers,32,33 are needed. 
 
http://www.cmaj.ca/content/182/14/E694.abstract 
 
 
 
 
Cases J. 2009; 2: 7487.
 
Published online 2009 May 18
 
Standardiz­ed natural product cannabis in pain management and observatio­ns at a Canadian compassion society: a case report 
 
The roughly 4000 members of the Green Cross Society find similar benefit from standardized natural product cannabis medicine. To follow, will be publication of the Society's demographic data regarding use for various conditions such as arthritis, fybromyalgia, HIV/AIDS, and chronic pain, to name a few. A breakdown of the illnesses, what strains (cannabinoid profiles) is most effective, and at what dosages will be published at a later time. 
 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740265/?report=abstract 
 
 
 
 
Effect of D9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans 
 
These findings confirm previous findings in dogs and indicate that CB receptors are also involved in the triggering of TLESRs in humans. 
 
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2008.00010.x/abstract 
 
 
 
Drugs: 9 July 2010 - Volume 70 - Issue 10 - pp 1245-1254
 
Pharmacological Management of Pain in Patients with Multiple Sclerosis 
 
Cannabinoids have been among the few treatments studied in well designed, randomized, placebo-controlled trials for central neuropathic pain. In the largest of these trials, which included 630 subjects, a 15-week comparison between Δ9-tetrahydrocannabinol and placebo was performed. More patients receiving active treatment perceived an improvement in pain than those receiving placebo, although approximately 20% of subjects reported worsening of pain while on active treatment. 
 
http://adisonline.com/drugs/pages/articleviewer.aspx?year=2010&amp;issue=70100&amp;article=00003&amp;type=abstract 
 
 
 
 
Cannabinoids control spasticity and tremor in a multiple sclerosis model 
 
The exacerbation of these signs after antagonism of the CB1 and CB2 receptors, notably the CB1 receptor, using SR141716A and SR144528 (ref. 8) indicate that the endogenous cannabinoid system may be tonically active in the control of tremor and spasticity. This provides a rationale for patients' indications of the therapeutic potential of cannabis in the control of the symptoms of multiple sclerosis2, and provides a means of evaluating more selective cannabinoids in the future. 
 
http://www.nature.com/nature/journal/v404/n6773/full/404084a0.html 
 
 
 
J Neurosci. 2007 Sep 5;27(36):9­537-44.
 
Nonpsychoa­ctive cannabidio­l prevents prion accumulati­on and protects neurons against prion toxicity.
 
 
*** Our results suggest that CBD may protect neurons against the multiple molecular and cellular factors involved in the different steps of the neurodegenerative process, which takes place during prion infection. When combined with its ability to target the brain and its lack of toxic side effects, CBD may represent a promising new anti-prion drug. 
 
 
http://www.jneurosci.org/content/27/36/9537.abstract]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1370968771.97";s:7:"message";s:44:"admin changed the comment status to approved";s:5:"event";s:15:"status-approved";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1370956087.58";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17284</wp:comment_id>
			<wp:comment_author><![CDATA[Brad]]></wp:comment_author>
			<wp:comment_author_email>braddyp@yahoo.com</wp:comment_author_email>
			<wp:comment_author_url>http://www.makeshiftmusic.com</wp:comment_author_url>
			<wp:comment_author_IP>75.64.210.73</wp:comment_author_IP>
			<wp:comment_date>2014-01-02 02:02:56</wp:comment_date>
			<wp:comment_date_gmt>2014-01-02 02:02:56</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Your point regarding Mad-Cow and other forms of acquired prion disease is well taken. I would ask that you clarify, however, that it is possible to use a "preventative" or prophylactic approach for one very important (and likely the most common) form of prion disease: Creautzfield Jakob Disease. CJD is a familial form of prion disease associated with genetic mutations that occur in chaperone proteins, thus predisposing the carrier to protein misfolding .  Given enough time, chance has it that one of these proteins will fold in a conformation that gives it "prion activity". Thus, if you have the gene, you are at great risk of dying from prion disease at a relatively early age. If cannabidiol is non-psychoactive and can be taken with no real adverse side effects, it may prove to be the best option out there for patients with family hx of CJD. (If your first degree relative has CJD, 50% chance that you also have the gene.)]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1388628176.31";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>15179</wp:comment_id>
			<wp:comment_author><![CDATA[Stephen Daniel]]></wp:comment_author>
			<wp:comment_author_email>stephenkdaniel@yahoo.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>98.219.164.17</wp:comment_author_IP>
			<wp:comment_date>2013-12-01 23:36:12</wp:comment_date>
			<wp:comment_date_gmt>2013-12-01 23:36:12</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Cannabidiol has no known bad side effects. Cannabidiol has no LD50. Just study someone who is infected. If it was garlic or some other herb that had not been demonized by the prohibition department we wouldn't be having this discussion. If it works then it works. If it does not work then it does not work. CBD works wonders for many illnesses but does not work for everything. But, we have 80 some other cannabinoids that are non psychoactive that will help with many diseases. These other cannabinoids may be effective in treating this disease. Unfortunately the prohibition department says they can not be studied because they are in schedule one. The DEA says they are extremely dangerous,  extremely addictive, and have no medical value just like CBD. They are wrong.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1385940972.06";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17410</wp:comment_id>
			<wp:comment_author><![CDATA[ericminikel]]></wp:comment_author>
			<wp:comment_author_email>ericminikel@gmail.com</wp:comment_author_email>
			<wp:comment_author_url>http://www.cureffi.org/</wp:comment_author_url>
			<wp:comment_author_IP>155.52.208.82</wp:comment_author_IP>
			<wp:comment_date>2014-01-03 21:00:22</wp:comment_date>
			<wp:comment_date_gmt>2014-01-03 21:00:22</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Please see <a href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/" rel="nofollow">this entry</a> from the Prion Alliance FAQ. The term CJD can refer either to sporadic or genetic forms of prion disease.  The distinction between treating before and after the disease starts is not quite the same as the distinction between treating peripheral prion infections and treating prion infections of the brain.  Peripheral prion infections can be tackled through a variety of mechanisms that aren't possible in the brain - for instance, killing off follicular dendritic cells [reviewed in <a href="http://www.ncbi.nlm.nih.gov/pubmed/11260798" rel="nofollow">Weissmann 2001</a>].  Therefore the (very marginal) effect of cannabidiol in peripheral infection should not be construed to imply value as a prophylactic treatment for carriers of genetic CJD.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>17284</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>hc_post_as</wp:meta_key>
				<wp:meta_value><![CDATA[wordpress]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>hc_avatar</wp:meta_key>
				<wp:meta_value><![CDATA[http://1.gravatar.com/avatar/464e77d43bce528d362e4911c0fa5b53?s=25&d=http%3A%2F%2Fs2.wp.com%2Fwp-content%2Fmu-plugins%2Fhighlander-comments%2Fimages%2Fwplogo.png&r=G]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>hc_foreign_user_id</wp:meta_key>
				<wp:meta_value><![CDATA[42917115]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>hc_wpcom_id_sig</wp:meta_key>
				<wp:meta_value><![CDATA[719495030ff2856f1642c0ce731b9aad78ce9828]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1388782848.85";s:7:"message";s:44:"admin changed the comment status to approved";s:5:"event";s:15:"status-approved";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1388782822.51";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17427</wp:comment_id>
			<wp:comment_author><![CDATA[Robert]]></wp:comment_author>
			<wp:comment_author_email>Robert.High@psc.hhs.gov</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>158.74.35.7</wp:comment_author_IP>
			<wp:comment_date>2014-08-28 20:15:04</wp:comment_date>
			<wp:comment_date_gmt>2014-08-28 20:15:04</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Hey Eric hope all is great with you.  Wanted to share this artical.  http://www.sciencedaily.com/releases/2014/08/140827131801.htm]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1409256904.518914;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Highlights from the 2013 CJD Family Foundation Conference</title>
		<link>http://www.prionalliance.org/2013/07/31/highlights-from-cjd2013/</link>
		<pubDate>Wed, 31 Jul 2013 11:44:24 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=341</guid>
		<description></description>
		<contentencoded><![CDATA[Earlier this month we had the opportunity to attend the <a href="http://www.cjdfoundation.org/2013-cjd-foundation-family-conference">2013 CJD Family Foundation Conference</a> in Washington, D.C.  Hats off to Florence Kranitz and everyone else at CJD Foundation for organizing an excellent event.

First and foremost, it was a great chance to meet people.  Thanks to all the other families we met who shared their stories.  It can feel like we're alone in this day-to-day, and meeting everyone was a wonderful reminder that the cause we're working for is much bigger than ourselves.  By the way - among the folks we met was <a href="https://twitter.com/cjddocumentary">Trevor Baierl</a>, who's making <a href="http://www.indiegogo.com/projects/one-in-a-million--3">a documentary</a> about his family's experience with CJD and his process of getting tested for the mutation - good luck, Trevor!

We also got to meet personally with several researchers and hear the latest updates and challenges.  A couple of the research presentations focused on diagnosis of prion diseases in human patients.  This is a huge challenge and will need to improve in order for clinical trials of any new treatments to be successful, because at present diagnoses are not made until disease is very advanced.  <a href="http://memory.ucsf.edu/ourcenter/staff/mgeschwind">Michael Geschwind</a> pointed out that at present, 2/3 of the disease course - time from first symptom to death - is lost just reaching the correct diagnosis [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23007691">Paterson 2012</a> (<a href="http://archneur.jamanetwork.com/article.aspx?articleid=1362174">ft</a>)], leaving precious little time for intervention.  Alberto Bizzi's research presentation covered diagnostic methods using MRI, and Byron Caughey discussed a new technique called RT-QuIC which can amplify prions in cerebrospinal fluid.  There's little doubt that MRI is an improvement over the 14-3-3 protein test for sporadic CJD [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12810484">Geschwind 2003</a> (<a href="http://archneur.jamanetwork.com/article.aspx?articleid=784310">ft</a>), <a href="http://www.ncbi.nlm.nih.gov/pubmed/15956529">Young 2005</a> (<a href="http://www.ajnr.org/content/26/6/1551.long">ft</a>), <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100134/">Vitali 2011</a>], but Bizzi's data suggest that the diagnosis of more obscure prion diseases - including fatal familial insomnia and <a href="http://www.cureffi.org/2012/10/06/vpspr-another-strain-of-sporadic-prion-disease/">VPSPr</a> - remain more challenging.  There are high hopes for RT-QuIC, which is just beginning to reach the clinic - apparently it has almost 100% sensitivity even for GSS, FFI and genetic forms of CJD [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556051/">Sano 2013</a>].

<a href="http://www.prion.ucl.ac.uk/research/mrc-research-groups/">Simon Mead</a> also flew in from London to present a great deal of research that has gone into preparing for future clinical trials in the U.K., including a sneak peek at MRC Prion Unit's vision for <a href="http://www.cureffi.org/2013/07/31/mrc-prion-unit-discusses-possible-clinical-trial-of-prn100-antibody/">a possible new clinical trial of an antibody against PrP</a>.  He began by observing that, though it's easy to measure survival time in prion diseases, increasing survival isn't an ideal goal in clinical trials because it doesn't mean much without improvements in quality of life.  Toward that end, he introduced a rating scale for functional decline in prion disease which his group has developed for use in future clinical trials.  In addition to better reflecting what patients and families want, this tool will also help to give more statistically meaningful results if MRC decides to pursue an open label clinical trial.  Open label means that all patients who enroll are treated, rather than 50% being assigned to a placebo group.  The risk of open label trials is that only the healthier patients want to enroll, which makes it difficult to compare them to historic data on untreated patients.  But by measuring the rate of disease progression rather than survival time, the new rating scale can still give more meaningful results.

There were several other good talks as well.  Paul Brown gave a highly entertaining history of the early days of prion research from scrapie through the discovery that kuru and CJD were transmissible.  (By the way, another excellent narrative of this history can be had in <a href="http://www.amazon.com/The-Family-That-Couldnt-Sleep/dp/081297252X">The Family That Couldn't Sleep</a>).  Bob Will discussed prion surveillance in the U.K. and argued for continued vigilance while reminding us that the risk of transmission is very low. Addressing concerns about transmission of CJD between people [presumably referring to <a href="http://www.ncbi.nlm.nih.gov/pubmed/9521256">Brown 1998</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/10984557">Hillier &amp; Salmon 2000</a> (<a href="http://qjmed.oxfordjournals.org/content/93/9/617.full">ft</a>), <a href="http://www.ncbi.nlm.nih.gov/pubmed/18332347/">Capellari 2008</a>] Dr. Will stated that there has never been a confirmed case of human-to-human transmission of prion disease.

Above all the conference was about people.  We were so impressed at the strength of all the families coping with prion disease, and at the commitment of researchers to moving science forward.  We're all in this together!]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>341</wp:post_id>
		<wppost_date>2013-07-31 11:44:24</wppost_date>
		<wppost_date_gmt>2013-07-31 11:44:24</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>highlights-from-cjd2013</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>3660</wp:comment_id>
			<wp:comment_author><![CDATA[Helen Noorthoek]]></wp:comment_author>
			<wp:comment_author_email>helenmae@comcast.net</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>24.7.107.57</wp:comment_author_IP>
			<wp:comment_date>2013-08-06 21:19:57</wp:comment_date>
			<wp:comment_date_gmt>2013-08-06 21:19:57</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I am Trevor Baierl's aunt.  I took care of my father in his last stages of CJD(altho this was in the 70's and not definitely diagnosed) and then watched my sister Mary Sue March die and then know for sure that it was familial and a terrible curse for the family so of course I am interested in any news re CJD.  thank you  Helen Noorthoek]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1375823997.81";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>3778</wp:comment_id>
			<wp:comment_author><![CDATA[Jennifer Gill]]></wp:comment_author>
			<wp:comment_author_email>jojengill@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>65.198.101.33</wp:comment_author_IP>
			<wp:comment_date>2013-08-09 19:26:54</wp:comment_date>
			<wp:comment_date_gmt>2013-08-09 19:26:54</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[My husband died on July-12-2013 of Sporadic CJD.  His first symptoms appeared in Spring 2011. We both thought is was Lyme Disease but the spinal tap came back with negative results.  Biospy done in February confirmed CJD.  Through this ordeal (August 2012 to July 2013), being his primary care-giver I am left with the feeling the something triggered the prion causing the sCJD.  My husband was quite healthy and watched what he ate.  He was concerned about his cholestorol which was high.  As I write this note, I am still in shock that he has gone.  Form 2011 to 2013.....what happened?  We did an autopsy and donated his brain fluid.  I would like to know that a cure is found so that the suffering ends soon.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1376076414.33";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17417</wp:comment_id>
			<wp:comment_author><![CDATA[Daisy knight]]></wp:comment_author>
			<wp:comment_author_email>daisybknight@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>101.171.127.244</wp:comment_author_IP>
			<wp:comment_date>2014-04-27 14:22:09</wp:comment_date>
			<wp:comment_date_gmt>2014-04-27 14:22:09</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Hello Jennifer,I Am sorry for your loss.I nursed,and lost my young sister ,she just turned fifty in January 2012 to sCJD.I am a registered nurse and was able to palliative her with the help of my mum in her own home.I too,wish every day that a cure will be found.The loss is almost too much to think about.You are not alone.I wish you good health.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1398608529.6880591;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>FFI and E200K mice arrive in U.S.</title>
		<link>http://www.prionalliance.org/2013/08/23/ffi-and-e200k-mice-arrive-in-u-s/</link>
		<pubDate>Fri, 23 Aug 2013 15:31:13 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=350</guid>
		<description></description>
		<contentencoded><![CDATA[Good news: two knock-in mouse models of genetic prion diseases - fatal familial insomnia (FFI) and E200K Creutzfeldt-Jakob disease (CJD) - have arrived in Montana under the auspices of <a href="http://mclaughlinresearch.org/research-scientists/faculty/george-carlson/">George Carlson</a> at <a href="http://mclaughlinresearch.org/">McLaughlin Research Institute</a>, and new litters of these mice have been born there.

Several months ago, we started a process of trying to import these two mouse models from <a href="http://www.dzne.de/en/sites/bonn/research-groups/jackson.html">Walker Jackson</a>'s lab in Germany to our collaborator Dr. Carlson's lab at McLaughlin.  Ironically, Dr. Jackson created these models as a postdoc at <a href="http://lindquistlab.wi.mit.edu/">Susan Lindquist</a>'s lab at M.I.T., scarcely a mile down the street from us.  But by the time Prion Alliance came into being, the mice were already in Europe.  Due to various holdups with breeding, import permits and so on, it proved surprisingly difficult to bring any mice back into the States.  But at last, the mice are now here.

There are a lot of mouse models of prion diseases, and they all come with pros and cons.  One pro of these mice is that they are <a href="http://www.cureffi.org/2012/11/13/the-difference-between-knock-in-and-transgenic-mice/">knock-in, not transgenic</a>, which can make for a more faithful and accurate model of human disease.  The FFI mice have the same D178N 129M genotype that causes FFI in humans, and they exhibit almost exactly the same sort of symptoms that humans with FFI do [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775465/">Jackson 2009</a>].  The E200K mice, whose development was just announced last week [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23959875">Jackson 2013</a>] exhibit symptoms distinct from those of the FFI mice and consistent with E200K Creutzfeldt-Jakob disease in humans.

An important lesson that the prion field is learning is that many potentially therapeutic compounds prove to be strain-specific.  Most recently this was demonstrated by <a href="http://www.cureffi.org/2013/06/01/2-aminothiazoles-exciting-progress-and-lessons-for-the-field/">2-aminothiazoles</a>, a class of compounds highly effective against some experimental rodent strains of prion but wholly ineffective against CJD prions.  Ideally, we'd do all our testing of drug candidates against human prion strains from the outset.  But the difficulty of getting human cell lines to propagate prions, and the expense of dealing with mice expressing human PrP, have so far made this option impractical.

The fact that these FFI and E200K mice reproduce features of the prion diseases caused by each of these mutations in humans is a good sign that these mouse models really model human disease.  The prions produced by these mice must share at least a very similar conformation to that of prions in humans with FFI and E200K, and thus we are hopeful that if we can find compounds effective against prions in these mice, they will translate reasonably well to therapeutic use in humans.

Looking forward, Dr. Carlson has plans to cross these mice with other mice that have bioluminescent transgenes that make it possible to monitor their health status visually day by day [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736416/">Tamguney 2009</a>].  Eventually we hope that these mice will allow us to test therapeutics that might be helpful for humans with genetic prion diseases, much like <a title="Support our project to test anle138b against genetic prion disease" href="http://www.prionalliance.org/2013/08/15/support-our-project-to-test-anle138b-against-genetic-prion-disease/">our current anle138b study in GSS mice</a>.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>350</wp:post_id>
		<wppost_date>2013-08-23 15:31:13</wppost_date>
		<wppost_date_gmt>2013-08-23 15:31:13</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>ffi-and-e200k-mice-arrive-in-u-s</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>4321</wp:comment_id>
			<wp:comment_author><![CDATA[Robert H.]]></wp:comment_author>
			<wp:comment_author_email>Rhigh@psc.gov</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>158.74.35.6</wp:comment_author_IP>
			<wp:comment_date>2013-08-23 16:11:48</wp:comment_date>
			<wp:comment_date_gmt>2013-08-23 16:11:48</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Nice work!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1377274308.96";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Support our project to test anle138b against genetic prion disease</title>
		<link>http://www.prionalliance.org/2013/08/15/support-our-project-to-test-anle138b-against-genetic-prion-disease/</link>
		<pubDate>Thu, 15 Aug 2013 18:31:59 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=352</guid>
		<description></description>
		<contentencoded><![CDATA[We're proud to announce <a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease">a Microryza crowdfunding campaign</a> to support our first therapeutic trial.

<a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease"><img class="alignnone size-full wp-image-355" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/08/microryza-1.png" alt="" width="581" height="226" /></a>

Anle138b, unveiled earlier this year [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661926/">Wagner 2013</a>] currently ranks as the most promising compound for treating prion diseases.  It was originally tested in mice infected with RML, a well-studied strain of rodent prions, and it delayed terminal disease by 30% even when it was administered fairly late in the game, after about 2/3 of the incubation time had passed and symptoms had already started to emerge.  It also interfered with the formation of human prion strains in a test tube, but it's never been tested against a human prion strain <em>in vivo</em>.

That's why we think another test of anle138b, against another prion strain relevant to human disease, is of critical importance.  Our project will fund the testing of anle138b in <a href="https://neurology.uchicago.edu/page/james-mastrianni-md-phd">Dr. James Mastrianni</a>'s model of the genetic prion disease Gerstmann-Straussler-Scheinker syndrome (GSS) [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749997/">Yang 2009</a>].  These mice carry the mouse equivalent of the human A117V mutation in the prion protein gene.

We'll test at two timepoints.  An early group of mice will receive the drug starting from weaning, while a late group of mice will receive the drug at the onset of symptoms of GSS.  Together these experiments will tell us how useful anle138b could be prophylactically and how useful it could be in symptomatic patients.

The compound's inventor, <a href="http://www.neuropathologie.med.uni-muenchen.de/forschungsgruppen/giese/index.html">Dr. Armin Giese</a>, has ambitions to move the drug to clinical trials, perhaps as soon as within 2 years.  If our GSS trial is successful, the results will help to advance anle138b towards those clinical trials.

It's possible that we'll learn that anle138b doesn't work against GSS - many anti-prion compounds have proven strain-specific.  But so far, anle138b appears to be more universal.  It worked against the aggregation of alpha-synuclein, the protein involved in Parkinson's disease, <em>in vitro</em> and also had therapeutic effects in two different mouse models of Parkinson's disease.  If it does work, there's a possibility that anle138b's reach will end up being much larger than prion disease.

<iframe src="//www.youtube.com/embed/pA5xUT4Nq3o" frameborder="0" width="420" height="315"></iframe>

We think this is an important project, and we hope you agree.  Visit <a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease">our Microryza project page</a> to contribute today!]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>352</wp:post_id>
		<wppost_date>2013-08-15 18:31:59</wppost_date>
		<wppost_date_gmt>2013-08-15 18:31:59</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>support-our-project-to-test-anle138b-against-genetic-prion-disease</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Yes, I really want to know</title>
		<link>http://www.prionalliance.org/2013/09/04/yes-i-really-want-to-know/</link>
		<pubDate>Wed, 04 Sep 2013 16:41:53 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=365</guid>
		<description></description>
		<contentencoded><![CDATA[A recent <a title="http://freakonomics.com/2013/06/20/do-you-really-want-to-know-your-future-full-transcript/" href="http://freakonomics.com/2013/06/20/do-you-really-want-to-know-your-future-full-transcript/">Freakonomics Radio podcast</a> poses a question frequently heard these days: “Do you really want to know your future?”  In our era of wildly proliferating genetic information, this question is on everyone’s lips: in labs and classrooms, in the media, at dinner parties.  This particular podcast was about Huntington’s Disease, an oft-cited example of a disease that is purely genetic (as far as we know), dominant (one copy of the gene with the mutation suffices to cause the disease), adult onset, highly penetrant (if you have the genetic mutation, you are very likely to develop the disease), fatal (at present) and untreatable (at present.)

Nancy Wexler, Professor of Neuropsychology at Columbia University, President of the Hereditary Disease Foundation, and member of an HD family, is quoted extensively throughout the story, as is Emily Oster, an economist at the University of Chicago who studies the effect of life expectancy on investment choices.  In closing, three women at risk for HD are briefly quoted on their viewpoints on getting tested.

All four of the women at risk for HD come out strongly against wanting to know their status.  Add to this picture Emily Oster’s research, which points to lower investment in education and higher rates of divorce among those knowingly carrying the HD mutation, and the emotional message of this story is very stark.  It is well summed up by this line from Nancy Wexler: “If you’re somebody who has a 50 percent risk as most people at risk around the world there is nothing, nothing whatsoever that you can do that makes any difference whatsoever, nothing, nothing, nothing, nothing, nothing, nothing.”

Grappling with a genetic disease in one’s own family is not easy, and my heart goes out to anyone who has abruptly found him or herself in this situation.   Of course every individual must find their own way through this terrible emotional territory, and make their own decision.

But all the same, that is a lot of “nothings.”

I would like to submit a reminder that there is a second, less-discussed side to this debate.  If the stance above can be summed up as the “ignorance is bliss” camp, there is also a “knowledge is power” camp.  I’ve made my life in this latter camp, and I think it deserves, at the least, to be known and heard from – to be part of our ongoing social dialogue, as tricky genetic questions go from rare medical novelties to just one more dimension of twenty-first century human health.

Genetic prion diseases, like HD, are dominant, adult onset, fatal (at present) neurodegenerative diseases for which we do not currently have treatment options.  When my husband Eric and I learned in fall 2011 that I was at risk for the genetic prion disease that had claimed by mother’s life the year before, we decided immediately to get me tested, and we have never looked back.

Our reasoning was that there was no going back to a time before I was knowingly at risk.  We only ever move forward in life, and to our minds, the time of true ignorance was behind us.  Choosing not to answer the question would not erase the question.  And given that we would be thinking about it anyway, it seemed better to know what we were up against.

I tested positive for the mutation that causes Fatal Familial Insomnia.  Up until the moment I received my results, I had no preconceived idea of what would happen either way – what effect the news, either good or bad, would have on the course of my life from that point on.  So it was with total surprise that I watched the events of the next year unfold.  From jobs in consulting and degrees in law and city planning, Eric and I set about transitioning into careers in neurodegenerative disease research.  By summer 2012 we were both working in science and had founded <a title="http://www.prionalliance.org" href="http://www.prionalliance.org">Prion Alliance</a> and <a href="http://cureffi.org" target="_blank">cureffi.org</a>.  Today, in summer 2013, you can help us <a title="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease" href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease">crowdfund our first therapeutic trial</a>.

Ours is an extreme story of how genetic news can launch positive action.  And it would not have been possible without a lot of luck, and a lot of help.  Most exceptionally, we were lucky to meet outstandingly bright, thoughtful and open-minded scientists at every step of the way.

With that said, I do think that there are “somethings” – opportunities for positive action – that are broadly available to those facing genetic news, even if one has no interest in becoming a scientist, or an advocate.  Below is a list of some that come to mind.  Importantly, as I’ll note throughout, many of these opportunities can be accessed without knowing one’s own test results, if that is one’s personal preference.

These thoughts are composed with dominant, adult-onset, currently untreatable genetic diseases in mind, such as HD and genetic prion diseases.  Their applicability to other types of genetic diseases may vary.

<strong>Reproductive decisionmaking.</strong>  The one benefit of testing that occasionally gets some air time, this angle is briefly alluded to in the Freakonomics story.  Armed with genetic information, for the first time in history, one can now make the decision to prevent a genetic disease from passing to the next generation.  <a title="http://brighamandwomens.org/Departments_and_Services/obgyn/services/mfm/Patient/CVSinfo.aspx" href="http://brighamandwomens.org/Departments_and_Services/obgyn/services/mfm/Patient/CVSinfo.aspx">Chorionic villus sampling</a> can be performed as early as 10-12 weeks and can identify genetic mutations of interest in a fetus.  And a yet more proactive option is also now available: <a title="http://www.pennmedicine.org/fertility/patient/clinical-services/pgd-preimplantation-genetic-diagnosis/" href="http://www.pennmedicine.org/fertility/patient/clinical-services/pgd-preimplantation-genetic-diagnosis/">pre-implantation genetic diagnosis</a>, in combination with in-vitro fertilization, is now a standard practice and has produced hundreds of healthy babies.    Expense and inconvenience notwithstanding, the PGD/IVF parents who I’ve talked to seem to feel profoundly satisfied with their decision. (For more information, this <a title="http://en.hdbuzz.net/036" href="http://en.hdbuzz.net/036">HDBuzz post</a> provides an excellent introduction to these topics.)

Notably, it is possible to go through PGD/IVF even without the parent at risk ever learning his or her own status.

<strong>Scientific progress.</strong>  A person who knew he was at risk for a genetic neurodegenerative disease once said the following to me: “I just have to be optimistic, live my life, and trust that science will find the answers.”  This was his explanation for why he was choosing not to get tested, and not to engage with the subject of his genetic risk at all.

There are many reasons to decide not to get tested – but this line of reasoning troubled me.  Science does not move forward like a train on a track, destined inevitably for the future.  Science moves forward because we gather information over time, and from it, draw the conclusions that allow us to sift through the crazy mysteries of human biology.  We all benefit, every day, from medical discoveries that would not have been possible without the sharing of information on mankind’s many maladies.

It may sound ridiculous, and I do not say it to trivialize -- but especially in the domain of rare diseases, the very fact of having a genetic mutation means that you have something worth sharing – something that can help science move forward.  And there are many different levels on which one can make this kind of contribution.

The scarce data surrounding rare diseases makes it difficult to answer even basic questions that have real ramifications for patients: how many people in the population have this mutation?  Of them, how many will develop the disease with which it is associated?  When in life does this usually happen?  What is the spectrum of symptoms?  Are there genetic modifiers that affect when or how the disease presents?  Are there environmental factors that affect disease progression?  Are there biomarkers that can help us predict disease course prior to the onset of symptoms?  The medical literature attempts to answer these questions, but is inevitably biased by which cases are reported, and which are not.  Age of onset, for example, often skews young because disease in a younger person is more likely to strike us as strange and drive us to pursue medical answers.

The most comprehensive research studies seek to combine trait information, genetic information, and family history in one data set.  Participating in a study like this, especially on an ongoing basis, is a large contribution that some people choose to make, for example the participants in <a title="http://www.cureffi.org/2012/04/13/diagnostic-clinical-study-ongoing-at-ucsf/" href="http://www.cureffi.org/2012/04/13/diagnostic-clinical-study-ongoing-at-ucsf/">UCSF’s diagnostic clinical study for prion diseases</a>.  But one-time donations, that carry no identifying information, can also be very valuable to researchers.  And this is true even in the case of HD or other “less rare” (one in ten thousand, as opposed to one in a million) rare disease mutations.  The search for genetic modifiers, for example, must cover the enormous search space of the genome in looking for secondary genes that might influence the course of disease.  Thousands upon thousands of data points are needed to draw meaningful conclusions in this kind of analysis.  And too often, the available data sets are simply too small.

Again, it is worth bearing in mind that it is possible to donate, for example, a blood sample to a research study without ever knowing one’s own status.

The case of the rare disease <a title="http://en.wikipedia.org/wiki/Transthyretin-related_hereditary_amyloidosis" href="http://en.wikipedia.org/wiki/Transthyretin-related_hereditary_amyloidosis">transthyretin familial amyloid polyneuropathy</a> provides an extreme, and very beautiful, example of the kind of scientific good that can come from sharing genetic information.  This disease was thought to be fully penetrant (those inheriting the mutation consistently developed the disease) until a physician noticed that in one family, it followed an atypical inheritance pattern.  Further investigation revealed that several family members carried the mutation but remained healthy.  Side-by-side genetic analysis of family members eventually uncovered the protective genetic modifier, the mechanism of which went on to serve as the template for <a title="http://en.wikipedia.org/wiki/Tafamidis" href="http://en.wikipedia.org/wiki/Tafamidis">Tafamidis</a> – a novel drug that slowed the progression of the disease in a placebo-controlled trial and is now approved for use in Europe.

<strong>Being counted.</strong>  Related to the above – science is expensive to do, and science funding is difficult to come by.  The NIH, the major source of research grants in the health sciences in the US, makes awards based partly on “relevance” – how big an impact research may have.  But the numbers of people who stand to benefit from treatments and cures are being systematically underestimated.  Being counted – even through an anonymous donation, without receiving a test result – is one simple way in which we cast a vote for more therapeutic research to be staffed, funded, and shared.

<strong>Being proactive.</strong>  Another thing troubles me about the idea of just waiting for science to find the answers.  Even if a treatment for, for example, HD were to be available, it would likely not benefit – or at least, not maximally benefit – people who waited until they were experiencing symptoms to seek it out.  Again, there are many valid reasons to choose not to know one’s status.  But one cost of that choice is that it limits one’s ability to act preventatively.  In the case of neurodegenerative diseases, a lot of damage is already done to the brain by the time clinical symptoms arise.  Therapeutic studies routinely find that it is far, far easier to intervene early in disease course than to try to repair existing damage or replace lost cells.

This is a little bit of wishful thinking on my part, as there is no preventative treatment for HD, nor for any other neurodegenerative disease – at the moment.  But surely we can agree that this is the best time in human history to be an optimist.  And although we don’t know what the near future holds, I for one want to know as soon as it gets here.

Being linked to people working against a genetic disease – be they families, support groups, genetic counselors, physicians, or researchers – is one way of keeping abreast of new developments.  Long before there is a cure, there will be clinical trials.  This will be the earliest opportunity to receive a potential treatment.  And related to the above about science needing <em>us</em> to move forward – only by recruiting from patient populations can treatments ever become approved and available for use.

<strong>Solidarity.</strong> This is to say nothing of the emotional and social benefits of being linked to a community that can relate to, or help provide context for a difficult genetic situation.  Learning that I was at risk was the most profoundly isolating thing that has ever happened to me – and I was lucky to have a supportive spouse, and a wonderful relationship with my father.  Some people living with uncertainty seek out support, but many choose to live with the secret.  Again, it works for some.  It could never have worked for me.

“Individually rare but collectively common” is the tagline of the National Organization for Rare Disorders.  And in my experience, I’ve found it to be true.  Statistically, I will never happen to run into another person with the FFI mutation walking down the street.  However, since sharing my story with my friend network I’ve been amazed to find that many people I know are personally linked to someone who has a genetic disease.  Perhaps it seems a paltry benefit in light of the heavy emotional costs of coming to terms with bad genetic news – but there is something to be said for learning both your own strength, and that of the strongest relationships in your life (spoiler alert: they may not be the ones you’d think they’d be.)  We never know the strength within us, and around us, until we see it in action.

<strong>Adaptation.</strong>  The psychological concept of <a title="http://en.wikipedia.org/wiki/Hedonic_adaptation" href="http://en.wikipedia.org/wiki/Hedonic_adaptation">adaptation</a> captures another potential emotional benefit of knowing.  Hundreds of studies have explored this phenomenon, by which people tend to respond to life events with largely transient dips or spikes in their happiness, before habituating to their new circumstances and returning more or less to baseline.  The field of positive psychology is not without its controversies, but there is a principle here that seems to ring true of minor changes – how quickly, for example, a new purchase loses its luster – and may even provide insight into larger life changes.  Emily Oster speaks to this effect when she says, “..[I]n the data we see evidence on whether people are depressed and we see people are initially, the first year after they get a bad test result they are somewhat more depressed, but then they basically return to baseline for quite a long time. Most people are kind of about the same amount of happy most of the time.”

When I consider the role of adaptation in my testing experience, what strikes me is the timing.  For me, until the limbo of 50/50 risk was resolved, I was unable to adapt.  The uncertainty had a different emotional flavor each time I focused on it.  Both potential outcomes clamored for my attention, but not always equally.  The subjective shifting of the risk made it hard for me to take my mind’s eye off of it.  Not long after being tested, though – for me, it was less than a year – I could feel that I was acclimating to my new knowledge.  Slowly but surely, as with other difficult things in life, the results became one more piece of furniture in my mind.  The obsession ended, and my life resumed – perhaps on a different trajectory, but no longer on pause.

<strong>Clarity for families.</strong> I recently met a young woman who knew herself to be at 50/50 risk for a fatal (at present) genetic disease.  She did not want to know her status, but also didn’t want to leave her family guessing in the event that she fell ill or passed away.  She chose to get tested and, without seeing them herself, to have the results held in a file that her family has permission to access, under specific circumstances.

It makes sense that families struggle with how to communicate about a genetic disease.  Everyone deals with risk differently, everyone deals with bad news differently, and family conflict around genetic diseases, sadly but understandably, seems to be very common.  As I’ve read more genealogical accounts of families uncovering a history of disease in their lineage, I’ve been struck by how much confusion and strife can result from a seemingly neutral desire to avoid the topic.  By burying the lead and obfuscating how loved ones passed away, families leave subsequent generations to re-encounter the same mysteries starting from scratch.  This puts later generations at a disadvantage regarding relevant medical advances, and denies them the opportunity to choose a different approach to their own risk.

Whether or not one chooses to be tested, delineation of one’s end-of-life wishes can provide a tremendous gift of clarity to a confused and grieving family in a terrible moment.  Anyone who has watched a loved one struggle on life support will recognize the ability of this uniquely stressful moment to divide even the closest clan.  No test result is required to set forth one’s intentions should different possible scenarios arise.  And along similar lines, no test result is needed for one to pledge tissue to science after death, should it prove to be of interest.

<strong>Reform and de-stigmatization.</strong> An oft-cited reason for not getting tested is fear about discrimination and stigma.  There is a not-unfounded sense that predictive genetic testing is too new – that in today’s world, one can’t be sure how the information will affect one’s social or financial life, and that given the uncertainties, the risk-minimizing option is to avoid receiving any information.

I’ve wrestled with these concerns myself, and the uncertainties are real.  It is true that despite positive developments, there remain some tricky questions about discrimination, insurance, and stigma surrounding genetic diseases.  But I’ve come to believe that no better world is owed to us, destined to arrive at some point in the enlightened future.  Like scientific progress, social and legal progress will arise from actions taken today, and from the collective strength of determined individuals.  History tells us that stigmas don’t erase themselves – this happens over time through the raising of a chorus of voices that say: We are here, and we want to live a good life.

In Massachusetts, a <a title="http://www.genomicslawreport.com/index.php/2011/02/14/genetic-bill-of-rights-proposed-in-massachusetts/" href="http://www.genomicslawreport.com/index.php/2011/02/14/genetic-bill-of-rights-proposed-in-massachusetts/">genetic bill of rights</a> was proposed in 2011.  Among other things, if it passed this bill would have supplemented <a title="http://www.genome.gov/24519851" href="http://www.genome.gov/24519851">GINA</a> (the federal Genetic Nondiscrimination Act) by providing protection against discrimination in life, disability, and long-term care insurance for carriers of genetic mutations, in addition to the protection against health insurance discrimination that GINA confers.  To my knowledge, neither this bill nor any similar state initiative has yet become law.  For the moment this may be for the best, as in addition to the admirable goals above, the MA bill proposed new genetic privacy measures that would have made genetic research more cumbersome and expensive to conduct.  From my perspective, a law making genetic research (which is already tightly regulated) harder to do would work squarely against the interests of those living with genetic risk – for whom treatments and cures that hinge critically on the pace of research are the ultimate goal.

All of that said – it is my hope that an improved version of this measure will come back around, and surface in other states, offering broad protections against insurance discrimination in all of its forms, while ensuring that research is not jeopardized.  This is precisely the sort of legal change that would help us build that better, de-stigmatized world.  And it would be great if we could count on de-stigmatizing legal movements to build themselves – but as we all know from observation, perceived need and demand are critical to moving history along.  We can incrementally speed the process by adding one more voice to the chorus, whether it be by lobbying and letter-writing, or simply by being counted and being cognizant.

Every time someone at genetic risk chooses to share that fact, on any scale, rather than keeping it a secret, the circle of people who are plugged into these issues grows.

&nbsp;

<strong>Final thoughts</strong>

I can only speak for me.  But with that caveat, here is what I can say: Getting tested was one of the best decisions I’ve made.  The hardest time by far was when we were waiting for results, holding our breath, waking up scared every morning.  Now, far from waking up every day worrying about my status, I rarely think about my genetic test results per se.  I’ve made a kind of peace with them, and to the extent they now enter my thoughts, I have a scientific framework within which to consider them – a framework that excites my curiosity, fills me with optimism, and motivates me every day.  I know I am doing what I can, and with that knowledge, I feel more empowered now, and prouder of how I spend my time, and better about myself in all regards, than I ever did in any previous phase of life.

Compare that to this excerpt from Nancy Wexler, discussing people who know their positive HD status:
<blockquote>“People think, I think, everyone thinks really that in some secret soul of their bodies or their minds that they’re truly unattractive and that nobody if they know this, they won’t love them… And especially, you know, when the outside world is saying this is repugnant, this is repulsive, then we act it out in bad ways. It is toxic knowledge, it is difficult.”</blockquote>
This observation is based on a career spent studying HD.  But it is important to remember that this isn’t the only story out there.

Whether to get tested is a profoundly personal decision.  No one piece of advice will work for everyone.  Above I’ve tried to capture some of the reasons that it was a good decision for me, some of the benefits of knowing, and some of the empowering and proactive steps one can take without ever learning one’s own test results.

Even in the face of the most arbitrary of arbitrary life events – a 50/50 coin flip for a life-altering genetic accident – I submit that there remain important ways in which we can control, if not life's random events, the stories that we tell with the lives that we build around those events, every day.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>365</wp:post_id>
		<wppost_date>2013-09-04 16:41:53</wppost_date>
		<wppost_date_gmt>2013-09-04 16:41:53</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>yes-i-really-want-to-know</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[2]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Yes, I really want to know http://wp.me/p2WBWF-5T]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>4778</wp:comment_id>
			<wp:comment_author><![CDATA[greta]]></wp:comment_author>
			<wp:comment_author_email>glbeekhuis@mac.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>24.23.41.188</wp:comment_author_IP>
			<wp:comment_date>2013-09-04 18:33:23</wp:comment_date>
			<wp:comment_date_gmt>2013-09-04 18:33:23</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Beautifully stated, Sonia! So proud to stamd with you in the Knowledge is POWER camp!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1378319604.02";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>4844</wp:comment_id>
			<wp:comment_author><![CDATA[Shawn Grover]]></wp:comment_author>
			<wp:comment_author_email>shawngrover@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>128.189.135.183</wp:comment_author_IP>
			<wp:comment_date>2013-09-05 14:54:11</wp:comment_date>
			<wp:comment_date_gmt>2013-09-05 14:54:11</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Great post. On the adaptation point, I was re-reading this book http://www.amazon.com/Stumbling-Happiness-Daniel-Gilbert/dp/1400077427 and it actually mentioned a 1992 study that confirmed the above: that people get a happiness boost when they undergo tests for Huntingtons and find out that they don't have the disease, people that find out that they DO have the disease still get a happiness boost but people for whom the test is inconclusive don't get any boost. Here's a link to the study: http://www.nejm.org/doi/pdf/10.1056/NEJM199211123272001.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1378392851.16";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:12:"1378392920.7";s:7:"message";s:44:"admin changed the comment status to approved";s:5:"event";s:15:"status-approved";s:4:"user";s:5:"admin";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>5360</wp:comment_id>
			<wp:comment_author><![CDATA[Chaiwat]]></wp:comment_author>
			<wp:comment_author_email>jinkszee@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>58.11.255.65</wp:comment_author_IP>
			<wp:comment_date>2013-09-13 05:02:54</wp:comment_date>
			<wp:comment_date_gmt>2013-09-13 05:02:54</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Please could you let me know how to treat or cure or relief the prion disease, I think that I was infected the prion disease from meat that i ate in TH. 
I fond from one website that Apple Vinegar might be help from this disease " earth clinic" I have some thing burn on the left side of my head and i use seruquel for catch protein do you have any idea make me longer life for waiting the great result from research from you .

Hope you can find the treatment of this diceses soon 

chaiwat]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1379048574.15";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>GSS study funded! Now fundraising for FFI and E200K</title>
		<link>http://www.prionalliance.org/2013/09/17/gss-study-funded-now-fundraising-for-ffi-and-e200k/</link>
		<pubDate>Tue, 17 Sep 2013 11:12:59 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=380</guid>
		<description></description>
		<contentencoded><![CDATA[As of 6:45 am today, our Microryza campaign has reached 100%.  Our study to test anle138b against the genetic prion disease GSS is officially funded!

<a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease"><img class="alignnone size-full wp-image-383" title="microryza-project-funded" src="http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-project-funded.png" alt="" width="600" height="322" /></a>

A huge thanks to everyone who made this possible!  The outpouring of support that we've seen in the past few weeks has given us renewed optimism and faith in humanity.  Close friends, new friends, friends-of-friends and perfect strangers have come out to support us generously, and we are humbled with gratitude.

We have 9 days left in the campaign, which ends on Friday 9/27.  We're pleased to announce that additional funds raised beyond the original goal will go towards an additional study of anle138b against two other genetic prion diseases: fatal familial insomnia (FFI) and E200K Creutzfeldt-Jakob disease (CJD).

These new studies will likely start in early 2014.  The mouse models only <a title="FFI and E200K mice arrive in U.S." href="http://www.prionalliance.org/2013/08/23/ffi-and-e200k-mice-arrive-in-u-s/">recently</a> arrived in the U.S., and our collaborator <a href="http://www.montana.edu/mri/carlson.html">Dr. George Carlson</a> is currently crossing them with <a href="http://jaxmice.jax.org/strain/009638.html">another strain of mice</a> that carries a bioluminescent transgene.  This bioluminescent gene will make it possible to monitor disease progression every other week by scanning the mice to see how much they glow.

Recent posts on CureFFI.org provide details of the <a href="http://www.cureffi.org/2013/09/08/study-design-for-therapeutic-trials-in-ffi-and-e200k-mice/">study design</a> including power calculations, and an <a href="http://www.cureffi.org/2013/09/16/revised-budget-for-studies-of-anle138b-in-ffi-and-e200k-mice/">itemized budget</a>.  The study will cost $8,800 total: $4,400 for FFI and $4,400 for E200K.  We will initially seek to raise $4,400 through our Microryza campaign, and (optimistically) if we reach that goal as well, we'll then aim to raise the whole $8,800.

A couple of people have asked us whether the new study will be contingent upon success in the first study - in other words, do we still want to study anle138b in FFI and E200K if we  should find that it's not effective against A117V GSS?

It's an excellent question and we think there's a healthy debate to be had on the merits for and against. Certainly, on one hand, if anle138b doesn't work against <em>all</em> prion strains, that will make it more difficult to bring to clinical trials and will limit its usefulness.

On the other hand, if it's effective against FFI and/or E200K CJD that would certainly be useful information to know!  Another important point is that these mouse models differ in more than just which genetic mutation they carry.  For instance, the FFI and E200K mice [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775465/">Jackson 2009</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/23959875">Jackson 2013</a>] produce only the normal amount of prion protein, while the GSS mice [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749997/">Yang 2009</a>] are engineered to produce 4-5 times the normal amount.  Testing anti-prion compounds in models of <em>genetic</em> prion disease is relatively new territory, and we don't yet know what factors may turn out to be important for predicting whether a drug candidate will prove effective in humans.  Having data from a few different models could prove useful.  Finally, these studies will mark the first time that this bioluminescence technology has been used for monitoring the progression of genetic prion disease.  Even if anle138b should prove ineffective, this effort will still be useful as a pilot study to characterize the disease progression in these mice and set the stage for future drug trials.

For these reasons, on the whole we think that it will be valuable to test anle138b's efficacy against FFI and E200K no matter what the results are from the first study.  As an added plus, this will allow us to get started sooner rather than waiting for results from the GSS study to come in.

If you haven't yet, please visit <a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease">our Microryza site</a> and chip in today!

<iframe src="http://www.youtube.com/embed/pA5xUT4Nq3o?feature=player_embedded" frameborder="0" width="600" height="337"></iframe>

&nbsp;]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>380</wp:post_id>
		<wppost_date>2013-09-17 11:12:59</wppost_date>
		<wppost_date_gmt>2013-09-17 11:12:59</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>gss-study-funded-now-fundraising-for-ffi-and-e200k</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>6652</wp:comment_id>
			<wp:comment_author><![CDATA[françoise]]></wp:comment_author>
			<wp:comment_author_email>fg45200@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>80.215.0.51</wp:comment_author_IP>
			<wp:comment_date>2013-10-01 17:15:00</wp:comment_date>
			<wp:comment_date_gmt>2013-10-01 17:15:00</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Bonsoir je ne parle pas anglais mais j espère que Quelqu yn me répondra s il vous plait. Je viens d apprendre que mon amie à la maladie de creutzfeldt jakob et je suis perdue et anéantie. Elle est rentrée à la maison dans le cadre de l hospitalisation à domicile. Répondez moi s il vous plait.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1380647700.26";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Here&#039;s what&#039;s next</title>
		<link>http://www.prionalliance.org/2013/09/27/heres-whats-next/</link>
		<pubDate>Fri, 27 Sep 2013 16:52:00 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=426</guid>
		<description></description>
		<contentencoded><![CDATA[On the heels of our successful Microryza campaign, we are excited to seize this momentum to begin fundraising for the next experiments!  Here's a peek at what we plan to do with <strong>donations received starting today</strong>:
<div style="display: block;">
<div style="width: 20%; float: left;"><img class="alignnone size-full wp-image-439" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/09/dnahelix.png" alt="" width="100" height="76" /></div>
<div style="float: left important!; width: 80% important!; padding-left: 25%;"><strong>Therapeutic studies in models of fatal familial insomnia and other genetic prion diseases.</strong>  We've now successfully funded three such studies of anle138b, which we consider to be the farthest along of the current drug candidates for prion disease.  But any one drug alone is unlikely to be a solution - we expect that prion diseases will ultimately be treated by drug cocktails much like HIV.  For this reason we are keeping tabs on the other potential treatments currently in the preclinical phase.  We want to step in and provide validation of the most promising candidates in genetic models, in order to speed their progress towards clinical trials.</div>
<div style="clear: both;"></div>
&nbsp;
<div style="width: 20%; float: left;"><img class="alignnone size-full wp-image-436" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/09/molecule999.png" alt="" width="100" height="91" /></div>
<div style="float: left important!; width: 80% important!; padding-left: 25%;"><strong>Early stage drug development.</strong>  It took years of work to bring anle138b to the point where it was ready for preclinical studies like the type we're doing today.  We were lucky to find that the drug's inventors, Dr. Armin Giese and Dr. Christian Griesinger, had already completed most of this work and had a strong drug candidate in hand.  This made it easy for us to step in and test the drug's effects on genetic prion diseases.  But dozens of other potential treatments are still in the early stages, with researchers working on understanding how the drugs work, how to make them more effective, and how to make them as non-toxic and long-lasting as possible.  We would like to help more potential drugs move past these initial stages.  Not all will be successful - it is important to have many horses in the race.</div>
<div style="clear: both;"></div>
&nbsp;
<div style="width: 20%; float: left;"><img class="alignnone size-full wp-image-437" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/09/silence.png" alt="" width="100" height="121" /></div>
<div style="float: left important!; width: 80% important!; padding-left: 25%;"><strong>Optimizing gene silencing.</strong>  While a few different drugs show promise of delaying disease, the only approach that has ever reversed prion disease after the onset of symptoms is to turn off the prion protein gene altogether.  This can be done therapeutically with RNA interference or "gene silencing" approaches, but it's a long road ahead.  An important first step is to have the best possible small RNA molecules to target the prion protein gene and suppress it.  To this end, we want to screen thousands of RNA sequences to determine which candidates to move forward with.</div>
<div style="clear: both;"></div>
&nbsp;
<div style="width: 20%; float: left;"><img class="alignnone size-full wp-image-438" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/09/cosmos.png" alt="" width="100" height="83" /></div>
<div style="float: left important!; width: 80% important!; padding-left: 25%;"><strong>Making treatments universal.</strong>  Some anti-prion treatments that have seemed promising in the past have turned out to only work against one or two very specific subtypes or <em>strains</em> of prion.  We want to understand why this is the case and develop new methods of searching for drugs that will be universal against all prion diseases.</div>
<div style="clear: both;"></div>
&nbsp;

</div>
To really push all of these experiments forward at full tilt, we estimate we could fruitfully spend at least $200,000 over the next several months in small grants to multiple different labs.  But first things first: we could get some first steps underway for each of these goals for about $15,000 each.

So our eye is on this prize.  We are going to start by looking to raise $15,000, and we'll go from there.

[sdprogress]1[/sdprogress]

Help us make it happen. To make a tax-deductible donation via PayPal please click below.

[sdonations]2[/sdonations]

Thank you.  Our faith in humanity is running at an all-time high.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>426</wp:post_id>
		<wppost_date>2013-09-27 16:52:00</wppost_date>
		<wppost_date_gmt>2013-09-27 16:52:00</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>heres-whats-next</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Microryza project closes at $17,217</title>
		<link>http://www.prionalliance.org/2013/09/28/microryza-project-closes-at-17217/</link>
		<pubDate>Sat, 28 Sep 2013 07:10:19 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=449</guid>
		<description></description>
		<contentencoded><![CDATA[As of a few minutes ago, <a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease">our first Microryza crowdfunding campaign</a> has just officially finished.  We raised a total of $17,217, which is 215% of our original $8,000 goal and a few hundred more than even our highest "stretch goal".

<a href="https://www.microryza.com/projects/can-anle138b-delay-the-onset-of-genetic-prion-disease"><img class="alignnone size-full wp-image-450" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/09/microryza-project-complete.png" alt="" width="600" height="272" /></a>

We will be in touch with lots more updates as things move forward.  But for now, it's 3:00 am in Boston, and we just want to say: thank you.  You are all amazing.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>449</wp:post_id>
		<wppost_date>2013-09-28 07:10:19</wppost_date>
		<wppost_date_gmt>2013-09-28 07:10:19</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>microryza-project-closes-at-17217</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Microryza project closes at $17,217]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>What are prions?</title>
		<link>http://www.prionalliance.org/2013/11/26/what-are-prions/</link>
		<pubDate>Tue, 26 Nov 2013 02:31:51 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=459</guid>
		<description></description>
		<contentencoded><![CDATA[<em>This post is part of a series introducing the basics of prion disease. Read the full series <a href="http://www.prionalliance.org/faq/">here</a>.</em>

The term <strong>prion</strong> was coined to mean <em>proteinaceous infectious particle</em> [<a href="http://www.ncbi.nlm.nih.gov/pubmed/6801762">Prusiner 1982</a>].  It's usually pronounced PREE-on in the U.S. and PRY-on in the U.K. Prions are bits of misfolded protein that have the ability to spread by making other proteins misfold.

The concept and the nomenclature surrounding it are easier to understand with a bit of historical background.

A couple of centuries ago, people started taking note of a unique disease afflicting sheep, which they called <strong>scrapie</strong> because the sheep became deranged and, among other things, started scraping their hindquarters raw. Scrapie was an unusual disease: it seemed to spread like a virus but in other ways it looked like a genetic disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14484073/">Parry 1962</a>]. Most peculiar of all, the infectious agent - whatever it was - seemed nearly indestructible. Viruses can usually be inactivated by heat and then used in vaccines, but scrapie survives high temperatures. In one notable incident, a herd of sheep were vaccinated against louping-ill virus with a heat-treated sample from other sheep [<a title="Gordon, W. S. &quot;Louping ill, tickborne fever and scrapie.&quot; Vet Rec 58 (1946): 516-525." href="http://scholar.google.com/scholar?q=Louping+ill%2C+tickborne+fever+and+scrapie&amp;btnG=&amp;hl=en&amp;as_sdt=0%2C22">Gordon 1946</a>]. The sample turned out to contain scrapie, and many of the inoculated sheep became ill with scrapie as a result.

People studied scrapie for about 150 years without much insight as to the true nature of the disease.  A breakthrough came in the mid-20th century when scientists started studying <strong>kuru</strong>, a neurological disease epidemic in the highlands of Papua New Guinea. Carleton Gajdusek won the <a href="http://www.nobelprize.org/nobel_prizes/medicine/laureates/1976/">1976 Nobel Prize</a> for demonstrating that kuru could be transmitted to chimpanzees [<a href="http://www.ncbi.nlm.nih.gov/pubmed/5922150">Gajdusek 1966</a>], as could Creutzfeldt-Jakob disease (CJD), another condition which wreaked havoc on people's brains. The damage from CJD looked a lot like that of kuru and scrapie under the microscope.

Soon the nature of the infectious agent became clear. The "scrapie agent," as it used to be called, was a protein [<a href="http://www.ncbi.nlm.nih.gov/pubmed/6801762">Prusiner 1982</a>]. Unlike bacteria and viruses, it has no DNA or RNA. This was a new thing in all of biology, and Stanley Prusiner won the <a href="http://www.nobelprize.org/nobel_prizes/medicine/laureates/1997/">1997 Nobel Prize</a> for demonstrating this [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC33918/">Prusiner 1998</a>].

So first there was the "scrapie agent", and then this was shown to be an infectious protein which Prusiner dubbed a "prion". Then when Prusiner discovered the protein of which prions were made, he called it "prion protein" (PrP for short) [<a href="http://www.ncbi.nlm.nih.gov/pubmed/6418385">Prusiner 1983</a>]. Next it turned out that PrP was a protein that everyone - even people who aren't sick - have in their bodies, and that there's a gene in your DNA, on chromosome 20, that contains instructions telling each cell how to make PrP [<a href="http://www.ncbi.nlm.nih.gov/pubmed/2859120">Oesch 1985</a>]. This gene was eventually called the <em>PRNP</em> (<span style="text-decoration: underline;">pr</span>io<span style="text-decoration: underline;">n</span> <span style="text-decoration: underline;">p</span>rotein) gene.

<a href="http://www.prionalliance.org/wp-content/uploads/2013/11/prnp-prp-prion.png"><img class="alignnone size-full wp-image-461" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/11/prnp-prp-prion.png" alt="" width="657" height="321" /></a>

If everyone has prion protein, then why do most people never get sick with a prion disease? It turns out that PrP normally exists in a healthy state called "cellular prion protein" or PrP<sup>C</sup>.  But it's capable of misfolding into a "scrapie prion protein" or PrP<sup>Sc</sup>. One particle of PrP<sup>Sc</sup> can cause other PrP<sup>C</sup> to convert into PrP<sup>Sc</sup>.

In the novel Cat's Cradle by Kurt Vonnegut, there's a sort of doomsday weapon called <em>ice-nine.</em>  Ice-nine is a fictional water crystal that has a higher melting point than ordinary ice - it's solid at room temperature.  One crystal of ice-nine causes other water molecules to become ice-nine and so it can freeze an entire ocean. PrP<sup>Sc</sup> is like ice-nine: it "teaches" the other prion proteins how to fold up into a disease state [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7913989">Kocisko 1994</a>].

<a href="http://www.prionalliance.org/wp-content/uploads/2013/11/kvcatscradle.jpg"><img class="alignnone size-full wp-image-460" title="kvcatscradle" src="http://www.prionalliance.org/wp-content/uploads/2013/11/kvcatscradle.jpg" alt="" width="555" height="403" /></a>

When Stanley Prusiner coined the term prion, there weren't many known prion diseases - just kuru, scrapie, and Creutzfeldt-Jakob disease, all of which turned out to be caused by the same protein, PrP. We now know that several other diseases - mad cow or bovine spongiform encephalopathy in cows, chronic wasting disease in deer, and fatal familial insomnia and Gerstmann-Straussler-Scheinker syndrome (just call it GSS!) in humans are all prion diseases, also caused by PrP.

And in fact, it turns out that the idea of proteins that can "teach" other proteins how to fold isn't limited to just PrP. There is now a growing body of scientific evidence to suggest that other neurodegenerative diseases such as Alzheimer's and Parkinson's disease are also caused by different proteins that can act like ice-nine [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22711819">Stohr 2012</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/23161999">Luk 2012</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/22723400">Prusiner 2012</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24005412">Jucker &amp; Walker 2013</a>]. Even more amazingly, it turns out that the idea of proteins that cause other proteins to fold up like themselves isn't <em>always</em> a bad thing. In yeast, it appears to be part of every day life - yeast cells will divide and pass on their "prions" to their daughter cells kind of like they pass on DNA, and those proteins will contain important information that could help the daughter cells survive [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22337056">Halfmann &amp; Jarosz 2012</a>].

So over the past several years, it's increasingly common to hear people use the term "prion" to refer to amyloid beta (the protein involved in Alzheimer's), alpha synuclein (the culprit in Parkinson's), and various proteins in yeast. When we say "prion disease" here at Prion Alliance, we're almost always referring just to the "original" prions - the misfolded PrP particles that cause Creutzfeldt-Jakob disease, fatal familial insomnia, and so on. Those are the diseases that we've made it our mission to cure. If you want to be very precise about terminology, you can call these "PrP prion diseases."

Want to learn more? For a fascinating history of prions and prion diseases, we recommend <a href="http://amzn.com/081297252X"><em>The Family That Couldn't Sleep</em></a> by D.T. Max (2006).]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>459</wp:post_id>
		<wppost_date>2013-11-26 02:31:51</wppost_date>
		<wppost_date_gmt>2013-11-26 02:31:51</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>what-are-prions</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="faq"><![CDATA[FAQ]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[What are prions? http://wp.me/p2WBWF-7p]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>14712</wp:comment_id>
			<wp:comment_author><![CDATA[sarada challa]]></wp:comment_author>
			<wp:comment_author_email>saradasastry@yahoo.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>99.43.175.98</wp:comment_author_IP>
			<wp:comment_date>2013-11-26 16:02:22</wp:comment_date>
			<wp:comment_date_gmt>2013-11-26 16:02:22</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[thank you eric for the info  how are you both doing love]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1385481742.82";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>14623</wp:comment_id>
			<wp:comment_author><![CDATA[Alma Pearson]]></wp:comment_author>
			<wp:comment_author_email>norma17@btinternet.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>5.81.133.150</wp:comment_author_IP>
			<wp:comment_date>2013-11-26 09:04:16</wp:comment_date>
			<wp:comment_date_gmt>2013-11-26 09:04:16</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I have just finished reading a fascinating book on Human Mad Cow Disease titled ' Who Killed My Son - By Christine Lord' an insight into how so many of us have been unknowingly exposed to BSE.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1385456656.56";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17414</wp:comment_id>
			<wp:comment_author><![CDATA[Dario]]></wp:comment_author>
			<wp:comment_author_email>rambodarius@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>12.205.97.53</wp:comment_author_IP>
			<wp:comment_date>2014-03-08 15:46:52</wp:comment_date>
			<wp:comment_date_gmt>2014-03-08 15:46:52</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[If someone could give any ifo about everything that Prions do or cuase it would be grateful... I"m a Hischool stundent and I'll be realizing and investigation about Prions
anything is useful!
Thanks]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1394293612.9047279;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17415</wp:comment_id>
			<wp:comment_author><![CDATA[James]]></wp:comment_author>
			<wp:comment_author_email>pstrjms@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>174.24.201.81</wp:comment_author_IP>
			<wp:comment_date>2014-03-23 12:33:14</wp:comment_date>
			<wp:comment_date_gmt>2014-03-23 12:33:14</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Prions are molecules of a normal body protein that have changed their normal configuration. They are capable of reproduction on their own and can become infectious, damage the body and negatively effect normal body function.
These prions have been found in neurological tissues such as the brain on autopsy.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1395577994.862582;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17416</wp:comment_id>
			<wp:comment_author><![CDATA[Ritchi]]></wp:comment_author>
			<wp:comment_author_email>rgarci13@cccemail.net</wp:comment_author_email>
			<wp:comment_author_url>http://prionalliance.ore</wp:comment_author_url>
			<wp:comment_author_IP>75.111.115.33</wp:comment_author_IP>
			<wp:comment_date>2014-04-21 04:54:35</wp:comment_date>
			<wp:comment_date_gmt>2014-04-21 04:54:35</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I am currently writing a literature review for class, and this article really helped to simplify the idea of a prion to me!!  Thanks!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1398056075.0896671;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17420</wp:comment_id>
			<wp:comment_author><![CDATA[Cludy]]></wp:comment_author>
			<wp:comment_author_email>drgclaudinet@yahoo.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>64.60.114.210</wp:comment_author_IP>
			<wp:comment_date>2014-05-21 22:35:11</wp:comment_date>
			<wp:comment_date_gmt>2014-05-21 22:35:11</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Interesting information, fascinating topic!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1400711711.570462;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>What are human prion diseases?</title>
		<link>http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/</link>
		<pubDate>Mon, 02 Dec 2013 15:59:24 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=465</guid>
		<description></description>
		<contentencoded><![CDATA[<em>This post is part of a series introducing the basics of prion disease. Read the full series <a href="http://www.prionalliance.org/faq/">here</a>.</em>

Prion diseases are a group of neurodegenerative diseases caused by <strong>prions</strong>, which are "proteinaceous infectious particles." For some background, first see <a title="What are prions?" href="http://www.prionalliance.org/2013/11/26/what-are-prions/">this introduction to prions</a>. Prion diseases are caused by misfolded forms of the prion protein, also known as PrP. These diseases affect a lot of different mammals in addition to humans - for instance, there is scrapie in sheep, mad cow disease in cows, and chronic wasting disease in deer.

The human forms of prion disease are most often the names <strong>Creutzfeldt-Jakob disease</strong> (CJD), <strong>fatal familial insomnia</strong> (FFI), <strong>Gertsmann-Straussler-Scheinker syndrome</strong> (GSS), <strong>kuru</strong> and <strong>variably protease-sensitive prionopathy</strong> (VPSPr). All of these diseases are caused by just slightly different versions of the same protein, so we refer to them all as prion diseases.

Even though prion diseases do come in slightly different forms, they have a whole lot in common.  In each disease, the prion protein (PrP) folds up the wrong way, becoming a <a title="What are prions?" href="http://www.prionalliance.org/2013/11/26/what-are-prions/"><strong>prion</strong></a>, and then causes other PrP molecules to do the same.  Prions can then spread "silently" across a person's brain for years without causing any symptoms. Eventually prions start to kill neurons, and once symptoms strike, the person has a very rapid cognitive decline. Most prion diseases are fatal within a few months, though some can last a few years [<a href="http://www.ncbi.nlm.nih.gov/pubmed/15361416">Pocchiari 2004</a>].

Prion diseases in humans are fairly rare - about 1 in 1 million people dies of a prion disease each year [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797136/">Holman 2010</a>]. Prion diseases can come about in one of three ways: acquired, genetic or sporadic.

<strong>Acquired</strong> means the person gets exposed to prions and becomes infected. Even though prions are scary, they're very hard to catch, and so infection is the least common way of getting a prion disease. There was a famous epidemic of <strong>kuru</strong>, a prion disease which was passed from person to person by cannibalism, in Papua New Guinea, but this has now mostly subsided. Then there is <strong>mad cow</strong> disease or <strong>bovine spongiform encephalopathy</strong>. This disease passed from cows to humans through contaminated food. The human form of the disease is called <strong>variant Creutzfeldt-Jakob Disease (vCJD)</strong> and has killed about 200 people in the U.K. since 1994 [<a href="http://www.cjd.ed.ac.uk/documents/figs.pdf">UK CJD Survelliance</a>].  Today there are only a few people are dying of this disease each year. There have also been cases where prion disease has been transmitted via contaminated surgical instruments, human growth hormone supplements, or transplants of dura mater (a tissue surrounding the brain). These medical infections are called "<strong>iatrogenic</strong>" infections.

Prion diseases can also be <strong>genetic</strong>. First, let's recall some biology basics. DNA contains instructions which get re-written in RNA, and then the instructions in RNA get translated into protein. So changes in a person's DNA can cause changes in the proteins their cells produce. Everyone has a gene called <em>PRNP</em> which codes for the protein called PrP, and most of the time this protein is perfectly healthy and fine. Some people have mutations in the DNA of their <em>PRNP</em> gene, which cause it to produce mutant forms of PrP.  These mutant forms don't form prions instantly, and most people with <em>PRNP</em> mutations live perfectly healthy for decades. But as people get older, the mutant forms of PrP are more and more likely to fold up the wrong way and form prions. Once they do, the person has a rapid neurodegenerative disease.

Some people refer to genetic prion diseases as "<strong>inherited</strong>" or "<strong>familial</strong>" prion diseases. We prefer not to use these terms: just because a disease is genetic doesn't mean it's inherited or familial. Every DNA mutation has to start somewhere, so some people with genetic prion disease are the first in their family - they didn't inherit the mutation, and it's not familial. According to one estimate, 60% of genetic prion disease patients have no family history of the disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23906487">Bechtel &amp; Geschwind 2013</a>].

Finally, prion diseases can simply be <strong>sporadic</strong>, meaning we don't know why they happen. Some people think that sporadic prion diseases happen when one prion protein just misfolds by chance, and then spreads from there. Others think that the disease may start with one cell that has a spontaneous DNA mutation and starts producing mutant PrP. We don't know what the real answer is. Either way, the effect is that people with no previous exposure to prions and no mutations in (most of) their DNA end up getting a prion disease out of nowhere.

The sporadic form of prion disease is by far the most common. It's often estimated that human prion disease cases are 85% sporadic, 15% genetic and &lt; 1% acquired [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304579/">Appleby &amp; Lyketsos 2011</a>, <a href="http://www.cdc.gov/ncidod/dvrd/cjd/">CDC Fact Sheet</a>, <a href="http://memory.ucsf.edu/sites/all/files/download/MAC_RPD_Primer.pdf">UCSF Primer</a>].

<a href="http://www.prionalliance.org/wp-content/uploads/2013/11/genetic-sporadic-acquired-400px.png"><img class="alignnone size-full wp-image-467" title="" src="http://www.prionalliance.org/wp-content/uploads/2013/11/genetic-sporadic-acquired-400px.png" alt="" width="400" height="277" /></a>

So prion diseases can be categorized by where they came from: acquired, sporadic, and genetic. But as mentioned at the top of this post, you'll also hear prion diseases categorized a different way, most often as <strong>Creutzfeldt-Jakob disease (CJD)</strong>, <strong>fatal familial insomnia (FFI)</strong>, and <strong>Gerstmann-Straussler-Scheinker (GSS)</strong> syndrome. The origin and use of these names can be confusing. The names were originally used to categorize patients by their symptoms, but later came to refer to particular strains or genetic varieties of prion disease.

For instance, the name fatal familial insomnia was originally applied to a family with a genetic disease with insomnia as the first and foremost symptom [<a href="http://www.ncbi.nlm.nih.gov/pubmed/3762620">Lugaresi 1986</a>]. After it was later found that a particular genetic mutation caused this disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/1346338">Medori 1992</a>], people started using FFI to refer to the disease caused by that one particular mutation, even though for some patients insomnia isn't a major part of the disease [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1739400/">Zarranz 2005</a>]. Later on scientists discovered a non-genetic form of FFI and called it sporadic fatal insomnia (sFI) [<a href="http://www.ncbi.nlm.nih.gov/pubmed/10371520">Parchi 1999</a>], but other people see it as a subtype of CJD and refer to it as "MM2 thalamic Creutzfeldt-Jakob disease" [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22288561">Moda 2012</a>].

To add another layer of complexity, new types of prion disease are still being discovered that don't fit into any of the original three categories (CJD, FFI or GSS). For example, the most recent new form was dubbed "variably protease-sensitive prionopathy" (VPSPr) [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20695009">Zou 2010</a>]. That's quite a mouthful.

Since the naming system can be confusing, we usually avoid it altogether and simply refer to all of these diseases as <strong>prion diseases</strong>.  For genetic prion diseases, it is useful to name the exact mutation - for instance, E200K or P102L (for how to interpret these numbers and letters see our upcoming primer on genetic prion diseases).  As for sporadic prion diseases, scientists have a system of biochemical subtypes such as "MV1", "VV2", "MM2 cortical" and so on.

One of the surprising things about prion protein is that this single protein can fold up in so many <em>different</em> ways that are toxic and cause disease. The diagram below illustrates how just one protein - PrP (green) - can fold up in several different ways, creating several different <strong>strains</strong> of prion (red).

<img class="alignnone size-full wp-image-492" title="Prion protein (green) can fold up into many different prion strains (red)" src="http://www.prionalliance.org/wp-content/uploads/2013/12/one-prp-many-prion-strains.png" alt="" width="600" height="212" />

There are actually a dizzying number of different forms of human prion disease.  Kuru and vCJD, two strains that people have acquired by infection, are probably the most famous but also the most rare. There are also at least 6 strains of sporadic prion disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21107851">Parchi 2011</a>] and over 40 genetic mutations that cause prion disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20583301">Beck 2010</a>].

Many of these different prion strains act pretty differently. They come from different sources, cause different disease symptoms and strike people of different ages. But since they're all caused by the same protein - PrP - we're hopeful that it will be possible to find one treatment that will treat all of these different diseases.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>465</wp:post_id>
		<wppost_date>2013-12-02 15:59:24</wppost_date>
		<wppost_date_gmt>2013-12-02 15:59:24</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>what-are-human-prion-diseases</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="faq"><![CDATA[FAQ]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[What are human prion diseases? http://wp.me/p2WBWF-7v]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>17411</wp:comment_id>
			<wp:comment_author><![CDATA[Ellen]]></wp:comment_author>
			<wp:comment_author_email>sextone@comcast.net</wp:comment_author_email>
			<wp:comment_author_url>http://Sexton</wp:comment_author_url>
			<wp:comment_author_IP>50.142.240.21</wp:comment_author_IP>
			<wp:comment_date>2014-01-17 14:50:31</wp:comment_date>
			<wp:comment_date_gmt>2014-01-17 14:50:31</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Give information about some of the different diseases, plz!!!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";s:13:"1389970231.49";s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17413</wp:comment_id>
			<wp:comment_author><![CDATA[cheryl]]></wp:comment_author>
			<wp:comment_author_email>chiquitagirl710@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>69.125.31.122</wp:comment_author_IP>
			<wp:comment_date>2014-02-18 11:57:21</wp:comment_date>
			<wp:comment_date_gmt>2014-02-18 11:57:21</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Thank you greatly! You gave me clarity, however briefly, before thrusting me back into confused. However, I am on a higher level of confusion as a result. Thus better satisfied with the knowledge I've acquired. Also, thank you for your dedication to the research and eventual treatment/cure of the diseases. When I hit the lottery, I would  be honored to contribute to your foundation. God bless. -Cheryl]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1392724641.1312621;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17421</wp:comment_id>
			<wp:comment_author><![CDATA[John B. Cullen]]></wp:comment_author>
			<wp:comment_author_email>j.cullen@live.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>69.74.253.62</wp:comment_author_IP>
			<wp:comment_date>2014-05-23 14:36:07</wp:comment_date>
			<wp:comment_date_gmt>2014-05-23 14:36:07</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Triflouroperazine may be an answer to fatal familial insomnia and others]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1400855767.132724;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17424</wp:comment_id>
			<wp:comment_author><![CDATA[talmage eastland]]></wp:comment_author>
			<wp:comment_author_email>cipher55@hotmail.com</wp:comment_author_email>
			<wp:comment_author_url>http://storiform.com</wp:comment_author_url>
			<wp:comment_author_IP>71.59.170.143</wp:comment_author_IP>
			<wp:comment_date>2014-07-11 23:31:50</wp:comment_date>
			<wp:comment_date_gmt>2014-07-11 23:31:50</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Excellent article. I've lost two loved ones to a CNS dementia that I think may have been prion disease. It was diagnosed as Binswanger's disease in the mother at autopsy, but the daughter who had the same clinical symptoms was told that she didn't have Binswanger's. When I talked to the neurologist, she didn't give prion disease a second thought. I can't remember now why she dismissed it, but I think the genetic and familial forms may not have been widely recognized at the time. The dementia is behaving like an autosomal dominant disease in the family so far, starting at age 45 and progressing with similarities to the descriptions I've read elsewhere on prion disease. Thanks again for this excellently written article.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1405121510.579993;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>hc_post_as</wp:meta_key>
				<wp:meta_value><![CDATA[wordpress]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>hc_avatar</wp:meta_key>
				<wp:meta_value><![CDATA[http://1.gravatar.com/avatar/dd7b044c161c9899224fc8323e2df971?s=25&d=http%3A%2F%2Fs2.wp.com%2Fwp-content%2Fmu-plugins%2Fhighlander-comments%2Fimages%2Fwplogo.png&r=G]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>hc_foreign_user_id</wp:meta_key>
				<wp:meta_value><![CDATA[26127317]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>hc_wpcom_id_sig</wp:meta_key>
				<wp:meta_value><![CDATA[209d68d3ed1d4fee51dbdccc75033a4b4f7b1c4e]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17425</wp:comment_id>
			<wp:comment_author><![CDATA[kenneth a bradley]]></wp:comment_author>
			<wp:comment_author_email>kennethabradley@bellsouth.net</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>74.240.136.176</wp:comment_author_IP>
			<wp:comment_date>2014-07-20 15:13:57</wp:comment_date>
			<wp:comment_date_gmt>2014-07-20 15:13:57</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Very informative article. Written is a form that the average layman can understand. We are still coping with the loss of our son last year. The disease was confirmed recently as a result of brain study.The disease is so complex that we are now going through the process of having the cause of death changed. We would like to find a source or group involved in making  awareness of the disease to the general public of this deadly disease.. Any suggestion.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1405869237.657259;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17436</wp:comment_id>
			<wp:comment_author><![CDATA[bioced2]]></wp:comment_author>
			<wp:comment_author_email>bioced2@gmail.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>170.142.177.61</wp:comment_author_IP>
			<wp:comment_date>2014-12-12 14:11:41</wp:comment_date>
			<wp:comment_date_gmt>2014-12-12 14:11:41</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[To Kenneth a Bradley The CDJ Foundation
341 W. 38th Street , Suite 501 
New York, NY 10081 1-800-659-1991]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1418393501.232517;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17446</wp:comment_id>
			<wp:comment_author><![CDATA[Pamela]]></wp:comment_author>
			<wp:comment_author_email>fotogenic15@comcast.net</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>76.105.177.54</wp:comment_author_IP>
			<wp:comment_date>2015-03-04 00:55:44</wp:comment_date>
			<wp:comment_date_gmt>2015-03-04 00:55:44</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Almost forgot.  Also he was not allowed to be in contact with the body to say his last goodbye because of how badly the disease was.  She was cremated. My son is only 43 years old to be a widower. How does a mother help her son to comfort him and everything.  Please let me know.  Thank you]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_as_submitted</wp:meta_key>
				<wp:meta_value><![CDATA[a:60:{s:15:"comment_post_ID";i:465;s:14:"comment_author";s:6:"Pamela";s:20:"comment_author_email";s:23:"fotogenic15@comcast.net";s:18:"comment_author_url";s:0:"";s:15:"comment_content";s:290:"Almost forgot.  Also he was not allowed to be in contact with the body to say his last goodbye because of how badly the disease was.  She was cremated. My son is only 43 years old to be a widower. How does a mother help her son to comfort him and everything.  Please let me know.  Thank you";s:12:"comment_type";s:0:"";s:14:"comment_parent";i:0;s:7:"user_ID";i:0;s:7:"user_ip";s:13:"76.105.177.54";s:10:"user_agent";s:72:"Mozilla/5.0 (Windows NT 6.1; WOW64; rv:35.0) Gecko/20100101 Firefox/35.0";s:8:"referrer";s:45:"http://jetpack.wordpress.com/jetpack-comment/";s:4:"blog";s:28:"http://www.prionalliance.org";s:9:"blog_lang";s:5:"en_US";s:12:"blog_charset";s:5:"UTF-8";s:9:"permalink";s:70:"http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/";s:21:"akismet_comment_nonce";s:6:"failed";s:15:"POST_hc_post_as";s:5:"guest";s:12:"POST_comment";s:290:"Almost forgot.  Also he was not allowed to be in contact with the body to say his last goodbye because of how badly the disease was.  She was cremated. My son is only 43 years old to be a widower. How does a mother help her son to comfort him and everything.  Please let me know.  Thank you";s:10:"POST_email";s:23:"fotogenic15@comcast.net";s:11:"POST_author";s:6:"Pamela";s:8:"POST_url";s:0:"";s:20:"POST_comment_post_ID";s:3:"465";s:19:"POST_comment_parent";s:1:"0";s:14:"POST_hc_avatar";s:166:"http://0.gravatar.com/avatar/fef71807b8d4980f6c08210519e0c132?s=80&d=https%3A%2F%2Fs2.wp.com%2Fwp-content%2Fmu-plugins%2Fhighlander-comments%2Fimages%2Fwplogo.png&r=G";s:23:"POST_subscribe_comments";s:9:"subscribe";s:8:"POST_sig";s:40:"933b6d74fcd71bbd8d88810b289c9b69eab9ac1b";s:15:"SERVER_SOFTWARE";s:6:"Apache";s:11:"REQUEST_URI";s:33:"/wp-comments-post.php?for=jetpack";s:14:"CONTENT_LENGTH";s:3:"692";s:12:"CONTENT_TYPE";s:33:"application/x-www-form-urlencoded";s:13:"DOCUMENT_ROOT";s:27:"/home3/prionall/public_html";s:17:"GATEWAY_INTERFACE";s:7:"CGI/1.1";s:11:"HTTP_ACCEPT";s:63:"text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8";s:20:"HTTP_ACCEPT_ENCODING";s:13:"gzip, deflate";s:20:"HTTP_ACCEPT_LANGUAGE";s:14:"en-US,en;q=0.5";s:15:"HTTP_CONNECTION";s:10:"keep-alive";s:11:"HTTP_COOKIE";s:0:"";s:9:"HTTP_HOST";s:21:"www.prionalliance.org";s:12:"HTTP_REFERER";s:45:"http://jetpack.wordpress.com/jetpack-comment/";s:15:"HTTP_USER_AGENT";s:72:"Mozilla/5.0 (Windows NT 6.1; WOW64; rv:35.0) Gecko/20100101 Firefox/35.0";s:19:"MAGICK_THREAD_LIMIT";s:1:"1";s:4:"PATH";s:13:"/bin:/usr/bin";s:12:"QUERY_STRING";s:11:"for=jetpack";s:15:"REDIRECT_STATUS";s:3:"200";s:11:"REMOTE_ADDR";s:13:"76.105.177.54";s:11:"REMOTE_PORT";s:5:"50515";s:14:"REQUEST_METHOD";s:4:"POST";s:15:"SCRIPT_FILENAME";s:48:"/home3/prionall/public_html/wp-comments-post.php";s:11:"SCRIPT_NAME";s:21:"/wp-comments-post.php";s:11:"SERVER_ADDR";s:13:"69.195.124.66";s:12:"SERVER_ADMIN";s:27:"webmaster@prionalliance.org";s:11:"SERVER_NAME";s:21:"www.prionalliance.org";s:11:"SERVER_PORT";s:2:"80";s:15:"SERVER_PROTOCOL";s:8:"HTTP/1.1";s:16:"SERVER_SIGNATURE";s:66:"<address>Apache Server at www.prionalliance.org Port 80</address>
";s:9:"UNIQUE_ID";s:24:"VPZYD0XDfEIAAA4Itn0AAAJJ";s:8:"PHP_SELF";s:21:"/wp-comments-post.php";s:18:"REQUEST_TIME_FLOAT";s:15:"1425430543.7427";s:12:"REQUEST_TIME";s:10:"1425430543";s:25:"comment_post_modified_gmt";s:19:"2013-12-02 16:02:19";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1425430544.4386959;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17445</wp:comment_id>
			<wp:comment_author><![CDATA[Pamela]]></wp:comment_author>
			<wp:comment_author_email>fotogenic15@comcast.net</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>76.105.177.54</wp:comment_author_IP>
			<wp:comment_date>2015-03-04 00:50:44</wp:comment_date>
			<wp:comment_date_gmt>2015-03-04 00:50:44</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[My oldest son's wife died about 2 weeks ago with this disease.  She had it so bad that when first dx, in 6 wks she was gone. I would love to learn more about this.  I'm just hoping my son does not come down with it.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_as_submitted</wp:meta_key>
				<wp:meta_value><![CDATA[a:61:{s:15:"comment_post_ID";i:465;s:14:"comment_author";s:6:"Pamela";s:20:"comment_author_email";s:23:"fotogenic15@comcast.net";s:18:"comment_author_url";s:0:"";s:15:"comment_content";s:215:"My oldest son's wife died about 2 weeks ago with this disease.  She had it so bad that when first dx, in 6 wks she was gone. I would love to learn more about this.  I'm just hoping my son does not come down with it.";s:12:"comment_type";s:0:"";s:14:"comment_parent";i:0;s:7:"user_ID";i:0;s:7:"user_ip";s:13:"76.105.177.54";s:10:"user_agent";s:72:"Mozilla/5.0 (Windows NT 6.1; WOW64; rv:35.0) Gecko/20100101 Firefox/35.0";s:8:"referrer";s:45:"http://jetpack.wordpress.com/jetpack-comment/";s:4:"blog";s:28:"http://www.prionalliance.org";s:9:"blog_lang";s:5:"en_US";s:12:"blog_charset";s:5:"UTF-8";s:9:"permalink";s:70:"http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/";s:21:"akismet_comment_nonce";s:6:"failed";s:15:"POST_hc_post_as";s:5:"guest";s:12:"POST_comment";s:215:"My oldest son's wife died about 2 weeks ago with this disease.  She had it so bad that when first dx, in 6 wks she was gone. I would love to learn more about this.  I'm just hoping my son does not come down with it.";s:10:"POST_email";s:23:"fotogenic15@comcast.net";s:11:"POST_author";s:6:"Pamela";s:8:"POST_url";s:0:"";s:19:"POST_subscribe_blog";s:9:"subscribe";s:20:"POST_comment_post_ID";s:3:"465";s:19:"POST_comment_parent";s:1:"0";s:14:"POST_hc_avatar";s:166:"http://0.gravatar.com/avatar/fef71807b8d4980f6c08210519e0c132?s=80&d=https%3A%2F%2Fs2.wp.com%2Fwp-content%2Fmu-plugins%2Fhighlander-comments%2Fimages%2Fwplogo.png&r=G";s:23:"POST_subscribe_comments";s:9:"subscribe";s:8:"POST_sig";s:40:"30489e1e9863e2af46410df47ff405916b686268";s:15:"SERVER_SOFTWARE";s:6:"Apache";s:11:"REQUEST_URI";s:33:"/wp-comments-post.php?for=jetpack";s:14:"CONTENT_LENGTH";s:3:"648";s:12:"CONTENT_TYPE";s:33:"application/x-www-form-urlencoded";s:13:"DOCUMENT_ROOT";s:27:"/home3/prionall/public_html";s:17:"GATEWAY_INTERFACE";s:7:"CGI/1.1";s:11:"HTTP_ACCEPT";s:63:"text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8";s:20:"HTTP_ACCEPT_ENCODING";s:13:"gzip, deflate";s:20:"HTTP_ACCEPT_LANGUAGE";s:14:"en-US,en;q=0.5";s:15:"HTTP_CONNECTION";s:10:"keep-alive";s:11:"HTTP_COOKIE";s:0:"";s:9:"HTTP_HOST";s:21:"www.prionalliance.org";s:12:"HTTP_REFERER";s:45:"http://jetpack.wordpress.com/jetpack-comment/";s:15:"HTTP_USER_AGENT";s:72:"Mozilla/5.0 (Windows NT 6.1; WOW64; rv:35.0) Gecko/20100101 Firefox/35.0";s:19:"MAGICK_THREAD_LIMIT";s:1:"1";s:4:"PATH";s:13:"/bin:/usr/bin";s:12:"QUERY_STRING";s:11:"for=jetpack";s:15:"REDIRECT_STATUS";s:3:"200";s:11:"REMOTE_ADDR";s:13:"76.105.177.54";s:11:"REMOTE_PORT";s:5:"50378";s:14:"REQUEST_METHOD";s:4:"POST";s:15:"SCRIPT_FILENAME";s:48:"/home3/prionall/public_html/wp-comments-post.php";s:11:"SCRIPT_NAME";s:21:"/wp-comments-post.php";s:11:"SERVER_ADDR";s:13:"69.195.124.66";s:12:"SERVER_ADMIN";s:27:"webmaster@prionalliance.org";s:11:"SERVER_NAME";s:21:"www.prionalliance.org";s:11:"SERVER_PORT";s:2:"80";s:15:"SERVER_PROTOCOL";s:8:"HTTP/1.1";s:16:"SERVER_SIGNATURE";s:66:"<address>Apache Server at www.prionalliance.org Port 80</address>
";s:9:"UNIQUE_ID";s:24:"VPZW4kXDfEIAAGzzVYYAAATB";s:8:"PHP_SELF";s:21:"/wp-comments-post.php";s:18:"REQUEST_TIME_FLOAT";s:15:"1425430243.0048";s:12:"REQUEST_TIME";s:10:"1425430243";s:25:"comment_post_modified_gmt";s:19:"2013-12-02 16:02:19";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1425430244.7487271;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17447</wp:comment_id>
			<wp:comment_author><![CDATA[Carol]]></wp:comment_author>
			<wp:comment_author_email>carol-d@hotmail.co.uk</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>82.36.123.38</wp:comment_author_IP>
			<wp:comment_date>2015-03-04 16:43:17</wp:comment_date>
			<wp:comment_date_gmt>2015-03-04 16:43:17</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[My son has recently received a letter from our health authority advising that neurosurgery he went through almost 6 years ago may leave him with GSS as a previous patient is now showing signs and the same instruments were used.  I am so scared of the outcome.  He is only 19.  This article has helped to understand.  If anyone can give me any more info it would be greatly appreciated.]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1425487397.4588211;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_as_submitted</wp:meta_key>
				<wp:meta_value><![CDATA[a:63:{s:15:"comment_post_ID";i:465;s:14:"comment_author";s:5:"Carol";s:20:"comment_author_email";s:21:"carol-d@hotmail.co.uk";s:18:"comment_author_url";s:0:"";s:15:"comment_content";s:385:"My son has recently received a letter from our health authority advising that neurosurgery he went through almost 6 years ago may leave him with GSS as a previous patient is now showing signs and the same instruments were used.  I am so scared of the outcome.  He is only 19.  This article has helped to understand.  If anyone can give me any more info it would be greatly appreciated.";s:12:"comment_type";s:0:"";s:14:"comment_parent";i:0;s:7:"user_ID";i:0;s:7:"user_ip";s:12:"82.36.123.38";s:10:"user_agent";s:68:"Mozilla/5.0 (Windows NT 6.3; WOW64; Trident/7.0; rv:11.0) like Gecko";s:8:"referrer";s:45:"http://jetpack.wordpress.com/jetpack-comment/";s:4:"blog";s:28:"http://www.prionalliance.org";s:9:"blog_lang";s:5:"en_US";s:12:"blog_charset";s:5:"UTF-8";s:9:"permalink";s:70:"http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/";s:21:"akismet_comment_nonce";s:6:"failed";s:15:"POST_hc_post_as";s:5:"guest";s:12:"POST_comment";s:387:"My son has recently received a letter from our health authority advising that neurosurgery he went through almost 6 years ago may leave him with GSS as a previous patient is now showing signs and the same instruments were used.  I am so scared of the outcome.  He is only 19.  This article has helped to understand.  If anyone can give me any more info it would be greatly appreciated.
";s:10:"POST_email";s:21:"carol-d@hotmail.co.uk";s:11:"POST_author";s:5:"Carol";s:8:"POST_url";s:0:"";s:19:"POST_subscribe_blog";s:9:"subscribe";s:20:"POST_comment_post_ID";s:3:"465";s:19:"POST_comment_parent";s:1:"0";s:14:"POST_hc_avatar";s:166:"http://2.gravatar.com/avatar/2acee6b9929daf70c37726a7048ef358?s=80&d=https%3A%2F%2Fs2.wp.com%2Fwp-content%2Fmu-plugins%2Fhighlander-comments%2Fimages%2Fwplogo.png&r=G";s:23:"POST_subscribe_comments";s:9:"subscribe";s:8:"POST_sig";s:40:"8a739f8e8a288af9100b2dab89d59099194dc3a2";s:15:"SERVER_SOFTWARE";s:6:"Apache";s:11:"REQUEST_URI";s:33:"/wp-comments-post.php?for=jetpack";s:14:"CONTENT_LENGTH";s:3:"813";s:12:"CONTENT_TYPE";s:33:"application/x-www-form-urlencoded";s:13:"DOCUMENT_ROOT";s:27:"/home3/prionall/public_html";s:17:"GATEWAY_INTERFACE";s:7:"CGI/1.1";s:11:"HTTP_ACCEPT";s:37:"text/html, application/xhtml+xml, */*";s:20:"HTTP_ACCEPT_ENCODING";s:13:"gzip, deflate";s:20:"HTTP_ACCEPT_LANGUAGE";s:5:"en-GB";s:18:"HTTP_CACHE_CONTROL";s:8:"no-cache";s:15:"HTTP_CONNECTION";s:10:"Keep-Alive";s:11:"HTTP_COOKIE";s:0:"";s:8:"HTTP_DNT";s:1:"1";s:9:"HTTP_HOST";s:21:"www.prionalliance.org";s:12:"HTTP_REFERER";s:45:"http://jetpack.wordpress.com/jetpack-comment/";s:15:"HTTP_USER_AGENT";s:68:"Mozilla/5.0 (Windows NT 6.3; WOW64; Trident/7.0; rv:11.0) like Gecko";s:19:"MAGICK_THREAD_LIMIT";s:1:"1";s:4:"PATH";s:13:"/bin:/usr/bin";s:12:"QUERY_STRING";s:11:"for=jetpack";s:15:"REDIRECT_STATUS";s:3:"200";s:11:"REMOTE_ADDR";s:12:"82.36.123.38";s:11:"REMOTE_PORT";s:5:"60511";s:14:"REQUEST_METHOD";s:4:"POST";s:15:"SCRIPT_FILENAME";s:48:"/home3/prionall/public_html/wp-comments-post.php";s:11:"SCRIPT_NAME";s:21:"/wp-comments-post.php";s:11:"SERVER_ADDR";s:13:"69.195.124.66";s:12:"SERVER_ADMIN";s:27:"webmaster@prionalliance.org";s:11:"SERVER_NAME";s:21:"www.prionalliance.org";s:11:"SERVER_PORT";s:2:"80";s:15:"SERVER_PROTOCOL";s:8:"HTTP/1.1";s:16:"SERVER_SIGNATURE";s:66:"<address>Apache Server at www.prionalliance.org Port 80</address>
";s:9:"UNIQUE_ID";s:24:"VPc2I0XDfEIAAEyV@twAAAGX";s:8:"PHP_SELF";s:21:"/wp-comments-post.php";s:18:"REQUEST_TIME_FLOAT";s:15:"1425487395.8332";s:12:"REQUEST_TIME";s:10:"1425487395";s:25:"comment_post_modified_gmt";s:19:"2013-12-02 16:02:19";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>What does it mean to have a genetic prion disease?</title>
		<link>http://www.prionalliance.org/2013/12/09/what-does-it-mean-to-have-a-genetic-prion-disease/</link>
		<pubDate>Mon, 09 Dec 2013 18:58:48 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=474</guid>
		<description></description>
		<contentencoded><![CDATA[<em>This post is part of a series introducing the basics of prion disease. Read the full series <a href="http://www.prionalliance.org/faq/">here</a>.</em>

In the last two posts we introduced the concept of a <strong><a title="What are prions?" href="http://www.prionalliance.org/2013/11/26/what-are-prions/">prion</a></strong> and introduced the <a title="What are human prion diseases?" href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/">human prion diseases</a>, better known as <strong>Creutzfeldt-Jakob disease (CJD)</strong>, <strong>fatal familial insomnia (FFI)</strong>, and <strong>Gertsmann-Straussler-Scheinker syndrome (GSS)</strong>.  Altogether these diseases are pretty rare, with an incidence of about 1 in 1 million people falling ill each year [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797136/">Holman 2010</a>]. The genetic forms of prion disease are even more rare, accounting for probably just 15% of all cases [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304579/">Appleby &amp; Lyketsos 2011</a>].

To understand how these diseases arise, we'll need to go back to some biology basics. The DNA in the nucleus of your cells is made up of 2 copies each of chromosomes 1-22, plus 2 copies of X (if you're female) or 1 X and 1 Y (if you're male). On chromosome 20 there's a gene called the <span style="text-decoration: underline;">pr</span>io<span style="text-decoration: underline;">n</span> <span style="text-decoration: underline;">p</span>rotein gene, or <em>PRNP</em>.  Since you have two copies of chromosome 20 you have two copies of <em>PRNP</em>. You got one of those two copies of <em>PRNP</em> from your mother, and the other one from your father.

<a href="http://www.prionalliance.org/wp-content/uploads/2013/12/prnp-on-chr20p.png"><img class="alignnone size-full wp-image-496" title="prnp-on-chr20p" alt="" src="http://www.prionalliance.org/wp-content/uploads/2013/12/prnp-on-chr20p.png" width="600" height="449" /></a>

DNA contains instructions that have to be converted into RNA, and then the message in the RNA is translated into protein. So the gene <em>PRNP</em> in your DNA spells out instructions for making, ultimately, the prion protein (PrP). Everyone has PrP on the surface of their cells, and most of the time this is a perfectly good and healthy thing.

Genetic <strong>mutations</strong> - think of these as typos in DNA - change the instructions and end up producing a slightly different protein. Most of the time that's fine, but some mutations are really bad.

There are two main ways that mutations can be bad. First, they can make a protein that doesn't do its job correctly. This is called a <strong>loss-of-function</strong> mutation. The other option is that they can make a protein that <em>does</em> do something new that it shouldn't be doing.  This is called a <strong>gain-of-function</strong> mutation.  Genetic prion diseases are caused by a <strong></strong>gain-of-function mutation in <em>PRNP</em>.  They produce a slightly altered version of prion protein (PrP).  A person can be pretty much healthy and fine with this version of PrP for decades, but as people get older, this protein is likely to eventually misfold and form a prion which can then attack other PrP and spread across the brain.

Prion protein mutations follow a <strong>dominant </strong>inheritance pattern. That just means that, unfortunately, it only takes <em>one</em> bad copy of the gene to cause the disease. If you have a parent who had a genetic prion disease, they probably had one bad copy of <em>PRNP</em>, and there's a 50% chance you inherited that one, and a 50% chance that you inherited the normal, good copy of <em>PRNP</em>.

You'll also hear genetic prion diseases described as being <strong>autosomal</strong>. That just means that they're not sex-linked - <em>PRNP</em> is on chromosome 20, not on a sex chromosome. Both sexes are affected equally by genetic prion disease.

Another term you'll hear tossed around is <strong>penetrance</strong>.  Penetrance is the percentage of people with the bad copy of the gene who will get the disease.  Most of the genetic prion diseases that we know of are <strong>completely penetrant</strong> in the sense that everyone who has the mutation will get the disease eventually, if<em> </em>they live long enough. Some of the genetic prion diseases tend to strike people in their 40s and 50s, and so (as far as we know) virtually everyone who has the mutation dies of it. Other genetic prion diseases tend to have an older age of onset, so that some percentage of people will end up dying of some other cause - heart attacks, cancer, and so on - before they ever have symptoms of prion disease.

There are over 40 different mutations that can cause genetic prion disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20583301">Beck 2010</a>], and each mutation tends to have its own particular symptoms, disease course, age of onset, and so on [<a href="https://cshmonographs.org/index.php/monographs/article/view/4035">Kong 2003</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/20216075">Mastrianni 2010</a> (<a href="http://www.nature.com/gim/journal/v12/n4/full/gim201032a.html">full text</a>)]. In other words, the mutation defines the disease.

Therefore it's important to have a system for naming mutations. The system that we use involves a lot of seemingly random numbers and letters such as "E200K." Let's break down what this code means.

Proteins are made of amino acids, and PrP in particular is made of 253 amino acids, which are referred to in order. So the 200 in E200K means there's a mutation in amino acid #200.  E is <a href="http://en.wikipedia.org/wiki/Amino_acid#Table_of_standard_amino_acid_abbreviations_and_properties">shorthand</a> for the amino acid <em>glutamate</em>, which is the amino acid that should normally be at position #200. K is the shorthand for the amino acid <em>lysine</em>, which is the amino acid that appears at position #200 instead of glutamate. Putting it all together, "E200K" means <em>lysine instead of glutamate at amino acid #200</em>.

Sometimes there are even more numbers and letters. For instance, fatal familial insomnia is caused by a mutation called D178N 129M.  Here, D178N means <em>asparagine (N) instead of aspartate (D) at amino acid #178</em>, and 129M means <em>... and then methionine (M) at amino acid #129.</em> Fatal familial insomnia is unusual in that the D178N mutation <em>causes</em> the disease, but the exact <em>type</em> of disease is determined by which amino acid is found at position #129 [<a href="http://www.ncbi.nlm.nih.gov/pubmed/1439789">Goldfarb 1992</a>].

Still other cases of genetic prion disease are not caused by a change in just one amino acid. One part of PrP has a repeating stretch of the same 8 amino acids over and over again, and this is called the "octapeptide repeat". Some genetic prion diseases are caused by having too many copies of this repeat, and these are named by the number of extra copies - for instance, "6-OPRI" means <em>6 extra copies of the octapeptide repeat inserted</em>.

Genetic counselors give people with genetic mutations advice on what their mutation means. Often this might include some statement about the typical age of disease onset for a person's mutation. Estimates like these can be useful, but it is worth taking them with a bit of caution. For most genetic prion disease mutations, the age of onset can vary by a few decades. The statistics are usually based on a review of patients' cases that doctors have reported in medical journals [<a href="https://cshmonographs.org/index.php/monographs/article/view/4035">Kong 2003</a>] and there are many possible biases here. Younger patients might be more likely to be reported, people who die of something else first are almost never reported, and the statistics often fail to take into account the people still alive with the mutation. Moreover, the predicted age of disease onset for any one person really depends on how old they are today - after all, a person who is 60 today can't have an age of onset of 50, even if that is the average for their mutation. For all of these reasons, statistics like "average age of onset" should never be taken as a hard-and-fast prediction about one's own life.

Even more importantly, there are good reasons for optimism that things will change, and that the diseases that we consider fatal and untreatable today will eventually be things of the past. We at Prion Alliance are working hard for a future where prion diseases don't kill people. And we're not alone - there are lots of bright scientists working in the prion field, and potential treatments at a variety of stages in the research pipeline. We can't say exactly when treatments will become available, but lots of excellent science is being done every day, and we think right now is a good time in history to be an optimist.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>474</wp:post_id>
		<wppost_date>2013-12-09 18:58:48</wppost_date>
		<wppost_date_gmt>2013-12-09 18:58:48</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>what-does-it-mean-to-have-a-genetic-prion-disease</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="faq"><![CDATA[FAQ]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[What does it mean to have a genetic prion disease? http://wp.me/p2WBWF-7E]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Donations matched 1:1 until year&#039;s end goal</title>
		<link>http://www.prionalliance.org/2013/12/09/donations-matched-11-until-years-end-goal/</link>
		<pubDate>Mon, 09 Dec 2013 19:14:54 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=505</guid>
		<description></description>
		<contentencoded><![CDATA[Good news: a generous donor will be matching your donations 1:1 until we hit our $15,000 goal for the end of the year! As of this posting, we're already 1/3 of the way there.

[sdprogress]1[/sdprogress]

To make a tax-deductible donation via PayPal please click below.

[sdonations]2[/sdonations]

You can also donate via Amazon on <a title="Donate" href="http://www.prionalliance.org/donate/">our donations page</a> or via personal check made out to Prion Alliance and mailed to:

Prion Alliance
PO Box 391953
Cambridge, MA 02139

Thanks for your support all year and for helping us with this final push for 2013!

<em>update: just to clarify, our status bar (above) is automatic if you donate through the PayPal link above but we have to manually update it for Amazon and personal check donations as well as for the 1:1 match - so don't be alarmed if it doesn't tick up immediately as soon as you donate!</em>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>505</wp:post_id>
		<wppost_date>2013-12-09 19:14:54</wppost_date>
		<wppost_date_gmt>2013-12-09 19:14:54</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>donations-matched-11-until-years-end-goal</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Donations matched 1:1 until year's end goal]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>End of the year goal reached!</title>
		<link>http://www.prionalliance.org/2013/12/16/end-of-the-year-goal-reached/</link>
		<pubDate>Mon, 16 Dec 2013 17:30:50 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=518</guid>
		<description></description>
		<contentencoded><![CDATA[Good news: we have met our $15,000 fundraising goal for the end of the year and are surging past it.  Thanks so much to all of you for your generosity!

[sdprogress]1[/sdprogress]

This means we'll have used all of the 1:1 match that we had available, which is fantastic. Of course, we're still eagerly accepting donations!  To make a tax-deductible donation via PayPal please click below.

[sdonations]2[/sdonations]

You can also donate via Amazon on <a title="Donate" href="http://www.prionalliance.org/donate/">our donations page</a> or via personal check made out to Prion Alliance and mailed to:

Prion Alliance
PO Box 391953
Cambridge, MA 02139

Thanks for your support all year and for helping us with this final push for 2013!
<div></div>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>518</wp:post_id>
		<wppost_date>2013-12-16 17:30:50</wppost_date>
		<wppost_date_gmt>2013-12-16 17:30:50</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>end-of-the-year-goal-reached</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[End of the year goal reached!]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Happy 2014</title>
		<link>http://www.prionalliance.org/2014/01/01/happy-2014/</link>
		<pubDate>Wed, 01 Jan 2014 22:47:50 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=528</guid>
		<description></description>
		<contentencoded><![CDATA[A huge thanks to everyone who helped us reach and surpass our fundraising goal for the end of 2013. Thanks to your generosity we passed our original goal of $15,000 and raised a total of $19,765.25.

<img class="alignnone size-full wp-image-529" title="" src="http://www.prionalliance.org/wp-content/uploads/2014/01/19765.png" alt="" width="321" height="56" />

Here's to a new year full of science and progress!

Cheers,

Sonia &amp; Eric]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>528</wp:post_id>
		<wppost_date>2014-01-01 22:47:50</wppost_date>
		<wppost_date_gmt>2014-01-01 22:47:50</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>happy-2014</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Happy 2014]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>What are the potential treatments for prion disease?</title>
		<link>http://www.prionalliance.org/2014/02/04/what-are-the-potential-treatments-for-prion-disease/</link>
		<pubDate>Tue, 04 Feb 2014 00:54:32 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=511</guid>
		<description></description>
		<contentencoded><![CDATA[<em>This post is part of a series introducing the basics of prion disease. Read the full series <a href="http://www.prionalliance.org/faq/">here</a>.</em>

If you've read the other entries in our <a href="http://www.prionalliance.org/faq">FAQ</a> you know that the <a title="What are human prion diseases?" href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/">human prion diseases</a> - Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI), and Gerstmann-Straussler-Scheinker syndrome (GSS) - are all caused by <a title="What are prions?" href="http://www.prionalliance.org/2013/11/26/what-are-prions/">prions</a> made of the same protein, called <strong><span style="text-decoration: underline;">pr</span>ion <span style="text-decoration: underline;">p</span>rotein</strong> or PrP.  Prion diseases can come in <a title="What does it mean to have a genetic prion disease?" href="http://www.prionalliance.org/2013/12/09/what-does-it-mean-to-have-a-genetic-prion-disease/">genetic</a>, sporadic or acquired forms.  The bad news is that as of today, prion diseases are completely incurable and untreatable. The good news is that <a href="http://www.prionalliance.org/our-story">we</a> and many other groups worldwide are actively working to find a treatment or cure for these diseases.

Prion diseases are different from most other types of diseases.  Prions can act like an infection as they travel from cell to cell in a person's body, yet unlike viruses or bacteria, they have no DNA or RNA - they're just made of protein.  There has never before been a treatment for a disease like this, so right now it isn't yet clear which strategy will ultimately lead to a treatment or cure.  Scientists are investigating a lot of different possible ways of treating these diseases.

<strong>small molecules</strong>

<a href="http://www.prionalliance.org/wp-content/uploads/2013/12/ibuprofen-3d-skeleton.png"><img class="alignnone size-full wp-image-512" title="" alt="" src="http://www.prionalliance.org/wp-content/uploads/2013/12/ibuprofen-3d-skeleton.png" width="300" height="204" /></a>

Odds are that most drugs you've ever taken, for anything from a headache to a bacterial infection to contraception, have been what we call <strong>small molecules</strong>.  For instance, ibuprofen, the painkiller whose molecular structure is shown above, is a small molecule. This just means it is made of relatively few atoms - 33 atoms in the case of ibuprofen.

The "small" in small molecule is important because it means that these drugs are often (though not always) pretty easy to administer. Think about painkillers for a moment - when you swallow a pill, that molecule is able to get from your stomach to just about every part of your body, which is why it can work whether you've hurt your foot or your neck.  This is a major advantage of small molecules that isn't necessarily true of the other therapeutic approaches we'll talk about in a minute.

Several research groups worldwide are working on finding small molecule drugs that can treat prion disease. For instance, efforts are actively ongoing at <a href="http://ind.ucsf.edu/">the Institute for Neurodegenerative Diseases</a> at UC San Francisco, the <a href="http://www.prion.ucl.ac.uk/research/university-departments/small-molecule-therapeutics/">MRC Prion Unit</a> in London, the <a href="https://www.en.uni-muenchen.de/about_lmu/research/research_centers/neuropathology1/index.html">prion center at LMU</a> in Munich, and the <a href="http://www.scripps.edu/philanthropy/priondiseases.html">prion group at Scripps</a> in Florida.

While none of these groups have found anything that's ready for a clinical trial in humans just yet, they've made several promising steps forward.  In fact, scientists have already discovered a few small molecules which work really well against mouse prion strains - cpd-b, IND24, and anle138b [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17881452/">Kawasaki 2007</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/23604588">Wagner 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24128760">Berry 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/23965382">Lu &amp; Giles 2013</a>].  The first two of those turned out not to work against common human prion strains; we are currently testing anle138b.  Meanwhile, new drug discovery efforts are continuing.  The biggest remaining challenge will be to find a molecule that will work against multiple human prion strains.

It's worth mentioning that over time, several different <em>existing </em>drugs have also been proposed as possible treatments for prion disease - for instance, quinacrine and doxycycline. We don't think the experimental evidence is very strong for any existing drug being an effective treatment for prion disease. We'll review a few of the most often-discussed candidates in an upcoming FAQ, but for now, suffice it to say we expect that finding a treatment will require discovering a brand new drug and bringing it to market specifically to treat prion diseases.

<strong>antibodies</strong>

Antibodies are proteins produced by the immune system which can bind to a particular "enemy" target - usually another protein.  Your body can produce antibodies naturally in response to viral infections, bacterial infections, cancer, and so on - they're a central part how you fight off infections.  And once your body has found an antibody against something bad, it remembers how to make it for future reference - that's why people usually don't get chicken pox twice.

Modern science is also capable of manufacturing antibodies outside the body to be used as treatments for diseases.  If you've taken a drug other than a small molecule, odds are good that it was an antibody - some of the most common ones are <a href="http://en.wikipedia.org/wiki/Adalimumab">Humira</a> and <a href="http://en.wikipedia.org/wiki/Trastuzumab">Herceptin</a>.  Antibodies have to be injected, not taken orally, and they're often for more serious conditions like autoimmune diseases or cancer - and not just for headaches.

Antibodies against PrP could be one potential treatment for prion diseases. Potential treatments for any disease usually start in a test tube, then move on to a mouse, and then finally move on to humans.  Antibodies are no exception.  When prion-infected cells in a dish were treated with antibodies against PrP, the infection was completely cleared [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11470893">Enari 2001</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/11507642">Peretz 2001</a>].  Shortly thereafter, antibodies were shown to be effective in treating prion-infected mice under certain conditions [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12621436">White 2003</a>].  As of earlier this year, the MRC Prion Unit in London has started <a href="http://www.cureffi.org/2013/07/31/mrc-prion-unit-discusses-possible-clinical-trial-of-prn100-antibody/">discussing</a> the possibility of launching a clinical trial of an anti-PrP antibody named PRN100 to treat sporadic Creutzfeldt-Jakob disease.  As of this writing, no trial has officially been announced and the MRC Prion Unit has not provided any estimates of when a trial might begin.

The major challenge for such a clinical trial will be that antibodies are huge - around a thousand times larger than most small molecule drugs.  One difficulty in developing drugs for prion diseases - or any other brain disease - is that in order to be effective, any treatment will need to get past the <a href="http://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrier"><strong>blood-brain barrier</strong></a>.  The cells surrounding blood vessels in the brain are so tightly packed that even many small molecule drugs can't get from the blood into the brain - only a special subset can do so. Antibodies are so large that only a vanishingly small amount of them can cross the blood brain barrier.

In the original mouse study that showed how antibodies could be effective, some groups of mice were infected with prions <strong>peripherally</strong>, meaning outside of the brain [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12621436">White 2003</a>]. When these mice were treated early on with antibodies, the antibodies were able to cure the infection before it ever reached the brain, and the mice never got sick. That's an amazing result, and to this day, antibodies are the only treatment shown to completely cure peripheral prion infections in mice. However, when mice were infected directly in their brain or when they weren't treated until after the infection had reached the brain, the antibodies had no detectable effect: the mice died at the same time as mice that weren't treated with any antibodies.

As far as we know, sporadic and genetic prion diseases in humans <em>start</em> in the brain, so there's no opportunity to treat them in the periphery.  From <a href="http://www.cureffi.org/2013/07/31/mrc-prion-unit-discusses-possible-clinical-trial-of-prn100-antibody/">what we know right now</a>, a clinical trial, if one happens, would most likely involve intravenous injections of antibodies in patients who are already experiencing symptoms.  This approach hasn't worked in mice [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12621436">White 2003</a>], presumably because not much of the antibody got into the brain.  The folks at MRC Prion Unit have pointed to evidence that the blood-brain barrier may be broken down in prion disease patients [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7583685">Chung 1995</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/9458163">Brandner 1998</a>], which would help the antibodies to get across, and as noted <a href="http://www.cureffi.org/2013/07/31/mrc-prion-unit-discusses-possible-clinical-trial-of-prn100-antibody/">here</a> they've also raised the possibility of eventually administering antibodies directly into the brain instead of into the bloodstream. In animal studies, direct injections of antibodies into the brain have been shown to have some small effect (survival was extended by ~8%) though the animals were not cured [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18474571">Song 2008</a> (<a href="http://vir.sgmjournals.org/content/89/6/1533.long">ft</a>)].

Overall, evidence in the scientific literature suggests that antibodies will probably <em>not</em> be a cure or really dramatically extend life in prion disease patients who are already experiencing symptoms, but they may prove to have some helpful effect.  Moreover, the improved delivery of antibodies to the brain is an area of active research (see for instance the recent <a href="http://www.cureffi.org/2014/01/16/whats-this-roche-brain-shuttle-all-about/">Brain Shuttle</a> announcement). So even if antibodies don't work on the first try, they may be a really valuable treatment once a better delivery system comes along.

<strong>gene silencing</strong>

<a href="http://www.prionalliance.org/wp-content/uploads/2013/09/silence.png"><img class="alignnone size-full wp-image-437" alt="silence" src="http://www.prionalliance.org/wp-content/uploads/2013/09/silence.png" width="100" height="121" /></a>

Gene silencing is the use of RNA or DNA to "turn off" a gene as a treatment for a disease.  This idea is much more experimental - many more years away from clinical trials - than small molecule drugs or antibodies - but in the long run, it might prove very promising.

One thing we know for sure about prions is that you can't have a prion disease without PrP [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8100741">Bueler 1993</a>]. When mice have been infected with prions and then later the prion protein gene was turned off, the mice fully recovered from the disease [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14593181">Mallucci 2003</a>].  So if we could figure out a way to turn off the prion protein gene, PRNP, in humans, and make it stop producing PrP, then we might be able to cure prion diseases altogether, even after patients have gotten sick.

But that's a big if. When researchers shut off the prion protein gene in mice, they used a special genetic manipulation that isn't possible in humans. Now, some researchers are looking for small molecule drugs that can make the body produce less PrP [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637718/">Karapetyan &amp; Sferrazza 2013</a>, <a href="http://www.sciencedirect.com/science/article/pii/S0968089614000066">Silber 2014</a>], but no really strong candidates have emerged just yet. So another possibility is to use gene silencing to shut off the supply of PrP. There are two major technologies for gene silencing that you'll hear talked about - <strong>RNA interference (RNAi)</strong> and <strong>antisense oligonucleotides (ASOs)</strong> - but the core principles of the two are similar.<strong>  </strong>Remember that the prion protein gene in your DNA has a message that gets converted into RNA, and then the message in the RNA gets translated into protein. Gene silencing means using tiny pieces of RNA, DNA, or chemically modified versions of those, that stick to the prion protein RNA and can either keep that RNA from being translated into protein, or can cause the cell to destroy the RNA altogether.

In principle, gene silencing is a brilliant idea, but it has some serious problems we haven't worked out yet. First and foremost, it has the same problem as antibodies: the pieces of RNA or DNA used are much, much larger than small molecules.  They cannot cross the blood-brain barrier and they don't move around much within the brain either. When scientists have injected them into the brains of prion-infected mice, they've only been able to reach a small area of the brain, and they only saw a small therapeutic effect, extending survival by about 18% [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474561/">White 2008</a>].  When you consider how much larger a human brain is than a mouse brain, odds are we couldn't see much of an effect at all with today's technology.

But the good news is, loads of scientists worldwide are working on figuring out how to deliver gene therapy to the brain and other parts of the body. Most of them are working on other diseases and not on prion disease in particular, but whatever techniques they come up with will probably be applicable to prion disease too. As of today, gene therapy for prion disease is still a little bit science fiction, but there's a chance that it could be a really effective therapy in 10 or 20 years. We think gene therapy is well worth investing our research energy in for the potential long-term benefit - but don't expect to be talking to your doctor about it anytime in the next few years.

<strong>a quick note about other technologies</strong>

Above we've introduced the three types of treatments we think could potentially be promising for prion disease: small molecules, antibodies, and gene silencing.  In the interest of thoroughness, we should also briefly address a couple of other treatment strategies.

One sometimes hear talk of <strong>vaccines</strong> for prion disease.  Because prion diseases can in rare cases be acquired as infections, it is tempting to make analogies to viruses, and to the huge advances in public health that have been made through vaccination campaigns against viruses like smallpox and polio.  But there are many reasons to think this strategy won't work for prion disease.  PrP isn't a foreign pathogen, it's a protein your own body produces, so causing the body to mount an immune response against PrP is both difficult to do and potentially dangerous. There are researchers working on strategies to address those problems, but there's also a much bigger issue which no research has yet addressed.  <a href="http://www.cureffi.org/2013/12/16/does-spontaneous-prion-disease-begin-in-the-brain/">As far as we know</a>, most prion disease <em>starts</em> in the brain, and the immune system doesn't normally attack proteins in the brain. Adding to that, patients almost never know they have prion disease until after they already have symptoms, but vaccinations are by nature a pre-emptive treatment - they need to be given before an infection starts. Anti-prion vaccine research has not addressed these fundamental limitations of vaccine technology. For this reasons we do not expect that vaccines will be a part of the treatment strategy for prion diseases.

Another proposed strategy is <strong>stem cell therapy</strong> for prion disease.  This has been proposed in various forms: it could involve trying to generate new brain cells to replace ones that patients have lost, or it could involve adding extra, genetically modified cells to a patient's brain to produce special proteins or other therapeutic agents that will slow down prion infection.  Our view is that any sort of stem cell therapy is probably quite a long way from being useful to prion disease patients. That's not to say it couldn't happen someday - it is an active area of research <a href="https://www.michaeljfox.org/understanding-parkinsons/living-with-pd/topic.php?stem-cells">for Parkinson's disease</a>, for instance, and we'll see what new technologies are developed.

If you made it this far, your next question may be: when will these new treatments become available?  Read <a title="When will treatments be available for prion disease?" href="http://www.prionalliance.org/2014/03/03/when-will-treatments-be-available-for-prion-disease/">our next post</a> to learn more.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>511</wp:post_id>
		<wppost_date>2014-02-04 00:54:32</wppost_date>
		<wppost_date_gmt>2014-02-04 00:54:32</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>what-are-the-potential-treatments-for-prion-disease</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[What are the potential treatments for prion disease? http://wp.me/p2WBWF-8f]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImage</wp:meta_key>
			<wp:meta_value><![CDATA[http://www.prionalliance.org/wp-content/uploads/2013/12/ibuprofen-3d-skeleton.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>17428</wp:comment_id>
			<wp:comment_author><![CDATA[Salome]]></wp:comment_author>
			<wp:comment_author_email>salomemartin@live.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>173.34.250.64</wp:comment_author_IP>
			<wp:comment_date>2014-11-14 18:07:38</wp:comment_date>
			<wp:comment_date_gmt>2014-11-14 18:07:38</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[This post is so informative and helpful! I am a student doing research on prions and this post really helped me understand the background and gave me so much insight to possible treatments. Your explanations were also amazing and easy to follow!
Thank you!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1415988458.049619;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17435</wp:comment_id>
			<wp:comment_author><![CDATA[tavia adamson]]></wp:comment_author>
			<wp:comment_author_email>tadamson@mandelaschoolnyc.org</wp:comment_author_email>
			<wp:comment_author_url>http://www.prionalliance.org</wp:comment_author_url>
			<wp:comment_author_IP>107.188.16.4</wp:comment_author_IP>
			<wp:comment_date>2014-12-03 23:26:18</wp:comment_date>
			<wp:comment_date_gmt>2014-12-03 23:26:18</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I am doing a research about prions and this information help me to do my assignment]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1417649178.769186;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17438</wp:comment_id>
			<wp:comment_author><![CDATA[Haley davis]]></wp:comment_author>
			<wp:comment_author_email>tanyathompson@hotmail.co.uk</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>213.205.241.203</wp:comment_author_IP>
			<wp:comment_date>2015-01-03 02:00:32</wp:comment_date>
			<wp:comment_date_gmt>2015-01-03 02:00:32</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[Need a cure my niece has pryons she is 27please help to do anything there must be a way of staving this bad thing off]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>17428</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1420250432.684418;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Donating skin to create personalized stem cells</title>
		<link>http://www.prionalliance.org/2014/01/18/donating-skin-to-create-personalized-stem-cells/</link>
		<pubDate>Sat, 18 Jan 2014 19:50:05 +0000</pubDate>
		<dccreator><![CDATA[sonia]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=537</guid>
		<description></description>
		<contentencoded><![CDATA[In this post, I’ll review my recent experience donating skin cells in order to have my very own line of induced pluripotent stem cells (iPSC) created for research.  First, I’ll provide a bit of background on what iPSC are, and why they’re useful.

<strong>From the researcher perspective</strong>

Induced pluripotent stem cells, or iPSC, are adult human cells that have been genetically transformed from a specific adult cell type (for example, skin cells) to a “pluripotent” stem cell state.  “Pluripotent” means the cells can become anything, much like cells in an embryo haven’t yet decided whether to become skin, or brain, or heart, or any other type of cell.  When scientists “reprogram” skin cells, the cells travel backwards in developmental time to a moment at which their cell fate is yet to be determined. And from there, according to a rapidly growing set of protocols, they can be “differentiated” into a particular cell type of interest.  This makes it possible to study human neurons in a way that has never been possible before.

[caption id="attachment_539" align="aligncenter" width="300"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/01/08155142.jpg"><img class="size-medium wp-image-539 " src="http://www.prionalliance.org/wp-content/uploads/2014/01/08155142-300x225.jpg" alt="" width="300" height="225" /></a> <em>Above, human induced pluripotent stem cells have been differentiated into NPCs, or neural progenitor cells -- an intermediate stage on the way to a neuronal fate.<br /></em>[/caption]

[caption id="attachment_541" align="aligncenter" width="300"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/01/03150509.jpg"><img class="wp-image-541 " src="http://www.prionalliance.org/wp-content/uploads/2014/01/03150509-300x225.jpg" alt="" width="300" height="225" /></a> <em>From NPCs, these cells have been differentiated into human neurons in a dish.</em>[/caption]

[caption id="attachment_544" align="aligncenter" width="300"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/01/AggFT-28n6-p45-2.jpg"><img class="size-medium wp-image-544 " src="http://www.prionalliance.org/wp-content/uploads/2014/01/AggFT-28n6-p45-2-300x225.jpg" alt="" width="300" height="225" /></a> <em>Sometimes, neurons-in-a-dish look like this! Crazy.</em>[/caption]

iPSC have, in the past several years, generated a huge amount of excitement as tools in human disease research.  The breakthrough iPSC paper that first demonstrated “reprogramming” of adult human cells to stem cells was <a href="http://www.ncbi.nlm.nih.gov/pubmed/16904174">published in 2006</a>, and for this work author Shinya Yamanaka shared the <a href="http://www.nobelprize.org/nobel_prizes/medicine/laureates/2012/">Nobel Prize for Physiology or Medicine in 2012</a>.   Yamanaka and colleagues started from  twenty-four genes thought to be important for pluripotency, and whittled them down to a core team of four essential genes that can be “added” to an adult cell in order to turn it back into a stem cell.

Today, these “Yamanaka factors” have been used to create hundreds of iPSC lines.  iPSC can now be created from a variety adult cell types, and according to a variety of protocols.  For more detail on the original Yamanaka paper and the work that has followed it, see <a href="http://www.cureffi.org/2013/01/21/advances-in-cell-reprogramming/" target="_blank">this blog post</a> on <a href="http://cureffi.org/" target="_blank">CureFFI.org</a>.

So why the excitement – how are iPSC useful, and how might they be even more useful in the future?  Three broad potential uses are generally cited for iPSC.  First, they can serve as a human disease model, allowing for in vitro observation of disease processes that are difficult to observe in real time when they’re happening inside the human body.  This provides a particular advantage for hard-to-access tissues like the brain.  Second, they may be able to serve as a screening platform for drugs.  If we can identify signatures of disease in iPS cells that have a certain disease-associated genetic mutation, then compounds can be screened in a high-throughput manner for their ability to “correct” this signature.  Thirdly, and most futuristically speaking, perhaps iPSC could someday serve as therapeutics, for example for own-tissue transplants.

These visions are at varying stages of realization.  In research, iPSC are being actively explored as models for dozens of diseases.  They are expensive and labor-intensive to maintain, but scores of labs have invested in iPSC-specific facilities.  The quest to identify disease signatures in cells is complex but ongoing.  Differentiation protocols have proven tricky to standardize, but many smart people are putting their minds to this problem.  In recognition of the potential of this technology, researchers in numerous different disease fields, including the prion field, are moving to create banks of iPS cell lines from patients.

I’m pretty familiar with the day-to-day of iPSC because for the past year, I’ve been responsible for a number of iPSC lines that my lab at the Center for Human Genetic Research at Mass General Hospital is using to study Huntington’s Disease.  HD is caused by a repeat expansion mutation, and the severity and onset of disease track with the size of the expansion.  Our lab looks at lines with various repeat lengths in parallel, in order to assess traits of the cells that are repeat-length dependent.

When I say the cells are a lot of work, I speak from the experience of trying to catch a cab home from the lab at 2am on a Saturday night (not easy, at bar time in Boston!) because the cells needed attention.  In general, they can’t go longer than a day without being looked at under a microscope by someone who understands their morphology.  Pluripotency isn’t “supposed” to last forever, and if any of their growth conditions are off, the cells are only too happy to randomly differentiate into a mess of different cell types, at which point they’re no longer useful for research.  My iPS cells have taught me a lot and are an amazing tool, but there is no relief like the relief I felt in December when I froze them all down for the holidays!

&nbsp;

[caption id="attachment_545" align="aligncenter" width="300"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/01/IMG_20140117_151959.jpg"><img class="size-medium wp-image-545" src="http://www.prionalliance.org/wp-content/uploads/2014/01/IMG_20140117_151959-300x225.jpg" alt="" width="300" height="225" /></a> <em>This is how I spend a lot of my time. The iPS room is a harsh mistress.</em>[/caption]

[caption id="attachment_549" align="aligncenter" width="300"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-28_18-08-49_440.jpg"><img class="size-medium wp-image-549" src="http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-28_18-08-49_440-300x169.jpg" alt="" width="300" height="169" /></a> <em>It was that sort of day.</em>[/caption]

<strong>From the patient perspective</strong>

Eric and I have been interested in having iPSC made from my cells for more than a year, and finally learned of an opportunity to do so through <a href="http://www.case.edu/med/pathology/faculty/zou.html">Dr. Wenquan Zou</a> at Case Western Reserve University.  In collaboration with other researchers, Dr. Zou is <a href="http://www.cjdfoundation.org/webfm_send/106">aiming</a> to create a repository of iPSC lines that have different prion disease mutations, in addition to several control lines.  Since I have the mutation that causes fatal familial insomnia, I was eligible to participate.

After speaking with Dr. Zou, I signed a consent form for study participation.  This form gave a bit of background on iPSC, and explained what would be required of me for the skin punch procedure and follow-up.  It gave an overview of the risks (discomfort from administration of the anesthetic, pain or itching after the anesthetic wears off, possible allergic reactions, emotional discomfort) and benefits (indirect – the advancement of science) of participation.  It conveyed to me that I was free to choose not to participate, and could choose to revoke consent at any time up to the creation of iPSC.  It also made clear that once the iPSC were created, I would not be able to control their fate – not which institutions were able to work with them, and not the nature of that work (some of which likely can’t even be predicted today.)  In addition, I agreed to forfeit commercial interest in the cells.  These risks all seemed tolerably mild and/or remote compared to the potential scientific benefit of creating the cell line, and the terms of the contract all seemed reasonable to me.

Once I was enrolled, we set about trying to find a dermatologist in Boston who would be able to do a skin biopsy, and then ship my tissue sample to Dr. Zou’s lab in Cleveland.  The search for a doctor wasn’t simple -- at least in the Boston area, quoted prices for this procedure varied almost fivefold.  We were rewarded for canvassing the options when we ultimately did locate a dermatologist at a local university hospital able to meet the study budget of $175.  My skin punch was scheduled for early in the week – a Tuesday morning – to ensure that the sample, after being shipped overnight, would be received on a weekday.

An interesting aspect of the scheduling process is that the local dermatologist, who I’ll refer to as Dr. W., at first expressed willingness to take a skin biopsy for a research study, but dithered when he realized that the focus of the research study was prion diseases.  There is a lot of slippage in the way the terms “infectious” and “transmissible” are applied to prion diseases in medical dialogue, and the word “prion” is uniquely able to raise a sort of nebulous alarm in medical professionals.  It’s important for PRNP mutation carriers to be aware of these misperceptions, and able to correct them.

In the cases of specific procedures, such as brain surgery, that bring implements into contact with the central nervous system of a patient, it is certainly important for doctors to be aware of best practices.  See, for example, the <a href="http://www.dhhs.state.nh.us/media/pr/2013/09-sept/09042013cjd.htm">recent incident</a> in New Hampshire.  But for most peripheral tissues (i.e. outside of the brain and spinal cord), no infectivity can be detected at all - even in patients with full-blown symptomatic prion disease [<a href="http://www.who.int/csr/resources/publications/bse/whocdscsraph2003.pdf">WHO 1999</a>].  Meanwhile, patients with a genetic mutation are healthy for decades before disease strikes, and there’s no reason to think these patients are infectious at all while they are still healthy [<a href="http://www.who.int/csr/resources/publications/bse/whocdscsraph2003.pdf">WHO 1999</a>].  All told, there is no evidence at all that peripheral tissue of an asymptomatic prion protein mutation carrier poses any threat or requires special precautions.  The appointment was scheduled once this distinction was clarified.

Upon arrival at the office, I was told that my appointment would last a half hour.  I met Dr. W., and we briefly discussed the procedure.  He showed me the box of supplies that had been sent to him from the Case Western lab a few days prior.  It contained a 15mL plastic Falcon tube with several mL of media into which he would immerse my tissue sample for transport, and cold packs that would keep the sample cool and upright in the box during shipping.

I mentioned to Dr. W. at this point that my skin is prone to scarring, and he recommended that we proceed with a 3mm-diameter biopsy. 4mm is typical, but he called Dr. Zou at Case Western to confirm that 3mm would be sufficient.

Skin biopsies for the creation of iPSC can be taken from various areas of the body; I’ve heard of samples being taken from the elbow, forearm, abdomen, thigh and flank.  To minimize discomfort, bleeding and visibility, Dr. W. gave me his recommendation that we choose a spot on my lower hip that wouldn’t be visible even in a swimsuit.  I donned a very stylish paper gown, and together we chose a discreet spot on my lower right hip, and he marked it with a pen.

I lay on my side on the patient table, and Dr. W. sterilized the site with alcohol and prepared a shot of the local anesthetic lidocaine.  This is the numbing agent typically used in minor surgeries or dental procedures.  The formulation contains epinephrine, which constricts arteries with the effect of reducing bleeding.  Epinephrine also delays the resorption of lidocaine, which functions to prolong the anesthetic effect.

Now we come to the only part of the procedure that hurt at all.  Dr. W. talked me through the injection of lidocaine into our chosen site, and I experienced the sting of the needle followed by several seconds of an acute burning sensation.  With the forewarning it was not bad – perhaps on par with a bee sting.  Within several seconds, it was over, and I could feel a curious lack of sensation setting in.

At this point Dr. W. left the room for about fifteen minutes to wait for the epinephrine to take effect.  I stayed on my side on the table.  When he returned, he probed my skin at the intended site and asked if I could feel anything.  The truthful answer is that I couldn’t; there was a faint sensation of pressure, but I had no idea what he was poking me with, or even specifically where.

What I know about what follows, I know from what Dr. W. narrated and what I have read about skin biopsy protocols.  Lying on my side, looking straight ahead, I had no awareness at all of the insertion of the skin punch, which “cores” the small designated amount of tissue.  I understand that he then stabilized the selected tissue with a forceps, and used a scalpel to cleanly remove it.  Finally, he sewed the wound together with one stitch, made with absorbable fiber so that I wouldn’t have to return to the office to have it removed.  Even this one stitch, he informed me, is not really necessary for a 3mm biopsy, which will typically easily heal on its own.  Throughout the whole process, I looked at the counter in front of me and felt nothing at all.

Dr. W. placed gauze and a Band-Aid over the site.  Because I was curious, he showed me the small chunk of tissue now floating in the 15mL tube.  The skin punch had gone deep enough to reach a fatty layer of subcutaneous tissue – I was newly amazed that I had felt nothing. Then the tube was packaged away for shipment.

I was told to avoid exertion, such as heavy lifting, for the rest of the day that might stretch the biopsy site and tear the stitch.  I was also given instructions for care of the site for the next two weeks: leave the bandage on for one day, and after that wash gently with soap and water twice a day, dry completely, apply Vaseline with a Q-tip to promote healing, and cover with a new bandage.

Leaving the office, I still felt a curious numb sensation in my hip, but otherwise felt completely normal.  I then proceeded with my normal daily activities: walking around the lab all day, carrying groceries home, climbing steps.  Also, kind of comically, I ended up moving some heavy boxes full of glassware and fruit flies for a friend who was setting up a new lab space, and needed a hand.  Turns out, I’m bad at saying no.  Happily, there were no adverse consequences to any of this.  Though the numbness wore off within an hour, I never felt any pain associated with the biopsy site.  I did get nervous when it came time, the next day, to change the Band Aid – without the input of a pain response, I felt like I had no idea what kind of carnage might be lurking underneath.  To my relief, the wound was astonishingly small – a red dot about the size of a mustard seed – and I had barely bled.  For the next two weeks, I was diligent about cleaning the site as instructed, and the wound began to heal.  Within four weeks, it was a small, flat, slightly darkened circle of skin, not easy to distinguish from my many lovely moles and skin imperfections.  I’m told that within a year, I probably won’t be able to discern the site, even if I look for it.

Dr. Zou has followed up with a few photos of my cells in culture – so far, as far as I know, they haven’t been transformed to iPS cells.  But I’m excited to follow their progress and to follow the work that is done on these cells in the future.  Especially since I work with iPSC in my day job, it’s neat to think of being part of a cutting-edge technology from a patient perspective as well.  I love the thought that even when I’m not actively working on prion disease, my cells are out there contributing to work getting done.  Readers of <a title="http://www.prionalliance.org/2013/09/04/yes-i-really-want-to-know/" href="http://www.prionalliance.org/2013/09/04/yes-i-really-want-to-know/">this previous post</a> will already know me as a fanatical believer in research participation, and in seizing one's opportunities to contribute -- I would have donated cells to make iPSC even if I expected the procedure to be long, painful, or expensive.  Instead, it was so easy that if something were to happen to the cells I’ve already donated, I’d give cells again without batting an eye.

To anyone considering donating skin cells for the creation of iPSC or any other research purpose, please feel free to <a href="http://www.prionalliance.org/contact/">contact me</a>  if you have any other questions.  I’m happy to talk about the pros and cons of this experience and research participation generally.  I genuinely think this was an incredible opportunity that I was lucky to have, and I’m excited to see what insights come of these resources in the years to come.

[caption id="attachment_548" align="aligncenter" width="169"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-26_18-08-13_158.jpg"><img class="size-medium wp-image-548" src="http://www.prionalliance.org/wp-content/uploads/2014/01/2013-03-26_18-08-13_158-169x300.jpg" alt="" width="169" height="300" /></a> <em>At the end of the day, tissue culture can be beautiful...</em>[/caption]]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>537</wp:post_id>
		<wppost_date>2014-01-18 19:50:05</wppost_date>
		<wppost_date_gmt>2014-01-18 19:50:05</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>donating-skin-to-create-personalized-stem-cells</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[2]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Donating skin cells to create iPSC http://wp.me/p2WBWF-8F]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>When will treatments be available for prion disease?</title>
		<link>http://www.prionalliance.org/2014/03/03/when-will-treatments-be-available-for-prion-disease/</link>
		<pubDate>Mon, 03 Mar 2014 15:14:28 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=611</guid>
		<description></description>
		<contentencoded><![CDATA[<em>This post is part of a series introducing the basics of prion disease. Read the full series <a href="http://www.prionalliance.org/faq/">here</a>.</em>

Running a research foundation devoted to finding a treatment for prion disease, the question we get most often is: are any experimental treatments available today?  Unfortunately, right now the answer is that there's nothing available for Creutzfeldt-Jakob disease or other human prion diseases.  If you read <a title="What are the potential treatments for prion disease?" href="http://www.prionalliance.org/2014/02/04/what-are-the-potential-treatments-for-prion-disease/">our last post</a> on what types of treatments could one day be available, you know that there are some good ideas in the pipeline - but they will take a while to be ready for patients.  To understand why, it's helpful to take a look at how new drugs are developed.

<strong>1. Finding a candidate</strong>

While there are <a title="What are the potential treatments for prion disease?" href="http://www.prionalliance.org/2014/02/04/what-are-the-potential-treatments-for-prion-disease/">a few different types</a> of treatments under investigation, pretty much any treatment option is going to start out in a test tube.  Small molecule drugs often come out of high-throughput screens, in which tens of thousands of chemical compounds are tested on small wells full of cells or purified proteins.  Antibodies were conceived as a potential treatment after it was shown they could cure prion infections in cells in a dish.  Gene silencing molecules have to be tested in cells to figure out which ones are effective enough to bother testing in animals, let alone humans.

[caption id="attachment_324" align="alignnone" width="600"]<a href="http://www.prionalliance.org/wp-content/uploads/2013/05/96-well-plate-600px.jpg"><img class="size-full wp-image-324" alt="A 96-well plate. In high-throughput screening, robotics are used to test hundreds of plates like these full of different chemical compounds." src="http://www.prionalliance.org/wp-content/uploads/2013/05/96-well-plate-600px.jpg" width="600" height="410" /></a> A 96-well plate. In high-throughput screening, robotics are used to test hundreds of plates like these full of different chemical compounds.[/caption]

<strong>2. Improving the candidate</strong>

As of today, hundreds of thousands of chemical compounds have been tested in high-throughput screening as potential drugs, and one or two dozen compounds have emerged as candidates worth pursuing further.  From there, these compounds often undergo a few months to a few years of follow-up experiments to figure out how they work and make them work better, and to see whether they can get into the brain in high enough concentrations to do their job.  In scientific and industry circles this step is often abbreviated ADME, because the four main properties you worry about with potential drugs are their <span style="text-decoration: underline;">a</span>bsorption (do they get into the body?), <span style="text-decoration: underline;">d</span>istribution (do they get to the right tissues within the body?), <span style="text-decoration: underline;">m</span>etabolism (how are they broken down?), and <span style="text-decoration: underline;">e</span>xcretion (how are the breakdown products disposed of?).

<strong>3. <em>In vivo</em> testing</strong>

The compounds that perform well on the above measures will eventually be tested for efficacy in animal models, usually mice.  In some cases, people will do step 3 first to see if a compound works at all, and then go back to step 2 and try to make it even better.  But in either case, one animal experiment can take several months.  To really canvass whether the compound works in a variety of animal models, against <a title="What are human prion diseases?" href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/">different forms of prion disease</a>, at different doses and different timepoints during disease can easily take a year or two.

<strong>4. Toxicity studies and more</strong>

If a potential drug looks very promising up through step 3, it will usually go on to a very rigorous battery of toxicity tests in a laboratory certified as using Good Laboratory Practices.  In the industry, this step is often abbreviated "GLP Tox".  It takes a lot of data from animals to see whether a treatment looks safe enough to be tested in humans. To make sure people don't fudge the numbers, drugs almost always need to have been tested under "GLP" conditions before they can get to a clinical trial.

In parallel with GLP Tox, anyone developing a new drug will also need to figure out how they're going to manufacture so that it's pure enough to give to humans, and how they'll design a clinical study so as to minimize risk to the people participating.

<strong>5. First-in-human safety studies</strong>

A potential treatment that's gotten through steps 1-4 with passing grades is ready to apply for <a href="http://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/investigationalnewdrugindapplication/default.htm">Investigational New Drug</a> (IND) status under the FDA in the United States, or equivalents in many other countries.  IND status means that a drug can now be tested for safety in humans under the tightly controlled and closely monitored conditions of a Phase I Clinical Trial.  A Phase I trial only seeks to test the safety of a potential drug. If the drug is expected to be pretty safe based on the animal data, the Phase I trial will often use healthy volunteers - adventurous souls who, for a couple thousand dollars, will take a molecule no human has ever taken before, and then be watched carefully to make sure they're okay.

Sometimes, instead of healthy volunteers, safety studies will be done directly in patients with the disease of interest.  This happens sometimes with drug candidates that appear perfectly safe, but is especially important if there are concerns about toxicity based on animal studies.  In very deadly conditions like metastatic cancer or, hypothetically, prion disease, a potential drug with some serious toxicity can sometimes still make it to the IND stage if its efficacy appears to outweigh its toxicity.  For such drug candidates, testing in patients is essential, as it wouldn't be ethical to give the drug to healthy volunteers.

<strong>6. Efficacy trials in humans</strong>

If a drug appears safe in Phase I, it can be given to patients for long enough to see if it helps them, in Phase II and Phase III Clinical Trials. "Helps them" can mean a lot of different things depending upon the clinical trial.  Before starting the trial, the scientists and/or drug company running the trial need to declare what the "endpoints" of the trial will be - what things they'll measure to see if the trial was a success.  For instance, in two recently-reported clinical trials for prion disease, of quinacrine [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24122181">Geschwind 2013</a>] and doxycycline [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24411709">Haik &amp; Marcon 2014</a>], the endpoint was simply survival: did treated patients live longer than untreated patients?  In the <a href="http://www.cureffi.org/2013/07/31/mrc-prion-unit-discusses-possible-clinical-trial-of-prn100-antibody/">proposed clinical trial of PRN100</a>, the endpoint would be a rating scale of patients' functional capacity: do treated patients retain more cognitive function than untreated patients?  Clinical trials can use plenty of other endpoints too - for example, a particular "biomarker" such as a patient's performance on a cognitive or motor test, or some measurement of their brain's appearance on an MRI scan, could be endpoints. So far, no specific biomarkers have been proposed as endpoints in prion disease.

There are a few different designs for Phase II and III Clinical Trials testing a potential drug's efficacy. The gold standard is a randomized placebo-controlled double-blind trial: half the patients get placebo and half get the real drug, and neither the patients nor the doctors treating them know which is which.  Success in such a trial means a lot, as many sources of bias can be ruled out.  A disadvantage is that not all patients get the drug - and for rare diseases, that means it's harder to find enough patients.  Some clinical trials are "open label", meaning that patients (or their families, on their behalf) can choose whether to take a drug, and the treated patients' endpoints are compared to historical data on other patients.  The risk in this type of trial is that a drug that doesn't work might appear effective just because the healthier patients are the ones who choose the drug.  For instance, both quinacrine and doxycycline appeared to be effective because patients that took them lived longer than patients that didn't [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24122181">Geschwind 2013</a>, <a href="http://www.alzheimersanddementia.com/article/S1552-5260(08)00533-5/abstract">Tagliavini 2008</a>, <a href="http://link.springer.com/article/10.1007/s15005-013-0230-3#page-1">Ponto 2013</a>], but ultimately did not appear effective in a randomized placebo-controlled double-blind trial [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24122181">Geschwind 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24411709">Haik &amp; Marcon 2014</a>].

<strong>7. Approval</strong>

If a drug can make it through all these steps and seems safe and effective, then it's time to apply to FDA - or the equivalent in other countries - for approval to sell the drug to patients.  Few drug candidates make it this far, and you often hear scary estimates of how much it costs (<a href="http://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/">ten billion dollars</a>!) and how long it takes (<a href="http://www.innovation.org/drug_discovery/objects/pdf/RD_Brochure.pdf">15 years</a>!).  We'll talk more about this in a minute.

<strong>Where are we now?</strong>

First, let's take a look at where potential drugs for prion disease are in this process.  Here's a quick diagram to show a bit of what's been happening recently:

[caption id="attachment_617" align="alignnone" width="553"]<a href="http://www.prionalliance.org/wp-content/uploads/2014/03/prion-drug-progress.png"><img class="size-full wp-image-617" alt="There are potential treatments for prion disease at many different stages of development." src="http://www.prionalliance.org/wp-content/uploads/2014/03/prion-drug-progress.png" width="553" height="432" /></a> There are potential treatments for prion disease at many different stages of development.[/caption]

At the top of the ladder, several different groups worldwide are working on <a href="http://www.cureffi.org/2013/07/30/comparison-of-high-throughput-screening-approaches-used-for-anti-prion-small-molecule-discovery/">high-throughput screening</a> to find new small molecule drugs against prion disease. Lately, <a href="http://www.cureffi.org/2013/11/18/new-high-throughput-screening-hits-from-the-prusiner-lab/">every</a> <a href="http://www.cureffi.org/2013/11/18/data-from-two-high-throughput-screens-to-deplete-prp-available-in-pubchem/">few</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/24530226">months</a> we learn about new studies in which tens or hundreds of thousands of compounds were tested.  Only a few tens of these compounds will look good enough to make it to steps 2 and 3.

Recently two notable compounds have failed in step 3: cpd-b and IND24.  These both looked really good in early animal studies with mouse prion strains, turned out not to work against <a title="What are human prion diseases?" href="http://www.prionalliance.org/2013/12/02/what-are-human-prion-diseases/">human prion strains</a> [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24128760">Berry 2013</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/23965382">Lu &amp; Giles 2013</a>].  That's disappointing, but the discovery of compounds that even work against mouse prions is still a really important proof-of-concept which demonstrates that it's feasible to use small molecule drugs to treat prion disease, and the lesson that some compounds might be strain-specific is an important one to have learned.

Other approaches are in the pipeline too - for instance, a variety of <a href="http://www.cureffi.org/2013/05/18/updates-on-gene-therapy-for-prion-diseases/">gene therapy</a> approaches are in various combinations of Step 2 and 3.  <a href="http://www.cureffi.org/2013/04/26/anle138b-the-new-most-promising-experimental-compound-for-treating-prion-diseases/">Anle138b</a> is in Steps 3 and 4 - it succeeded against one mouse prion strain and is currently being tested against other prion strains, while it also <a href="http://www.mpg.de/7955496/anle138b_alzheimer_parkinson">recently</a> got an investment to carry it through Step 4.

MRC Prion Unit's PRN100 antibody has apparently completed all of its preclinical development and the possibility of a first-in-human safety study is <a href="http://www.cureffi.org/2013/07/31/mrc-prion-unit-discusses-possible-clinical-trial-of-prn100-antibody/">being discussed</a>.

Finally, as mentioned above, two already-approved drugs, <a href="http://www.cureffi.org/2012/10/23/quinacrine/">quinacrine</a> and <a href="http://www.cureffi.org/2014/02/04/why-doxycyclines-failure-in-cjd-clinical-trials-is-no-surprise/">doxycycline</a>, were able to skip all the preliminary steps and go straight to Step 6, where they appear to have failed, though <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022233-28/IT">one clinical trial</a> of doxycycline is still ongoing.

<strong>So when will new drugs be available?</strong>

The true answer is that we don't know. It's good to be mentally prepared for drug discovery to be a many-year-long process, but on the other hand, one shouldn't take those estimates of, say, 15 years as being a minimum.  The truth is, drugs don't usually fail just because costs are high and regulations are tough - they fail because they don't work! When we find something that <em>does</em> work, which is what matters, it will be quicker.

And as you see from the above diagram, it is not as though we are standing empty-handed at the beginning of the process.  Many things have been tried and failed in prion disease, and we've learned a <em>lot</em> from all those failures.  Other things are still being tried and may yet work.

Finally, it's not necessarily the case that patients can't get a drug until it's approved. Patients who participate in clinical trials get drugs much sooner, and in some cases, once a drug has received IND status, <a href="http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/AccesstoInvestigationalDrugs/ucm176098.htm">Expanded Access</a> can let some patients receive the drug who don't qualify to enter the clinical trial.  Note that this option is not available today for any potential drugs for prion disease. We receive frequent inquiries about anle138b, and we're told that MRC Prion Unit receives frequent inquiries about PRN100, however, neither of these treatments has achieved IND status at this time.

<strong>conclusion</strong>

No one can predict the future, and we don't know better than anyone else does when exactly a new treatment for prion disease will reach people who need it.  But the two most important take-home messages are that: 1) there are many possible treatments at various stages in the pipeline, 2) we've learned from things that have been tried and failed, so we're not at the very beginning of this process.

In addition, if you've read the rest of our <a title="Frequently Asked Questions" href="http://www.prionalliance.org/faq/">FAQ</a>, you may have noticed one other big advantage that we have in looking for a treatment for prion disease: the <a title="What are prions?" href="http://www.prionalliance.org/2013/11/26/what-are-prions/">fundamental biology of prions</a> is really well understood, more so than the biology of many other diseases.  That's one of many reasons why, though there are no treatments available today, we are very optimistic about the long-term prospects for treating prion disease.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>611</wp:post_id>
		<wppost_date>2014-03-03 15:14:28</wppost_date>
		<wppost_date_gmt>2014-03-03 15:14:28</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>when-will-treatments-be-available-for-prion-disease</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="faq"><![CDATA[FAQ]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImage</wp:meta_key>
			<wp:meta_value><![CDATA[http://www.prionalliance.org/wp-content/uploads/2014/03/prion-drug-progress.png]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[When will treatments be available for prion disease? http://wp.me/p2WBWF-9R]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:comment>
			<wp:comment_id>17423</wp:comment_id>
			<wp:comment_author><![CDATA[Danell]]></wp:comment_author>
			<wp:comment_author_email>danellskunky@yahoo.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>184.166.252.215</wp:comment_author_IP>
			<wp:comment_date>2014-06-03 10:23:08</wp:comment_date>
			<wp:comment_date_gmt>2014-06-03 10:23:08</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I am so glad there is help and i would love go try the. Quincirine]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1401790988.4142671;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
		<wp:comment>
			<wp:comment_id>17426</wp:comment_id>
			<wp:comment_author><![CDATA[Wendy. Murphy]]></wp:comment_author>
			<wp:comment_author_email>wendymurphy35@yahoo.com</wp:comment_author_email>
			<wp:comment_author_url></wp:comment_author_url>
			<wp:comment_author_IP>24.183.195.219</wp:comment_author_IP>
			<wp:comment_date>2014-07-23 00:32:54</wp:comment_date>
			<wp:comment_date_gmt>2014-07-23 00:32:54</wp:comment_date_gmt>
			<wp:comment_content><![CDATA[I would try anything that would help!!!]]></wp:comment_content>
			<wp:comment_approved>1</wp:comment_approved>
			<wp:comment_type></wp:comment_type>
			<wp:comment_parent>0</wp:comment_parent>
			<wp:comment_user_id>0</wp:comment_user_id>
			<wp:commentmeta>
				<wp:meta_key>akismet_result</wp:meta_key>
				<wp:meta_value><![CDATA[false]]></wp:meta_value>
			</wp:commentmeta>
			<wp:commentmeta>
				<wp:meta_key>akismet_history</wp:meta_key>
				<wp:meta_value><![CDATA[a:4:{s:4:"time";d:1406075574.140398;s:7:"message";s:28:"Akismet cleared this comment";s:5:"event";s:9:"check-ham";s:4:"user";s:0:"";}]]></wp:meta_value>
			</wp:commentmeta>
		</wp:comment>
	</item>
	<item>
				<title>Prion2014 recap</title>
		<link>http://www.prionalliance.org/2014/06/22/prion2014-recap/</link>
		<pubDate>Sun, 22 Jun 2014 21:35:15 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=628</guid>
		<description></description>
		<contentencoded><![CDATA[Last month we attended the Prion2014 meeting in Trieste, Italy. It was the biggest Prion conference to date, with over 500 scientists in attendance. Here's a quick rundown of just a few of the conference's highlights with regards to the quest to develop a drug for prion disease.

[caption id="attachment_629" align="alignnone" width="600"]<img src="http://www.prionalliance.org/wp-content/uploads/2014/06/trieste-at-night-600px.jpg" alt="The Piazza Unit&agrave; D&#039;Italia in central Trieste." width="600" height="450" class="size-full wp-image-629" /> The Piazza Unit&agrave; D'Italia in central Trieste.[/caption]

The first few days of the conference featured a powerful lineup of basic science discoveries and clever new approaches to studying prions. There were several excellent talks on the molecular structure of infectious prions, including both new data and new models to try to fit the data. There were new mouse models, new cell culture models, and new approaches to studying PrP outside of its normal environment, in cell-free conditions or in yeast. Given our personal connection to fatal familial insomnia (FFI), we were especially excited to see Dr. Supattapone's work on forming synthetic prion-like aggregates from pure PrP with the FFI mutation, and at the poster session, we saw data from a new mouse model of FFI by Roberto Chiesa's group.

There were also several updates from groups working on therapeutic development. Dr. Prusiner presented data in his keynote address on new compounds his lab has developed, Giovanna Mallucci gave an update on her lab's work on PERK inhibitors, Benoit Schneider presented his work on PDK1 inhibition, and Adriano Aguzzi gave an update on luminescent conjugated polymers.

The final day of the conference focused on advances in the clinic, particularly in the earlier and more accurate diagnosis of prion disease. The progress in this area has been truly impressive. Michael Geschwind gave a bit of historical perspective on how diagnosis has evolved. Just 10 years ago, the 14-3-3 test was considered the primary tool for diagnosing prion disease. In the past decade, he and others have achieved much higher accuracy in diagnosis by applying imaging techniques - especially diffusion-weighted MRI - and gathering data on how the imaging signatures correlate with disease. The newest diagnostic tool is the biochemical test RT-QuIC, in which patient samples can be used to "seed" a reaction with purified normal PrP in order to very sensitively detect the presence of prions. While we've been hearing about RT-QuIC in a research setting for years now, it has finally become a reality in the clinic. Pierluigi Gambetti told us that in January 2014, the National Prion Disease Pathology Surveillance Center began running RT-QuIC on cerebrospinal fluid samples they receive from patients with suspected Creutzfeldt-Jakob disease. Inga Zerr is now using the assay at her center in Germany as well. Until now, it's been necessary to perform a spinal tap to conduct the test, but Byron Caughey and Gianluigi Zanusso presented their work demonstrating that non-invasive nasal brushings can be used to run the test as well. They - and we - are hopeful that this will lead to much earlier and more accurate diagnosis, setting the stage for more effective clinical trials. Toward that end, Simon Mead also presented his analysis of historical data on disease progression from the MRC Prion Unit, and offered a new model to improve statistical power in clinical trials.

And those are just a few of the highlights - you can read all of our notes from <a href="http://www.cureffi.org/2014/05/27/prion2014-day-1-keynotes/">Day 1</a>, <a href="http://www.cureffi.org/2014/05/28/prion2014-day-2/">Day 2</a>, <a href="http://www.cureffi.org/2014/05/29/prion2014-day-3/">Day 3</a>, <a href="http://www.cureffi.org/2014/05/30/prion2014-day-4/">Day 4</a> and the <a href="http://www.cureffi.org/2014/06/04/prion2014-posters/">poster sessions</a> on CureFFI.org.

We - Sonia and Eric - also took the stage on the final day to speak on "Proteinaceous Infectious Optimism." We introduced ourselves to the community, told our story, offered a patient perspective on recent scientific discoveries, and explained why - in spite of all the challenges in drug discovery - we are optimistic about the prospects for a treatment. The conference organizers will be posting a video of the talk online eventually, and we'll share that video here when they do.

[caption id="attachment_630" align="alignnone" width="600"]<img src="http://www.prionalliance.org/wp-content/uploads/2014/06/sonia-and-eric-presenting-at-prion2014.jpg" alt="&quot;Proteinaceous Infectious Optimism.&quot; We present our story at Prion2014. Photo by Ekaterina Kochegurova." width="600" height="450" class="size-full wp-image-630" /> "Proteinaceous Infectious Optimism." We present our story at Prion2014. <em>Photo by Ekaterina Kochegurova.</em>[/caption]

We also presented a poster on our research on human genetic variation in the prion protein gene, and were awarded the Hans Kretzschmar Poster Prize for best poster in the Prion and Prion-Like Diseases in Humans category. We thank the judges, the organizers and the research community for this huge honor.

As we've gotten deeper into our own careers as scientists, we've come to appreciate just how powerful it is to have an opportunity to gather all the great minds of the field in one room for a few days each year. Just as last year, the conference was a reminder to be grateful for how much is understood about the fundamental science of prions. We look forward to attending next year's Prion meeting in Fort Collins, Colorado.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>628</wp:post_id>
		<wppost_date>2014-06-22 21:35:15</wppost_date>
		<wppost_date_gmt>2014-06-22 21:35:15</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion2014-recap</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Prion2014 recap http://wp.me/p2WBWF-a8]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImage</wp:meta_key>
			<wp:meta_value><![CDATA[http://www.prionalliance.org/wp-content/uploads/2014/06/trieste-at-night-100px.png]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Proteinaceous Infectious Optimism at Prion2014</title>
		<link>http://www.prionalliance.org/2014/07/15/proteinaceous-infectious-optimism-at-prion2014/</link>
		<pubDate>Tue, 15 Jul 2014 21:53:35 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=637</guid>
		<description></description>
		<contentencoded><![CDATA[We've posted a video of our talk at <a href="http://www.prionalliance.org/2014/06/22/prion2014-recap/" title="Prion2014 recap">Prion2014</a> on YouTube, have a look!

<iframe width="560" height="315" src="//www.youtube.com/embed/yD5Oi-eh0Hc" frameborder="0" allowfullscreen></iframe>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>637</wp:post_id>
		<wppost_date>2014-07-15 21:53:35</wppost_date>
		<wppost_date_gmt>2014-07-15 21:53:35</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>proteinaceous-infectious-optimism-at-prion2014</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Proteinaceous Infectious Optimism at Prion2014]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>No anticipation in E200K prion disease</title>
		<link>http://www.prionalliance.org/2014/10/02/no-anticipation-in-e200k-prion-disease/</link>
		<pubDate>Thu, 02 Oct 2014 16:43:11 +0000</pubDate>
		<dccreator><![CDATA[eric]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=641</guid>
		<description></description>
		<contentencoded><![CDATA[Today marks the publication of my first paper since I set out to become a scientist and devote my life to studying prions. The paper was <a href="http://www.cell.com/ajhg/abstract/S0002-9297(14)00386-3">published</a> in <em>American Journal of Human Genetics</em> today. You can read the full text <a href="http://www.cureffi.org/media/2014/10/minikel-2014-ascertainment-bias-authoracceptedmanuscript.pdf">here</a>.

<a href="http://www.prionalliance.org/wp-content/uploads/2014/10/e200k-paper-ajhg-title.png"><img class="alignnone size-full wp-image-642" alt="e200k-paper-ajhg-title" src="http://www.prionalliance.org/wp-content/uploads/2014/10/e200k-paper-ajhg-title.png" width="750" height="196" /></a>

Any E200K family members who were at the 2012 CJD Foundation meeting in Washington, D.C. will remember <a href="http://www.cjdfoundation.org/shared/cjdfoundation/files/webfm/admin/2012-conference/Eva-Mitrova.pdf">this presentation</a> claiming that age of onset is decreasing over the generations, such that people with the E200K mutation on average die 12 years younger than their parent with the mutation did. You may also have seen <a href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060376">this publication</a> arguing the same, which was discussed in the CURE CJD Facebook group several months ago. If you're anything like us, these claims probably made you pretty worried.

The good news is, in our new paper we find that the apparent difference between parent and child age of onset is simply an artifact of the way that patients are ascertained for studies of genetic disease. In <a href="http://www.cureffi.org/2014/10/02/a-cautionary-tale-of-ascertainment-bias/">my post at CureFFI.org</a> I walk through the logic behind this in plain language and tell the backstory of how this paper came about. I'm proud to have collaborated with several of the prion field's best geneticists and neurologists - Michael Geschwind at UCSF, Simon Mead at MRC Prion Unit, Inga Zerr from German CJD Surveillance and Steve Collins from the Australian National CJD Registry are all co-authors.

I owe a huge thank you to all of the patients and family members who contributed data to these scientists over the years - your contributions were critical for making this study work.]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>641</wp:post_id>
		<wppost_date>2014-10-02 16:43:11</wppost_date>
		<wppost_date_gmt>2014-10-02 16:43:11</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>no-anticipation-in-e200k-prion-disease</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[3]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[No anticipation in E200K prion disease]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Crowdsourced genetics at ASHG2014</title>
		<link>http://www.prionalliance.org/2014/10/22/crowdsourced-genetics-at-ashg2014/</link>
		<pubDate>Wed, 22 Oct 2014 16:38:39 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=645</guid>
		<description></description>
		<contentencoded><![CDATA[Here is a video of our talk on Crowdsourced Genetics at the American Society of Human Genetics meeting in San Diego, CA on October 19, 2014.

<iframe width="420" height="315" src="//www.youtube.com/embed/d9d_8SzXfIc" frameborder="0" allowfullscreen></iframe>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>645</wp:post_id>
		<wppost_date>2014-10-22 16:38:39</wppost_date>
		<wppost_date_gmt>2014-10-22 16:38:39</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>crowdsourced-genetics-at-ashg2014</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Crowdsourced genetics at ASHG2014]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Sonia Vallabh on Nightly Business Report</title>
		<link>http://www.prionalliance.org/2014/11/19/sonia-vallabh-on-nightly-business-report/</link>
		<pubDate>Wed, 19 Nov 2014 02:50:56 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=647</guid>
		<description></description>
		<contentencoded><![CDATA[During the Partnering for Cures conference in New York this week, Prion Alliance's Sonia Vallabh was interviewed on Nightly Business Report, along with NIH Director Francis Collins and philanthropist Mike Milken.

<iframe width="560" height="315" src="//www.youtube.com/embed/Y76a5PGeKS8?start=1408" frameborder="0" allowfullscreen></iframe>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>647</wp:post_id>
		<wppost_date>2014-11-19 02:50:56</wppost_date>
		<wppost_date_gmt>2014-11-19 02:50:56</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>sonia-vallabh-on-nightly-business-report</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Sonia Vallabh on Nightly Business Report]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Prion Alliance talk at Partnering for Cures 2014</title>
		<link>http://www.prionalliance.org/2014/11/19/prion-alliance-talk-at-partnering-for-cures-2014/</link>
		<pubDate>Wed, 19 Nov 2014 20:22:54 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=650</guid>
		<description></description>
		<contentencoded><![CDATA[Here is our Time Equals Lives talk from <a href="http://www.partneringforcures.org/">Partnering for Cures</a> conference in New York on November 17, 2014. We tell the story of our journey from patients to scientists and explain why for us, striving to be the best scientists we can be is at the heart of our mission.

<iframe width="560" height="315" src="//www.youtube.com/embed/OZZbNIFKc4k" frameborder="0" allowfullscreen></iframe>]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>650</wp:post_id>
		<wppost_date>2014-11-19 20:22:54</wppost_date>
		<wppost_date_gmt>2014-11-19 20:22:54</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>prion-alliance-talk-at-partnering-for-cures-2014</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_mess</wp:meta_key>
			<wp:meta_value><![CDATA[Prion Alliance talk at Partnering for Cures 2014]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
	<item>
				<title>Eric and Sonia featured in The Atlantic</title>
		<link>http://www.prionalliance.org/2015/02/05/eric-and-sonia-featured-in-the-atlantic/</link>
		<pubDate>Thu, 05 Feb 2015 15:11:22 +0000</pubDate>
		<dccreator><![CDATA[admin]]></dccreator>
		<guid isPermaLink="false">http://www.prionalliance.org/?p=653</guid>
		<description></description>
		<contentencoded><![CDATA[Eric and Sonia are featured in <a href="http://www.theatlantic.com/health/archive/2015/02/insomnia-that-kills/384841/">an article</a> by Aimee Swartz in <i>The Atlantic</i> today. The article tells their personal story and their decision to devote their lives to science. Thanks to <a href="http://joelwattslab.org/">Joel Watts</a> for making a cameo with some kind quotes!]]></contentencoded>
		<excerpt:encoded><![CDATA[]]></excerpt:encoded>
		<wp:post_id>653</wp:post_id>
		<wppost_date>2015-02-05 15:11:22</wppost_date>
		<wppost_date_gmt>2015-02-05 15:11:22</wppost_date_gmt>
		<wp:comment_status>open</wp:comment_status>
		<wp:ping_status>closed</wp:ping_status>
		<wp:post_name>eric-and-sonia-featured-in-the-atlantic</wp:post_name>
		<wpstatus>publish</wpstatus>
		<wp:post_parent>0</wp:post_parent>
		<wp:menu_order>0</wp:menu_order>
		<wppost_type>post</wppost_type>
		<wp:post_password></wp:post_password>
		<wp:is_sticky>0</wp:is_sticky>
		<category domain="category" nicename="uncategorized"><![CDATA[Uncategorized]]></category>
		<wp:postmeta>
			<wp:meta_key>_edit_last</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_done_all</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardCancel</wp:meta_key>
			<wp:meta_value><![CDATA[no]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>twitterCardType</wp:meta_key>
			<wp:meta_value><![CDATA[summary]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>cardImgSize</wp:meta_key>
			<wp:meta_value><![CDATA[mobile-non-retina]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265063</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265071</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
		<wp:postmeta>
			<wp:meta_key>_wpas_skip_2265077</wp:meta_key>
			<wp:meta_value><![CDATA[1]]></wp:meta_value>
		</wp:postmeta>
	</item>
</channel>
</rss>
